Cover Page - USD ($) $ in Billions	12 Months Ended
Cover Page - USD ($) $ in Billions	Dec. 28, 2019	Feb. 06, 2020	Jun. 14, 2019
Document and Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 28, 2019
Document Transition Report	false
Entity File Number	1-1183
Entity Registrant Name	PepsiCo, Inc.
Entity Incorporation, State or Country Code	NC
Entity Tax Identification Number	13-1584302
Entity Address, Address Line One	700 Anderson Hill Road
Entity Address, City or Town	Purchase
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10577
City Area Code	914
Local Phone Number	253-2000
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 185.4
Entity Common Stock, Shares Outstanding		1,389,544,618
Documents Incorporated by Reference [Text Block]	Portions of the Proxy Statement relating to PepsiCo, Inc.’s 2020 Annual Meeting of Shareholders are incorporated by reference into Part III of this Form 10-K.
Amendment Flag	false
Entity Central Index Key	0000077476
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-28
Common stock, par value 1-2/3 cents per share
Document and Entity Information [Line Items]
Title of 12(b) Security	Common Stock, par value 1-2/3 cents per share
Trading Symbol	PEP
Security Exchange Name	NASDAQ
Two Point Five Percent Notes Due 2022
Document and Entity Information [Line Items]
Title of 12(b) Security	2.500% Senior Notes Due 2022
Trading Symbol	PEP22a
Security Exchange Name	NASDAQ
One Point Seven Five Percent Notes Due 2021
Document and Entity Information [Line Items]
Title of 12(b) Security	1.750% Senior Notes Due 2021
Trading Symbol	PEP21a
Security Exchange Name	NASDAQ
Two Point Six Two Five Percent Notes Due 2026
Document and Entity Information [Line Items]
Title of 12(b) Security	2.625% Senior Notes Due 2026
Trading Symbol	PEP26
Security Exchange Name	NASDAQ
Zero Point Eight Seven Five Percent Notes Due 2028
Document and Entity Information [Line Items]
Title of 12(b) Security	0.875% Senior Notes Due 2028
Trading Symbol	PEP28
Security Exchange Name	NASDAQ
Zero Point Seven Five Percent Notes Due 2027
Document and Entity Information [Line Items]
Title of 12(b) Security	0.750% Senior Notes Due 2027
Trading Symbol	PEP27
Security Exchange Name	NASDAQ
One Point One Two Five Percent Notes Due 2031
Document and Entity Information [Line Items]
Title of 12(b) Security	1.125% Senior Notes Due 2031
Trading Symbol	PEP31
Security Exchange Name	NASDAQ
Zero Point Eight Seven Five Notes Due 2039
Document and Entity Information [Line Items]
Title of 12(b) Security	0.875% Senior Notes Due 2039
Trading Symbol	PEP39
Security Exchange Name	NASDAQ

Consolidated Statement of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Income Statement [Abstract]
Net Revenue	$ 67,161	$ 64,661	$ 63,525
Cost of sales	30,132	29,381	28,796
Gross profit	37,029	35,280	34,729
Selling, general and administrative expenses	26,738	25,170	24,453
Operating Profit	10,291	10,110	10,276
Other pension and retiree medical benefits (expense)/income	(44)	298	233
Interest expense	(1,135)	(1,525)	(1,151)
Interest income and other	200	306	244
Income before income taxes	9,312	9,189	9,602
Provision for/(benefit from) income taxes (See Note 5)	1,959	(3,370)	4,694
Net income	7,353	12,559	4,908
Less: Net income attributable to noncontrolling interests	39	44	51
Net Income Attributable to PepsiCo	$ 7,314	$ 12,515	$ 4,857
Net Income Attributable to PepsiCo per Common Share
Basic	$ 5.23	$ 8.84	$ 3.40
Diluted	$ 5.20	$ 8.78	$ 3.38
Weighted-average common shares outstanding
Basic	1,399	1,415	1,425
Diluted	1,407	1,425	1,438

Consolidated Statement of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Net income	$ 7,353	$ 12,559	$ 4,908
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax	628	(1,641)	1,109
Other comprehensive loss
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax	(90)	40	(36)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax	283	(467)	(159)
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax	(2)	6	(68)
Pension and retiree medical:
Other Comprehensive Income, Other, Net of Tax	0	0	16
Other Comprehensive Income/(Loss), after-tax amount	819	(2,062)	862
Comprehensive income	8,172	10,497	5,770
Comprehensive income attributable to noncontrolling interests	(39)	(44)	(51)
Comprehensive Income Attributable to PepsiCo	$ 8,133	$ 10,453	$ 5,719

Consolidated Statement of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Operating Activities
Net income	$ 7,353	$ 12,559	$ 4,908
Depreciation and amortization	2,432	2,399	2,369
Share-based compensation expense	237	256	292
Restructuring and impairment charges	370	308	295
Cash payments for restructuring charges	(350)	(255)	(113)
Pension and retiree medical plan expenses	519	221	221
Pension and retiree medical plan contributions	(716)	(1,708)	(220)
Deferred income taxes and other tax charges and credits	453	(531)	619
Other net tax benefits related to international reorganizations	(2)	(4,347)	0
Net tax (benefit)/expense related to the TCJ Act	(8)	(28)	2,451
Tax payments related to the TCJ Act	(423)	(115)	0
Change in assets and liabilities [Abstract]
Accounts and notes receivable	(650)	(253)	(202)
Inventories	(190)	(174)	(168)
Prepaid expenses and other current assets	(87)	9	20
Accounts payable and other current liabilities	735	882	201
Income taxes payable	(287)	448	(338)
Other, net	263	(256)	(305)
Net Cash Provided by (Used in) Operating Activities	9,649	9,415	10,030
Investing Activities
Capital spending	(4,232)	(3,282)	(2,969)
Sales of property, plant and equipment	170	134	180
Acquisition of SodaStream, net of cash and cash equivalents acquired	(1,939)	(1,197)	0
Other acquisitions and investments in noncontrolled affiliates	(778)	(299)	(61)
Divestitures	253	505	267
Short-term investments, by original maturity:
More than three months - purchases	0	(5,637)	(18,385)
More than three months - maturities	16	12,824	15,744
More than three months - sales	62	1,498	790
Three months or less, net	19	16	2
Other investing, net	(8)	2	29
Net Cash (Used for)/Provided by Investing Activities	(6,437)	4,564	(4,403)
Financing Activities
Proceeds from issuances of long-term debt	4,621	0	7,509
Payments of long-term debt	(3,970)	(4,007)	(4,406)
Cash tender and exchange offers/debt redemptions	(1,007)	(1,589)	0
Short-term borrowings, by original maturity
More than three months - proceeds	6	3	91
More than three months - payments	(2)	(17)	(128)
Three months or less, net	(3)	(1,352)	(1,016)
Cash dividends paid	(5,304)	(4,930)	(4,472)
Share repurchases - common	(3,000)	(2,000)	(2,000)
Share repurchases - preferred	0	(2)	(5)
Proceeds from exercises of stock options	329	281	462
Withholding tax payments on RSUs, PSUs and PEPunits converted	(114)	(103)	(145)
Other financing	(45)	(53)	(76)
Net Cash Used for Financing Activities	(8,489)	(13,769)	(4,186)
Effect of exchange rate changes on cash and cash equivalents and restricted cash	78	(98)	47
Cash and Cash Equivalents and Restricted Cash, Period Increase (Decrease)	(5,199)	112	1,488
Cash and cash equivalents and restricted cash	$ 5,570	$ 10,769	$ 10,657

Consolidated Balance Sheet - USD ($) $ in Millions	Dec. 28, 2019	Dec. 29, 2018
ASSETS
Cash and cash equivalents	$ 5,509	$ 8,721
Short-term Investments	229	272
Restricted Cash	0	1,997
Accounts and notes receivable, net	7,822	7,142
Inventories	3,338	3,128
Prepaid expenses and other current assets	747	633
Assets, Current	17,645	21,893
Property, Plant and Equipment, net	19,305	17,589
Amortizable Intangible Assets, net	1,433	1,644
Goodwill	15,501	14,808
Indefinite-lived Intangible Assets (Excluding Goodwill)	14,610	14,181
Indefinite-Lived Intangible Assets	30,111	28,989
Equity Method Investments	2,683	2,409
Deferred Income Tax Assets, Net	4,359	4,364
Other Assets	3,011	760
Total Assets	78,547	77,648
LIABILITIES AND EQUITY
Short-term debt obligations	2,920	4,026
Accounts payable and other current liabilities	17,541	18,112
Liabilities, Current	20,461	22,138
Long-Term Debt Obligations	29,148	28,295
Deferred Income Tax Liabilities, Net	4,091	3,499
Other Liabilities, Noncurrent	9,979	9,114
Liabilities	63,679	63,046
Commitments and contingencies
PepsiCo Common Shareholders’ Equity
Common stock, par value 12/3¢ per share (authorized 3,600 shares, issued, net of repurchased common stock at par value: 1,391 and 1,409 shares, respectively)	23	23
Additional Paid in Capital, Common Stock	3,886	3,953
Retained Earnings (Accumulated Deficit)	61,946	59,947
Accumulated Other Comprehensive Income (Loss), Net of Tax	(14,300)	(15,119)
Treasury Stock, Value	(36,769)
Stockholders' Equity Attributable to Parent	14,786	14,518
Stockholders' Equity Attributable to Noncontrolling Interest	82	84
Total Equity	14,868	14,602
Liabilities and Equity	78,547	77,648
Additional Paid-in Capital [Member]
PepsiCo Common Shareholders’ Equity
Stockholders' Equity Attributable to Parent	3,886	3,953
Retained Earnings [Member]
PepsiCo Common Shareholders’ Equity
Stockholders' Equity Attributable to Parent	61,946	59,947
AOCI Attributable to Parent [Member]
PepsiCo Common Shareholders’ Equity
Stockholders' Equity Attributable to Parent	(14,300)	(15,119)
Treasury Stock [Member]
PepsiCo Common Shareholders’ Equity
Stockholders' Equity Attributable to Parent	(36,769)	(34,286)
Common Stock
PepsiCo Common Shareholders’ Equity
Stockholders' Equity Attributable to Parent	$ 23	$ 23

Consolidated Statement of Equity - USD ($)
$ in Millions

Total

Preferred Stock

Repurchased Preferred Stock

Common Stock

Capital In Excess Of Par Value

Retained Earnings

Accumulated Other Comprehensive Loss

Repurchased Common Stock

Total Common Shareholders' Equity

Noncontrolling Interests

Preferred Stock, Value, Outstanding

$ 41

$ (192)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets

$ 0

Stockholders' Equity Attributable to Noncontrolling Interest

$ 104

Preferred Stock, Shares Issued, Beginning of year at Dec. 31, 2016

800,000

(700,000)

Stockholders' Equity Attributable to Parent at Dec. 31, 2016

$ 24

$ 4,091

52,518

$ (13,919)

$ (31,468)

Stock Repurchased During Period, Value

$ (2,000)

Conversion of Stock, Shares Converted

Retirement of preferred stock

Convertible Preferred Stock Converted to Other Securities

$ 0

Retirement of preferred stock, value

$ 0

Preferred Stock, Shares Issued, End of year at Dec. 30, 2017

803,953

(700,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Redemptions (in shares)

Redemptions

$ (5)

Balance, beginning of year (in shares) at Dec. 31, 2016

(438,000,000)

Balance, end of year (in shares) at Dec. 30, 2017

(446,000,000)

Balance, outstanding, beginning of year (in shares) at Dec. 31, 2016

1,428,000,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock Repurchased During Period, Shares

(8,000,000)

(18,000,000)

Balance, outstanding, end of year (in shares) at Dec. 30, 2017

1,420,000,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share-based compensation expense

290

Stock option exercises, RSUs, PSUs and PEPunits converted

$ 708

Stock Options Exercises RSUs and Performance Stock Units Converted

(236)

Share-based Payment Arrangement, Decrease for Tax Withholding Obligation

(145)

Other

(4)

Share repurchases

$ 0

Stock option exercises (in shares)

10,000,000

Other (in shares)

Other

$ 3

(1)

Dividends, Common Stock, Cash

^[1]

(4,536)

Net Income (Loss) Attributable to Noncontrolling Interest

$ 51

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

(62)

Other comprehensive income/(loss) attributable to PepsiCo

862

Balance, end of year at Dec. 30, 2017

10,981

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

$ 4,857

4,857

Stockholders' Equity Attributable to Parent at Dec. 30, 2017

$ 24

3,996

52,839

(13,057)

(32,757)

$ 11,045

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock Issued During Period, Shares, Conversion of Convertible Securities

Common Stock, Dividends, Per Share, Declared

$ 3.1675

Preferred Stock, Value, Outstanding

$ 41

$ (197)

New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets

(145)

Stockholders' Equity Attributable to Noncontrolling Interest

Stock Repurchased During Period, Value

$ (2,000)

Conversion of Stock, Shares Converted

(100,000)

Retirement of preferred stock

(700,000)

700,000

Convertible Preferred Stock Converted to Other Securities

$ (6)

$ 0

Retirement of preferred stock, value

$ (35)

$ 199

(164)

Preferred Stock, Shares Issued, End of year at Dec. 29, 2018

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Redemptions (in shares)

Redemptions

$ (2)

Balance, end of year (in shares) at Dec. 29, 2018

(458,000,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock Repurchased During Period, Shares

(12,000,000)

(18,000,000)

Balance, outstanding, end of year (in shares) at Dec. 29, 2018

1,409,000,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share-based compensation expense

250

Stock option exercises, RSUs, PSUs and PEPunits converted

$ 469

Stock Options Exercises RSUs and Performance Stock Units Converted

(193)

Share-based Payment Arrangement, Decrease for Tax Withholding Obligation

(103)

Other

(3)

Share repurchases

$ (1)

Stock option exercises (in shares)

6,000,000

Other (in shares)

Other

$ 2

(3)

Dividends, Common Stock, Cash

^[1]

(5,098)

Net Income (Loss) Attributable to Noncontrolling Interest

$ 44

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

(49)

Other comprehensive income/(loss) attributable to PepsiCo

(2,062)

Balance, end of year at Dec. 29, 2018

14,602

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

12,515

Stockholders' Equity Attributable to Parent at Dec. 29, 2018

$ 14,518

$ 23

3,953

59,947

(15,119)

(34,286)

14,518

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock Issued During Period, Shares, Conversion of Convertible Securities

1,000,000

Common Stock, Dividends, Per Share, Declared

$ 3.5875

Preferred Stock, Value, Outstanding

$ 0

New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets

Stockholders' Equity Attributable to Noncontrolling Interest

$ 84

Stock Repurchased During Period, Value

$ (3,000)

Conversion of Stock, Shares Converted

Retirement of preferred stock

Convertible Preferred Stock Converted to Other Securities

$ 0

Retirement of preferred stock, value

$ 0

Preferred Stock, Shares Issued, End of year at Dec. 28, 2019

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Redemptions (in shares)

Redemptions

$ 0

Balance, end of year (in shares) at Dec. 28, 2019

(476,000,000)

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock Repurchased During Period, Shares

(18,000,000)

(24,000,000)

Balance, outstanding, end of year (in shares) at Dec. 28, 2019

1,391,000,000

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Share-based compensation expense

235

Stock option exercises, RSUs, PSUs and PEPunits converted

$ 516

Stock Options Exercises RSUs and Performance Stock Units Converted

(188)

Share-based Payment Arrangement, Decrease for Tax Withholding Obligation

(114)

Other

Share repurchases

$ 0

Stock option exercises (in shares)

4,882,000

6,000,000

Other (in shares)

Other

$ 1

Dividends, Common Stock, Cash

^[1]

(5,323)

Net Income (Loss) Attributable to Noncontrolling Interest

$ 39

Noncontrolling Interest, Decrease from Distributions to Noncontrolling Interest Holders

(42)

Other comprehensive income/(loss) attributable to PepsiCo

819

Balance, end of year at Dec. 28, 2019

14,868

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Net income

7,314

Stockholders' Equity Attributable to Parent at Dec. 28, 2019

$ 14,786

$ 23

$ 3,886

$ 61,946

$ (14,300)

$ (36,769)

$ 14,786

Increase (Decrease) in Stockholders' Equity [Roll Forward]

Stock Issued During Period, Shares, Conversion of Convertible Securities

Common Stock, Dividends, Per Share, Declared

$ 3.7925

Preferred Stock, Value, Outstanding

$ 0

Stockholders' Equity Attributable to Noncontrolling Interest

$ 82

[1]	(a) Cash dividends declared per common share were $3.7925, $3.5875 and $3.1675 for 2019, 2018 and 2017, respectively.

Basis of Presentation and Our Divisions

12 Months Ended

Dec. 28, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis Of Presentation and Our Divisions

Note 1 — Basis of Presentation and Our Divisions

Basis of Presentation

The accompanying consolidated financial statements have been prepared in accordance with U.S. GAAP and include the consolidated accounts of PepsiCo, Inc. and the affiliates that we control. In addition, we include our share of the results of certain other affiliates using the equity method based on our economic ownership interest, our ability to exercise significant influence over the operating or financial decisions of these affiliates or our ability to direct their economic resources. We do not control these other affiliates, as our ownership in these other affiliates is generally 50% or less. Intercompany balances and transactions are eliminated. As a result of exchange restrictions and other operating restrictions, we do not have control over our Venezuelan subsidiaries. As such, our Venezuelan subsidiaries are not included within our consolidated financial results for any period presented.

Raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw materials handling facilities, are included in cost of sales. The costs of moving, storing and delivering finished product, including merchandising activities, are included in selling, general and administrative expenses.

The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect reported amounts of assets, liabilities, revenues, expenses and disclosure of contingent assets and liabilities. Estimates are used in determining, among other items, sales incentives accruals, tax reserves, share-based compensation, pension and retiree medical accruals, amounts and useful lives for intangible assets and future cash flows associated with impairment testing for indefinite-lived brands, goodwill and other long-lived assets. We evaluate our estimates on an ongoing basis using our historical experience, as well as other factors we believe appropriate under the circumstances, such as current economic conditions, and adjust or revise our estimates as circumstances change. As future events and their effect cannot be determined with precision, actual results could differ significantly from these estimates.

Our fiscal year ends on the last Saturday of each December, resulting in an additional week of results every five or six years. While our North America results are reported on a weekly calendar basis, substantially all of our international operations report on a monthly calendar basis. Certain operations in our Europe segment report on a weekly calendar basis. The following chart details our quarterly reporting schedule for the three years presented:



Quarter	United States and Canada	International
First Quarter	12 weeks	January, February
Second Quarter	12 weeks	March, April and May
Third Quarter	12 weeks	June, July and August
Fourth Quarter	16 weeks	September, October, November and December

Unless otherwise noted, tabular dollars are in millions, except per share amounts. All per share amounts reflect common per share amounts, assume dilution unless otherwise noted, and are based on unrounded amounts. Certain reclassifications were made to the prior years’ consolidated financial statements to conform to the current year presentation.

Our Divisions

During the fourth quarter of 2019, we realigned our ESSA and AMENA reportable segments to be consistent

with a recent strategic realignment of our organizational structure and how our Chief Executive Officer assesses the performance of, and allocates resources to, our reportable segments. As a result, our beverage, food and snack businesses in North Africa, the Middle East and South Asia that were part of our former AMENA segment and our businesses in Sub-Saharan Africa that were part of our former ESSA segment are now reported together as our AMESA segment. The remaining beverage, food and snack businesses that were part of our former AMENA segment are now reported together as our APAC segment and our beverage, food and snack businesses in Europe are now reported as our Europe segment.

These changes did not impact our FLNA, QFNA, PBNA or LatAm reportable segments or our consolidated financial results.

Our historical segment reporting presented in this report has been retrospectively revised to reflect the new organizational structure.

We are organized into seven reportable segments (also referred to as divisions), as follows:


1)	FLNA, which includes our branded food and snack businesses in the United States and Canada;


2)	QFNA, which includes our cereal, rice, pasta and other branded food businesses in the United States and Canada;


3)	PBNA, which includes our beverage businesses in the United States and Canada;


4)	LatAm, which includes all of our beverage, food and snack businesses in Latin America;


5)	Europe, which includes all of our beverage, food and snack businesses in Europe;


6)	AMESA, which includes all of our beverage, food and snack businesses in Africa, the Middle East and South Asia; and


7)	APAC, which includes all of our beverage, food and snack businesses in Asia Pacific, Australia and New Zealand and China region.

Through our operations, authorized bottlers, contract manufacturers and other third parties, we make, market, distribute and sell a wide variety of convenient beverages, foods and snacks, serving customers and consumers in more than 200 countries and territories with our largest operations in the United States, Mexico, Russia, Canada, the United Kingdom, China and Brazil.

The accounting policies for the divisions are the same as those described in Note 2, except for the following allocation methodologies:


•	share-based compensation expense;


•	pension and retiree medical expense; and


•	derivatives.

Share-Based Compensation Expense

Our divisions are held accountable for share-based compensation expense and, therefore, this expense is allocated to our divisions as an incremental employee compensation cost.

The allocation of share-based compensation expense of each division is as follows:



	2019		2018		2017
FLNA	13	%	13	%	13	%
QFNA	1	%	1	%	1	%
PBNA	17	%	18	%	18	%
LatAm	7	%	8	%	7	%
Europe	17	%	9	%	9	%
AMESA	3	%	4	%	5	%
APAC	5	%	4	%	4	%
Corporate unallocated expenses	37	%	43	%	43	%

The expense allocated to our divisions excludes any impact of changes in our assumptions during the year which reflect market conditions over which division management has no control. Therefore, any variances between allocated expense and our actual expense are recognized in corporate unallocated expenses.

Pension and Retiree Medical Expense

Pension and retiree medical service costs measured at fixed discount rates are reflected in division results. The variance between the fixed discount rate used to determine the service cost reflected in division results and the discount rate as disclosed in Note 7 is reflected in corporate unallocated expenses.

Derivatives

We centrally manage commodity derivatives on behalf of our divisions. These commodity derivatives include energy, agricultural products and metals. Commodity derivatives that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit. Therefore, the divisions realize the economic effects of the derivative without experiencing any resulting mark-to-market volatility, which remains in corporate unallocated expenses. These derivatives hedge underlying commodity price risk and were not entered into for trading or speculative purposes.

Net revenue and operating profit of each division are as follows:



	Net Revenue						Operating Profit
	2019^(a)		2018^(a)		2017		2019			2018			2017
FLNA	$	17,078	$	16,346	$	15,798	$	5,258		$	5,008		$	4,793
QFNA	2,482		2,465		2,503		544			637			640
PBNA	21,730		21,072		20,936		2,179			2,276			2,700
LatAm	7,573		7,354		7,208		1,141			1,049			924
Europe	11,728		10,973		10,522		1,327			1,256			1,199
AMESA	3,651		3,657		3,674		671			661			789
APAC	2,919		2,794		2,884		477			619			401
Total division	67,161		64,661		63,525		11,597			11,506			11,446
Corporate unallocated expenses	—		—		—		(1,306		)	(1,396		)	(1,170		)
Total	$	67,161	$	64,661	$	63,525	$	10,291		$	10,110		$	10,276

(a)

Our primary performance obligation is the distribution and sales of beverage products and food and snack products to our customers, with our food and snack business representing approximately 55% of our consolidated net revenue. Internationally, LatAm’s food and snack business is approximately 90% of the segment’s net revenue, Europe’s beverage business and food and snack business are approximately 55% and 45%, respectively, of the segment’s net revenue, AMESA’s beverage business and food and snack business are approximately 40% and 60%, respectively, of the segment’s net revenue and APAC’s beverage business and food and snack business are approximately 25% and 75%, respectively, of the segment’s net revenue. Beverage revenue from company-owned bottlers, which primarily includes our consolidated bottling operations in our PBNA and Europe segments, is approximately 40% of our consolidated net revenue. Generally, our

finished goods beverage operations produce higher net revenue, but lower operating margins as compared to concentrate sold to authorized bottling partners for the manufacture of finished goods beverages. See Note 2 for further information.

Corporate Unallocated Expenses

Corporate unallocated expenses include costs of our corporate headquarters, centrally managed initiatives such as commodity derivative gains and losses, foreign exchange transaction gains and losses, our ongoing business transformation initiatives, unallocated research and development costs, unallocated insurance and benefit programs, and certain other items.

Other Division Information

Total assets and capital spending of each division are as follows:



	Total Assets				Capital Spending
	2019		2018		2019		2018		2017
FLNA	$	7,519	$	6,577	$	1,227	$	840	$	665
QFNA	941		870		104		53		44
PBNA	31,449		29,878		1,053		945		904
LatAm	7,007		6,458		557		492		481
Europe	17,814		16,887		613		466		463
AMESA	3,672		3,252		267		198		181
APAC	4,113		3,704		195		138		145
Total division	72,515		67,626		4,016		3,132		2,883
Corporate^(a)	6,032		10,022		216		150		86
Total	$	78,547	$	77,648	$	4,232	$	3,282	$	2,969


(a)	Corporate assets consist principally of certain cash and cash equivalents, restricted cash, short-term investments, derivative instruments, property, plant and equipment and tax assets. In 2019, the change in assets was primarily due to a decrease in cash and cash equivalents and restricted cash. Refer to the cash flow statement for additional information.

Amortization of intangible assets and depreciation and other amortization of each division are as follows:



	Amortization of Intangible Assets						Depreciation and Other Amortization
	2019		2018		2017		2019		2018		2017
FLNA	$	7	$	7	$	7	$	492	$	457	$	449
QFNA	—		—		—		44		45		47
PBNA	29		31		31		857		821		780
LatAm	5		5		5		270		253		245
Europe	37		23		22		341		319		317
AMESA	2		2		2		116		169		170
APAC	1		1		1		76		80		99
Total division	81		69		68		2,196		2,144		2,107
Corporate	—		—		—		155		186		194
Total	$	81	$	69	$	68	$	2,351	$	2,330	$	2,301

Net revenue and long-lived assets by country are as follows:



	Net Revenue						Long-Lived Assets^(a)
	2019		2018		2017		2019		2018
United States	$	38,644	$	37,148	$	36,546	$	30,601	$	29,169
Mexico	4,190		3,878		3,650		1,666		1,404
Russia	3,263		3,191		3,232		4,314		3,926
Canada	2,831		2,736		2,691		2,695		2,565
United Kingdom	1,723		1,743		1,650		827		759
China	1,300		1,164		963		705		509
Brazil	1,295		1,335		1,427		590		639
All other countries	13,915		13,466		13,366		12,134		11,660
Total	$	67,161	$	64,661	$	63,525	$	53,532	$	50,631

(a)

Long-lived assets represent property, plant and equipment, indefinite-lived intangible assets, amortizable intangible assets and investments in noncontrolled affiliates. These assets are reported in the country where they are primarily used.

Our Significant Accounting Policies

12 Months Ended

Dec. 28, 2019

Accounting Policies [Abstract]

Our Significant Accounting Policies

Revenue Recognition

We recognize revenue when our performance obligation is satisfied. Our primary performance obligation (the distribution and sales of beverage products and food and snack products) is satisfied upon the shipment or delivery of products to our customers, which is also when control is transferred. Merchandising activities are performed after a customer obtains control of the product, are accounted for as fulfillment of our performance obligation to ship or deliver product to our customers and are recorded in selling, general and administrative expenses. Merchandising activities are immaterial in the context of our contracts.

The transfer of control of products to our customers is typically based on written sales terms that do not allow for a right of return. However, our policy for DSD and certain chilled products is to remove and replace damaged and out-of-date products from store shelves to ensure that consumers receive the product quality and freshness they expect. Similarly, our policy for certain warehouse-distributed products is to replace damaged and out-of-date products. As a result, we record reserves, based on estimates, for anticipated damaged and out-of-date products.

As a result of the implementation of the revenue recognition guidance adopted in the first quarter of 2018, which did not have a material impact on our accounting policies, we recorded an adjustment in the first quarter of 2018 of $137 million to beginning retained earnings to reflect marketplace spending that our customers and independent bottlers expect to be entitled to in line with revenue recognition. In addition, starting in 2018, we excluded from net revenue and cost of sales all sales, use, value-added and certain excise taxes assessed by governmental authorities on revenue-producing transactions. The impact of these taxes previously recognized in net revenue and cost of sales was approximately $75 million for the fiscal year ended December 30, 2017, with no impact on operating profit.

Our products are sold for cash or on credit terms. Our credit terms, which are established in accordance with local and industry practices, typically require payment within 30 days of delivery in the United States, and generally within 30 to 90 days internationally, and may allow discounts for early payment.

We estimate and reserve for our bad debt exposure based on our experience with past due accounts and collectibility, write-off history, the aging of accounts receivable and our analysis of customer data. Bad debt expense is classified within selling, general and administrative expenses on our income statement.

We are exposed to concentration of credit risk from our major customers, including Walmart. In 2019, sales to Walmart and its affiliates (including Sam’s) represented approximately 13% of our consolidated net revenue, including concentrate sales to our independent bottlers, which were used in finished goods sold by them to Walmart. We have not experienced credit issues with these customers.

Total Marketplace Spending

We offer sales incentives and discounts through various programs to customers and consumers. Total marketplace spending includes sales incentives, discounts, advertising and other marketing activities. Sales incentives and discounts are primarily accounted for as a reduction of revenue and include payments to customers for performing activities on our behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. Sales incentives and discounts also include support provided to our independent bottlers through funding of advertising and other marketing activities.

A number of our sales incentives, such as bottler funding to independent bottlers and customer volume rebates, are based on annual targets, and accruals are established during the year, as products are delivered, for the expected payout, which may occur after year end once reconciled and settled. These accruals are based on contract terms and our historical experience with similar programs and require management judgment with respect to estimating customer and consumer participation and performance levels. Differences between estimated expense and actual incentive costs are normally insignificant and are recognized in earnings in the period such differences are determined. In addition, certain advertising and marketing costs are also based on annual targets and recognized during the year as incurred.

The terms of most of our incentive arrangements do not exceed a year, and, therefore, do not require highly uncertain long-term estimates. Certain arrangements, such as fountain pouring rights, may extend beyond one year. Upfront payments to customers under these arrangements are recognized over the shorter of the economic or contractual life, primarily as a reduction of revenue, and the remaining balances of $272 million as of December 28, 2019 and $218 million as of December 29, 2018 are included in prepaid expenses and other current assets and other assets on our balance sheet.

For interim reporting, our policy is to allocate our forecasted full-year sales incentives for most of our programs to each of our interim reporting periods in the same year that benefits from the programs. The allocation methodology is based on our forecasted sales incentives for the full year and the proportion of each interim period’s actual gross revenue or volume, as applicable, to our forecasted annual gross revenue or volume, as applicable. Based on our review of the forecasts at each interim period, any changes in estimates and the related allocation of sales incentives are recognized beginning in the interim period that they are identified. In addition, we apply a similar allocation methodology for interim reporting purposes for certain advertising and other marketing activities. Our annual consolidated financial statements are not impacted by this interim allocation methodology.

Advertising and other marketing activities, reported as selling, general and administrative expenses, totaled $4.7 billion in 2019, $4.2 billion in 2018 and $4.1 billion in 2017, including advertising expenses of $3.0 billion in 2019, $2.6 billion in 2018 and $2.4 billion in 2017. Deferred advertising costs are not expensed until the year first used and consist of:


•	media and personal service prepayments;


•	promotional materials in inventory; and


•	production costs of future media advertising.

Deferred advertising costs of $55 million and $47 million as of December 28, 2019 and December 29, 2018, respectively, are classified as prepaid expenses and other current assets on our balance sheet.

Distribution Costs

Distribution costs, including the costs of shipping and handling activities, which include certain merchandising activities, are reported as selling, general and administrative expenses. Shipping and handling expenses were $10.9 billion in 2019, $10.5 billion in 2018 and $9.9 billion in 2017.

Software Costs

We capitalize certain computer software and software development costs incurred in connection with developing or obtaining computer software for internal use when both the preliminary project stage is completed and it is probable that the software will be used as intended. Capitalized software costs include (1) external direct costs of materials and services utilized in developing or obtaining computer software, (2) compensation and related benefits for employees who are directly associated with the software projects and (3) interest costs incurred while developing internal-use computer software. Capitalized software costs are included in property, plant and equipment on our balance sheet and amortized on a straight-line basis when placed into service over the estimated useful lives of the software, which approximate five to 10 years. Software amortization totaled $166 million in 2019, $204 million in 2018 and $224 million in 2017. Net capitalized software and development costs were $572 million and $577 million as of December 28, 2019 and December 29, 2018, respectively.

Commitments and Contingencies

We are subject to various claims and contingencies related to lawsuits, certain taxes and environmental matters, as well as commitments under contractual and other commercial obligations. We recognize liabilities for contingencies and commitments when a loss is probable and estimable.

Research and Development

We engage in a variety of research and development activities and continue to invest to accelerate growth and to drive innovation globally. Consumer research is excluded from research and development costs and included in other marketing costs. Research and development costs were $711 million, $680 million and $737 million in 2019, 2018 and 2017, respectively, and are reported within selling, general and administrative expenses.

Goodwill and Other Intangible Assets

Indefinite-lived intangible assets and goodwill are not amortized and, as a result, are assessed for impairment at least annually, using either a qualitative or quantitative approach. We perform this annual assessment during our third quarter, or more frequently if circumstances indicate that the carrying value may not be recoverable. Where we use the qualitative assessment, first we determine if, based on qualitative factors, it is more likely than not that an impairment exists. Factors considered include macroeconomic, industry and competitive conditions, legal and regulatory environment, historical financial performance and significant changes in the brand or reporting unit. If the qualitative assessment indicates that it is more likely than not that an impairment exists, then a quantitative assessment is performed.

In the quantitative assessment for indefinite lived-intangible assets and goodwill, an assessment is performed to determine the fair value of the indefinite-lived intangible asset and the reporting unit, respectively. Estimated fair value is determined using discounted cash flows and requires an analysis of several estimates including future cash flows or income consistent with management’s strategic business plans, annual sales growth rates, perpetuity growth assumptions and the selection of assumptions underlying a discount rate (weighted-average cost of capital) based on market data available at the time. Significant management judgment is necessary to estimate the impact of competitive operating, macroeconomic and other factors to estimate future levels of sales, operating profit or cash flows. All assumptions used in our impairment evaluations for indefinite-lived intangible assets and goodwill, such as forecasted growth rates (including perpetuity growth assumptions) and weighted-average cost of capital, are based on the best available market

information and are consistent with our internal forecasts and operating plans. A deterioration in these assumptions could adversely impact our results.

Amortizable intangible assets are only evaluated for impairment upon a significant change in the operating or macroeconomic environment. If an evaluation of the undiscounted future cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on its discounted future cash flows.

See Note 4 for further information.

Other Significant Accounting Policies

Our other significant accounting policies are disclosed as follows:


•	Basis of Presentation – Note 1 includes a description of our policies regarding use of estimates, basis of presentation and consolidation.


•	Property, Plant and Equipment – Note 4.


•	Income Taxes – Note 5.


•	Share-Based Compensation – Note 6.


•	Pension, Retiree Medical and Savings Plans – Note 7.


•	Financial Instruments – Note 9.


•	Cash Equivalents – Cash equivalents are highly liquid investments with original maturities of three months or less.


•	Inventories – Note 15. Inventories are valued at the lower of cost or net realizable value. Cost is determined using the average; first-in, first-out (FIFO) or, in limited instances, last-in, first-out (LIFO) methods.

•

Translation of Financial Statements of Foreign Subsidiaries – Financial statements of foreign subsidiaries are translated into U.S. dollars using period-end exchange rates for assets and liabilities and weighted-average exchange rates for revenues and expenses. Adjustments resulting from translating net assets are reported as a separate component of accumulated other comprehensive loss within common shareholders’ equity as currency translation adjustment.

Our Significant Accounting Policies Recently Issued Accounting Pronouncements (Notes)	12 Months Ended
	Dec. 28, 2019
Accounting Policies [Abstract]
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Pronouncements - Adopted In 2018, the Financial Accounting Standards Board (FASB) issued guidance related to the TCJ Act for the optional reclassification of the residual tax effects, arising from the change in corporate tax rate, in accumulated other comprehensive loss to retained earnings. The reclassification is the difference between the amount previously recorded in other comprehensive income at the historical U.S. federal tax rate that remains in accumulated other comprehensive loss at the time the TCJ Act was effective and the amount that would have been recorded using the newly enacted rate. This guidance became effective during the first quarter of 2019; however, we did not elect to make the optional reclassification. In 2017, the FASB issued guidance to amend and simplify the application of hedge accounting guidance to better portray the economic results of risk management activities in the financial statements. The guidance expands the ability to hedge nonfinancial and financial risk components, reduces complexity in fair value hedges of interest rate risk, eliminates the requirement to separately measure and report hedge ineffectiveness, as well as eases certain hedge effectiveness assessment requirements. Under this guidance, certain of our derivatives used to hedge commodity price risk that did not previously qualify for hedge accounting treatment can now qualify prospectively. We adopted this guidance during the first quarter of 2019; the adoption did not have a material impact on our consolidated financial statements or disclosures. See Note 9 for further information. In 2016, the FASB issued guidance on leases, with amendments issued in 2018. The guidance requires lessees to recognize most leases on the balance sheet, but does not change the manner in which expenses are recorded in the income statement. For lessors, the guidance modifies the classification criteria and the accounting for sales-type and direct financing leases. The two permitted transition methods under the guidance are the modified retrospective transition approach, which requires application of the guidance for all comparative periods presented, and the cumulative effect adjustment approach, which requires prospective application at the adoption date. We utilized a comprehensive approach to assess the impact of this guidance on our consolidated financial statements and related disclosures, including the increase in the assets and liabilities on our balance sheet and the impact on our current lease portfolio from both a lessor and lessee perspective. We completed our comprehensive review of our lease portfolio, including significant leases by geography and by asset type that were impacted by the new guidance, and enhanced our controls. In addition, we implemented a new software platform, and corresponding controls, for administering our leases and facilitating compliance with the new guidance. We adopted the guidance prospectively during the first quarter of 2019. As part of our adoption, we elected not to reassess historical lease classification, recognize short-term leases on our balance sheet, nor separate lease and non-lease components for our real estate leases. In addition, we utilized the portfolio approach to group leases with similar characteristics and did not use hindsight to determine lease term. The adoption did not have a material impact on our consolidated financial statements, resulting in an increase of 2% to each of our total assets and total liabilities on our balance sheet, and had an immaterial increase to retained earnings as of the beginning of 2019. See Note 13 for further information. Recently Issued Accounting Pronouncements - Not Yet Adopted In 2019, the FASB issued guidance to simplify the accounting for income taxes. The guidance primarily addresses how to (1) recognize a deferred tax liability after we transition to or from the equity method of accounting, (2) evaluate if a step–up in the tax basis of goodwill is related to a business combination or is a separate transaction, (3) recognize all the effects of a change in tax law in the period of enactment, including adjusting the estimated annual tax rate, and (4) include the amount of tax based on income in the income tax provision and any incremental amount as a tax not based on income for hybrid tax regimes. The guidance is effective in the first quarter of 2021 with early adoption permitted. We are currently evaluating the impact of this guidance on our consolidated financial statements and the timing of adoption. In 2016, the FASB issued guidance that changes the impairment model used to measure credit losses for most financial assets. For our trade, certain other receivables and certain other financial instruments, we will be required to use a new forward-looking expected credit loss model that will replace the existing incurred credit loss model, which would generally result in earlier recognition of allowances for credit losses. We will adopt the guidance when it becomes effective in the first quarter of 2020. The guidance is not expected to have a material impact on our consolidated financial statements or disclosures.

Restructuring, Impairment and Integration Charges

12 Months Ended

Dec. 28, 2019

Restructuring and Related Activities [Abstract]

Restructuring, Impairment, and Other Activities Disclosure [Text Block]

Restructuring and Impairment Charges

A summary of our restructuring and impairment charges and other productivity initiatives is as follows:



	2019		2018		2017
2019 Productivity Plan	$	370	$	138	$	—
2014 Productivity Plan	—		170		295
Total restructuring and impairment charges	370		308		295
Other productivity initiatives	3		8		16
Total restructuring and impairment charges and other productivity initiatives	$	373	$	316	$	311

2019 Multi-Year Productivity Plan

The 2019 Productivity Plan, publicly announced on February 15, 2019, will leverage new technology and business models to further simplify, harmonize and automate processes; re-engineer our go-to-market and information systems, including deploying the right automation for each market; and simplify our organization and optimize our manufacturing and supply chain footprint. In connection with this plan, we expect to incur pre-tax charges of approximately $2.5 billion and cash expenditures of approximately $1.6 billion. These pre-tax charges are expected to consist of approximately 70% of severance and other employee-related costs, 15% for asset impairments (all non-cash) resulting from plant closures and related actions, and 15% for other costs associated with the implementation of our initiatives. We expect to complete this plan by 2023.

The total expected plan pre-tax charges are expected to be incurred by division approximately as follows:



	FLNA		QFNA		PBNA		LatAm		Europe		AMESA		APAC		Corporate
Expected pre-tax charges	11	%	2	%	30	%	10	%	25	%	8	%	5	%	9	%

A summary of our 2019 Productivity Plan charges is as follows:



	2019		2018
Cost of sales	$	115	$	3
Selling, general and administrative expenses	253		100
Other pension and retiree medical benefits expense	2		35
Total restructuring and impairment charges	$	370	$	138
After-tax amount	$	303	$	109
Net income attributable to PepsiCo per common share	$	0.21	$	0.08



	2019		2018		Plan to Date through 12/28/2019
FLNA	$	22	$	31	$	53
QFNA	2		5		7
PBNA	51		40		91
LatAm	62		9		71
Europe	99		6		105
AMESA	38		3		41
APAC	47		2		49
Corporate	47		7		54
	368		103		471
Other pension and retiree medical benefits expense	2		35		37
Total	$	370	$	138	$	508



	Plan to Date through 12/28/2019
Severance and other employee costs	$	286
Asset impairments	92
Other costs ^(a)	130
Total	$	508


(a)	Includes other costs associated with the implementation of our initiatives, including contract termination costs, consulting and other professional fees.

A summary of our 2019 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs			Total
2018 restructuring charges	$	137		$	—		$	1		$	138
Non-cash charges and translation	(32		)	—			—			(32		)
Liability as of December 29, 2018	105			—			1			106
2019 restructuring charges	149			92			129			370
Cash payments ^(a)	(138		)	—			(119		)	(257		)
Non-cash charges and translation	12			(92		)	10			(70		)
Liability as of December 28, 2019	$	128		$	—		$	21		$	149


(a)	Excludes cash expenditures of $4 million reported in the cash flow statement in pension and retiree medical contributions.

Substantially all of the restructuring accrual at December 28, 2019 is expected to be paid by the end of 2020.

2014 Multi-Year Productivity Plan

The 2014 Productivity Plan, publicly announced on February 13, 2014, included the next generation of productivity initiatives that we believed would strengthen our beverage, food and snack businesses by: accelerating our investment in manufacturing automation; further optimizing our global manufacturing footprint, including closing certain manufacturing facilities; re-engineering our go-to-market systems in developed markets; expanding shared services; and implementing simplified organization structures to drive efficiency. To build on the 2014 Productivity Plan, in the fourth quarter of 2017, we expanded and extended the plan through the end of 2019 to take advantage of additional opportunities within the initiatives described above that further strengthened our beverage, food and snack businesses.

The 2014 Productivity Plan was completed in 2019. In 2019, there were no material pre-tax charges related to this plan and all cash payments were paid at year end. The total plan pre-tax charges and cash expenditures approximated the previously disclosed plan estimates of $1.3 billion and $960 million, respectively. These total plan pre-tax charges consisted of 59% of severance and other employee costs, 15% of asset impairments and 26% of other costs, including costs associated with the implementation of our initiatives, including certain consulting and other contract termination costs. These total plan pre-tax charges were incurred by division as follows: FLNA 14%, QFNA 3%, PBNA 29%, LatAm 15%, Europe 23%, AMESA 3%, APAC 3% and Corporate 10%.

A summary of our 2014 Productivity Plan charges is as follows:



	2018		2017
Selling, general and administrative expenses	$	169	$	229
Other pension and retiree medical benefits expense	1		66
Total restructuring and impairment charges	$	170	$	295
After-tax amount	$	143	$	224
Net income attributable to PepsiCo per common share	$	0.10	$	0.16



	2018			2017
FLNA	$	8		$	67
QFNA	2			11
PBNA	51			54
LatAm	30			63
Europe	53			53
AMESA	15			2
APAC ^(a)	12			(5		)
Corporate ^(b)	(1		)	50
Total	$	170		$	295


(a)	Income amount primarily reflects a gain on the sale of property, plant and equipment.


(b)	Income amount primarily relates to other pension and retiree medical benefits.

A summary of our 2014 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs				Total
Liability as of December 31, 2016	$	88		$	—		$	8			$	96
2017 restructuring charges	280			21			(6		)	^(a)	295
Cash payments	(91		)	—			(22		)		(113		)
Non-cash charges and translation	(65		)	(21		)	34				(52		)
Liability as of December 30, 2017	212			—			14				226
2018 restructuring charges	86			28			56				170
Cash payments ^(b)	(203		)	—			(52		)		(255		)
Non-cash charges and translation	(4		)	(28		)	5				(27		)
Liability as of December 29, 2018	91			—			23				114
Cash payments	(77		)	—			(16		)		(93		)
Non-cash charges and translation	(14		)	—			(7		)		(21		)
Liability as of December 28, 2019	$	—		$	—		$	—			$	—


(a)	Income amount represents adjustments for changes in estimates and a gain on the sale of property, plant, and equipment.


(b)	Excludes cash expenditures of $11 million reported in the cash flow statement in pension and retiree medical plan contributions.

Other Productivity Initiatives

There were no material charges related to other productivity and efficiency initiatives outside the scope of the 2019 and 2014 Productivity Plans.

We regularly evaluate different productivity initiatives beyond the productivity plans and other initiatives described above.

Property, Plant and Equipment and Intangible Assets

12 Months Ended

Dec. 28, 2019

Property, Plant And Equipment And Intangible Assets [Abstract]

Property, Plant and Equipment and Intangible Assets

A summary of our property, plant and equipment is as follows:



	Average Useful Life (Years)	2019			2018			2017
Property, plant and equipment, net
Land		$	1,130		$	1,078
Buildings and improvements	15 - 44	9,314			8,941
Machinery and equipment, including fleet and software	5 - 15	29,390			27,715
Construction in progress		3,169			2,430
		43,003			40,164
Accumulated depreciation		(23,698		)	(22,575		)
Total		$	19,305		$	17,589
Depreciation expense		$	2,257		$	2,241		$	2,227

Property, plant and equipment is recorded at historical cost. Depreciation and amortization are recognized on a straight-line basis over an asset’s estimated useful life. Land is not depreciated and construction in progress is not depreciated until ready for service.

A summary of our amortizable intangible assets is as follows:



		2019							2018							2017
	Average Useful Life (Years)	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Amortizable intangible assets, net
Acquired franchise rights	56 – 60	$	846	$	(158	)	$	688	$	838	$	(140	)	$	698
Reacquired franchise rights	5 – 14	106		(105		)	1		106		(105		)	1
Brands	20 – 40	1,326		(1,066		)	260		1,306		(1,032		)	274
Other identifiable intangibles ^(a)	10 – 24	810		(326		)	484		959		(288		)	671
Total		$	3,088	$	(1,655	)	$	1,433	$	3,209	$	(1,565	)	$	1,644
Amortization expense							$	81						$	69	$	68


(a)	The change from 2018 to 2019 primarily reflects revisions to the purchase price allocation for our acquisition of SodaStream.

Amortization of intangible assets for each of the next five years, based on existing intangible assets as of December 28, 2019 and using average 2019 foreign exchange rates, is expected to be as follows:



	2020		2021		2022		2023		2024
Five-year projected amortization	$	82	$	80	$	77	$	75	$	74

Depreciable and amortizable assets are evaluated for impairment upon a significant change in the operating or macroeconomic environment. In these circumstances, if an evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on discounted future cash flows. Useful lives are periodically evaluated to determine whether events or circumstances have occurred which indicate the need for revision.

Indefinite-Lived Intangible Assets

We did not recognize any impairment charges for goodwill in each of the years ended December 28, 2019, December 29, 2018 and December 30, 2017. We did not recognize any material impairment charges for indefinite-lived intangible assets in each of the years ended December 28, 2019, December 29, 2018 and December 30, 2017. As of December 28, 2019, the estimated fair values of our indefinite-lived reacquired and acquired franchise rights recorded at PBNA exceeded their carrying values. However, there could be an

impairment of the carrying value of PBNA’s reacquired and acquired franchise rights if future revenues and their contribution to the operating results of PBNA’s CSD business do not achieve our expected future cash flows or if macroeconomic conditions result in a future increase in the weighted-average cost of capital used to estimate fair value. We have also analyzed the impact of the macroeconomic conditions in Russia and Brazil on the estimated fair value of our indefinite-lived intangible assets in these countries and have concluded that there were no impairments for the year ended December 28, 2019. However, there could be an impairment of the carrying value of certain brands in these countries, including juice and dairy brands in Russia, if there is a deterioration in these conditions, if future revenues and their contributions to the operating results do not achieve our expected future cash flows (including perpetuity growth assumptions), if there are significant changes in the decisions regarding assets that do not perform consistent with our expectations, or if macroeconomic conditions result in a future increase in the weighted-average cost of capital used to estimate fair value. For further information on our policies for indefinite-lived intangible assets, see Note 2.

The change in the book value of indefinite-lived intangible assets is as follows:



	Balance, Beginning 2018		Acquisitions/ (Divestitures)			Translation and Other			Balance, End of 2018		Acquisitions/ (Divestitures)			Translation and Other			Balance, End of 2019
FLNA
Goodwill	$	280	$	28		$	(11	)	$	297	$	(3	)	$	5		$	299
Brands	25		138			(2		)	161		—			1			162
Total	305		166			(13		)	458		(3		)	6			461
QFNA
Goodwill	175		9			—			184		6			(1		)	189
Brands	—		25			—			25		(14		)	—			11
Total	175		34			—			209		(8		)	(1		)	200
PBNA ^(a)
Goodwill	9,854		—			(41		)	9,813		66			19			9,898
Reacquired franchise rights	7,126		—			(68		)	7,058		—			31			7,089
Acquired franchise rights	1,525		—			(15		)	1,510		—			7			1,517
Brands	353		—			—			353		418			(8		)	763
Total	18,858		—			(124		)	18,734		484			49			19,267
LatAm
Goodwill	555		—			(46		)	509		—			(8		)	501
Brands	141		—			(14		)	127		—			(2		)	125
Total	696		—			(60		)	636		—			(10		)	626
Europe ^{(b) (c)}
Goodwill	3,202		526			(367		)	3,361		440			160			3,961
Reacquired franchise rights	549		(1		)	(51		)	497		—			8			505
Acquired franchise rights	195		(25		)	(9		)	161		—			(4		)	157
Brands	2,545		1,993			(350		)	4,188		(139		)	132			4,181
Total	6,491		2,493			(777		)	8,207		301			296			8,804
AMESA
Goodwill	437		—			—			437		11			(2		)	446
Total	437		—			—			437		11			(2		)	446
APAC
Goodwill	241		—			(34		)	207		—			—			207
Brands	111		—			(10		)	101		—			(1		)	100
Total	352		—			(44		)	308		—			(1		)	307

Total goodwill	14,744		563			(499		)	14,808		520			173			15,501
Total reacquired franchise rights	7,675		(1		)	(119		)	7,555		—			39			7,594
Total acquired franchise rights	1,720		(25		)	(24		)	1,671		—			3			1,674
Total brands	3,175		2,156			(376		)	4,955		265			122			5,342
Total	$	27,314	$	2,693		$	(1,018	)	$	28,989	$	785		$	337		$	30,111


(a)	The change in acquisitions/(divestitures) in 2019 is primarily related to our acquisition of CytoSport Inc.


(b)	The change in acquisitions/(divestitures) in 2019 and 2018 is primarily related to our acquisition of SodaStream. See Note 14 for further information.

(c)

The change in translation and other in 2019 primarily reflects the appreciation of the Russian ruble. The change in translation and other in 2018 primarily reflects the depreciation of the Russian ruble, euro and Pound sterling.

Income Taxes

12 Months Ended

Dec. 28, 2019

Income Tax Disclosure [Abstract]

Income Taxes

The components of income before income taxes are as follows:



	2019		2018		2017
United States	$	4,123	$	3,864	$	3,452
Foreign	5,189		5,325		6,150
	$	9,312	$	9,189	$	9,602

The provision for/(benefit from) income taxes consisted of the following:



		2019			2018			2017
Current:	U.S. Federal	$	652		$	437		$	4,925
	Foreign	807			378			724
	State	196			63			136
		1,655			878			5,785
Deferred:	U.S. Federal	325			140			(1,159		)
	Foreign	(31		)	(4,379		)	(9		)
	State	10			(9		)	77
		304			(4,248		)	(1,091		)
		$	1,959		$	(3,370	)	$	4,694

A reconciliation of the U.S. Federal statutory tax rate to our annual tax rate is as follows:



	2019		2018		2017
U.S. Federal statutory tax rate	21.0	%	21.0	%	35.0	%
State income tax, net of U.S. Federal tax benefit	1.6		0.5		0.9
Lower taxes on foreign results	(0.9	)	(2.2	)	(9.4	)
One-time mandatory transition tax - TCJ Act	(0.1	)	0.1		41.4
Remeasurement of deferred taxes - TCJ Act	—		(0.4	)	(15.9	)
International reorganizations	—		(47.3	)	—
Tax settlements	—		(7.8	)	—
Other, net	(0.6	)	(0.6	)	(3.1	)
Annual tax rate	21.0	%	(36.7	)%	48.9	%

Tax Cuts and Jobs Act

During the fourth quarter of 2017, the TCJ Act was enacted in the United States. Among its many provisions, the TCJ Act imposed a mandatory one-time transition tax on undistributed international earnings and reduced the U.S. corporate income tax rate from 35% to 21%, effective January 1, 2018.

In 2017, the SEC issued guidance related to the TCJ Act which allowed recording of provisional tax expense using a measurement period, not to exceed one year, when information necessary to complete the accounting for the effects of the TCJ Act is not available. We elected to apply the measurement period provisions of this guidance to certain income tax effects of the TCJ Act when it became effective in the fourth quarter of 2017.

As a result of the enactment of the TCJ Act, we recognized a provisional net tax expense of $2.5 billion ($1.70 per share) in the fourth quarter of 2017. Included in the provisional net tax expense of $2.5 billion recognized in 2017, was a provisional mandatory one-time transition tax of approximately $4 billion on undistributed international earnings, included in other liabilities. This provisional mandatory one-time transition tax was partially offset by a provisional $1.5 billion benefit resulting from the required

remeasurement of our deferred tax assets and liabilities to the new, lower U.S. corporate income tax rate, effective January 1, 2018. The effect of the remeasurement was recorded in the fourth quarter of 2017, consistent with the enactment date of the TCJ Act, and reflected in our provision for income taxes.

The provisional measurement period allowed by the SEC ended in the fourth quarter of 2018. As a result, in 2018, we recognized a net tax benefit of $28 million ($0.02 per share) related to the TCJ Act, primarily reflecting the impact of the final analysis of certain foreign exchange gains or losses, substantiation of foreign tax credits, as well as cash and cash equivalents as of November 30, 2018, the tax year-end of our foreign subsidiaries, partially offset by additional transition tax guidance issued by the United States Department of Treasury, as well as the TCJ Act impact of both the conclusion of certain international tax audits and the resolution with the IRS of all open matters related to the audits of taxable years 2012 and 2013, each discussed below.

While our accounting for the recorded impact of the TCJ Act was deemed to be complete, additional guidance issued by the IRS impacted, and may continue to impact, our recorded amounts after December 29, 2018. In 2019, we recognized a net tax benefit totaling $8 million ($0.01 per share) related to the TCJ Act, including the impact of additional guidance issued by the IRS in the first quarter of 2019 and adjustments related to the filing of our 2018 U.S. federal tax return.

As of December 28, 2019, our mandatory transition tax liability was $3.3 billion, which must be paid through 2026 under the provisions of the TCJ Act. We reduced our liability through cash payments and application of tax overpayments by $663 million in 2019 and $150 million in 2018. We currently expect to pay approximately $0.1 billion of this liability in 2020.

The TCJ Act also created a requirement that certain income earned by foreign subsidiaries, known as global intangible low-tax income (GILTI), must be included in the gross income of their U.S. shareholder. The FASB allows an accounting policy election of either recognizing deferred taxes for temporary differences expected to reverse as GILTI in future years or recognizing such taxes as a current-period expense when incurred. During the first quarter of 2018, we elected to treat the tax effect of GILTI as a current-period expense when incurred.

Other Tax Matters

On May 19, 2019, a public referendum held in Switzerland passed the TRAF, effective January 1, 2020. The enactment of certain provisions of the TRAF in 2019 resulted in adjustments to our deferred taxes. During 2019, we recorded net tax expense of $24 million related to the impact of the TRAF. Enactment of the TRAF provisions subsequent to December 28, 2019 is expected to result in adjustments to our consolidated financial statements and related disclosures in future periods. The future impact of the TRAF cannot currently be reasonably estimated; we will continue to monitor and assess the impact the TRAF may have on our business and financial results.

In 2018, we reorganized certain of our international operations, including the intercompany transfer of certain intangible assets. As a result, we recognized other net tax benefits of $4.3 billion ($3.05 per share) in 2018. The related deferred tax asset of $4.4 billion is being amortized over a period of 15 years beginning in 2019. Additionally, the reorganization generated significant net operating loss carryforwards and related deferred tax assets that are not expected to be realized, resulting in the recording of a full valuation allowance.

Deferred tax liabilities and assets are comprised of the following:



	2019			2018
Deferred tax liabilities
Debt guarantee of wholly-owned subsidiary	$	578		$	578
Property, plant and equipment	1,583			1,303
Recapture of net operating losses	335			414
Right-of-use assets	345			—
Other	167			71
Gross deferred tax liabilities	3,008			2,366
Deferred tax assets
Net carryforwards	4,168			4,353
Intangible assets other than nondeductible goodwill	793			985
Share-based compensation	94			106
Retiree medical benefits	154			167
Other employee-related benefits	350			303
Pension benefits	104			221
Deductible state tax and interest benefits	126			110
Lease liabilities	345			—
Other	741			739
Gross deferred tax assets	6,875			6,984
Valuation allowances	(3,599		)	(3,753		)
Deferred tax assets, net	3,276			3,231
Net deferred tax assets	$	(268	)	$	(865	)

A summary of our valuation allowance activity is as follows:



	2019			2018			2017
Balance, beginning of year	$	3,753		$	1,163		$	1,110
Provision	(124		)	2,639			33
Other (deductions)/additions	(30		)	(49		)	20
Balance, end of year	$	3,599		$	3,753		$	1,163

Reserves

A number of years may elapse before a particular matter, for which we have established a reserve, is audited and finally resolved. The number of years with open tax audits varies depending on the tax jurisdiction. Our major taxing jurisdictions and the related open tax audits are as follows:



Jurisdiction	Years Open to Audit	Years Currently Under Audit
United States	2014-2018	2014-2016
Mexico	2017-2018	None
United Kingdom	2017-2018	2017
Canada (Domestic)	2015-2018	2015-2016
Canada (International)	2010-2018	2010-2016
Russia	2016-2018	None

In 2018, we recognized a non-cash tax benefit of $364 million ($0.26 per share) resulting from the conclusion of certain international tax audits. Additionally, in 2018, we recognized non-cash tax benefits of $353 million ($0.24 per share) as a result of our agreement with the IRS resolving all open matters related to the audits

of taxable years 2012 and 2013, including the associated state impact. The conclusion of certain international tax audits and the resolution with the IRS, collectively, resulted in non-cash tax benefits totaling $717 million ($0.50 per share) in 2018.

Our annual tax rate is based on our income, statutory tax rates and tax planning strategies and transactions, including transfer pricing arrangements, available to us in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax rate and in evaluating our tax positions. We establish reserves when, despite our belief that our tax return positions are fully supportable, we believe that certain positions are subject to challenge and that we likely will not succeed. We adjust these reserves, as well as the related interest, in light of changing facts and circumstances, such as the progress of a tax audit, new tax laws or tax authority settlements. Settlement of any particular issue would usually require the use of cash. Favorable resolution would be recognized as a reduction to our annual tax rate in the year of resolution.

As of December 28, 2019, the total gross amount of reserves for income taxes, reported in other liabilities, was $1.4 billion. We accrue interest related to reserves for income taxes in our provision for income taxes and any associated penalties are recorded in selling, general and administrative expenses. The gross amount of interest accrued, reported in other liabilities, was $250 million as of December 28, 2019, of which $84 million of tax expense was recognized in 2019. The gross amount of interest accrued, reported in other liabilities, was $179 million as of December 29, 2018, of which $64 million of tax benefit was recognized in 2018.

A reconciliation of unrecognized tax benefits is as follows:



	2019			2018
Balance, beginning of year	$	1,440		$	2,212
Additions for tax positions related to the current year	179			142
Additions for tax positions from prior years	93			197
Reductions for tax positions from prior years	(201		)	(822		)
Settlement payments	(74		)	(233		)
Statutes of limitations expiration	(47		)	(42		)
Translation and other	5			(14		)
Balance, end of year	$	1,395		$	1,440

Carryforwards and Allowances

Operating loss carryforwards totaling $24.7 billion at year-end 2019 are being carried forward in a number of foreign and state jurisdictions where we are permitted to use tax operating losses from prior periods to reduce future taxable income. These operating losses will expire as follows: $0.2 billion in 2020, $20.3 billion between 2021 and 2039 and $4.2 billion may be carried forward indefinitely. We establish valuation allowances for our deferred tax assets if, based on the available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized.

Undistributed International Earnings

In 2018, we repatriated $20.4 billion of cash, cash equivalents and short-term investments held in our foreign subsidiaries without such funds being subject to further U.S. federal income tax liability, related to the TCJ Act. As of December 28, 2019, we had approximately $6 billion of undistributed international earnings. We intend to continue to reinvest $6 billion of earnings outside the United States for the foreseeable future and while future distribution of these earnings would not be subject to U.S. federal tax expense, no deferred tax liabilities with respect to items such as certain foreign exchange gains or losses, foreign withholding taxes or state taxes have been recognized. It is not practicable for us to determine the amount of unrecognized tax expense on these reinvested international earnings.

Share-Based Compensation

12 Months Ended

Dec. 28, 2019

Share-based Payment Arrangement, Noncash Expense [Abstract]

Stock-Based Compensation

Note 6 — Share-Based Compensation

Our share-based compensation program is designed to attract and retain employees while also aligning employees’ interests with the interests of our shareholders. PepsiCo has granted stock options, RSUs, PSUs, PEPunits and long-term cash awards to employees under the shareholder-approved PepsiCo, Inc. Long-Term Incentive Plan (LTIP). Executives who are awarded long-term incentives based on their performance may generally elect to receive their grant in the form of stock options or RSUs, or a combination thereof. Executives who elect stock options receive four stock options for every one RSU that would have otherwise been granted. Certain executive officers and other senior executives do not have a choice and are granted 66% PSUs and 34% long-term cash, each of which are subject to pre-established performance targets.

The Company may use authorized and unissued shares to meet share requirements resulting from the exercise of stock options and the vesting of RSUs, PSUs and PEPunits.

As of December 28, 2019, 59 million shares were available for future share-based compensation grants under the LTIP.

The following table summarizes our total share-based compensation expense and excess tax benefits recognized:



	2019			2018			2017
Share-based compensation expense - equity awards	$	237		$	256		$	292
Share-based compensation expense - liability awards	8			20			13
Restructuring charges	(2		)	(6		)	(2		)
Total ^(a)	$	243		$	270		$	303
Income tax benefits recognized in earnings related to share-based compensation	$	39		$	45		$	89		^(b)
Excess tax benefits related to share-based compensation	$	50		$	48		$	115


(a)	Primarily recorded in selling, general and administrative expenses.


(b)	Reflects tax rates effective for the 2017 tax year.

As of December 28, 2019, there was $284 million of total unrecognized compensation cost related to nonvested share-based compensation grants. This unrecognized compensation cost is expected to be recognized over a weighted-average period of two years.

Method of Accounting and Our Assumptions

The fair value of share-based award grants is amortized to expense over the vesting period, primarily three years. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. In addition, we use historical data to estimate forfeiture rates and record share-based compensation expense only for those awards that are expected to vest.

We do not backdate, reprice or grant share-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP.

Stock Options

A stock option permits the holder to purchase shares of PepsiCo common stock at a specified price. We account for our employee stock options under the fair value method of accounting using a Black-Scholes valuation model to measure stock option expense at the date of grant. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of grant and generally have a 10-year term.

Our weighted-average Black-Scholes fair value assumptions are as follows:



	2019		2018		2017
Expected life	5 years		5 years		5 years
Risk-free interest rate	2.4	%	2.6	%	2.0	%
Expected volatility	14	%	12	%	11	%
Expected dividend yield	3.1	%	2.7	%	2.7	%

The expected life is the period over which our employee groups are expected to hold their options. It is based on our historical experience with similar grants. The risk-free interest rate is based on the expected U.S. Treasury rate over the expected life. Volatility reflects movements in our stock price over the most recent historical period equivalent to the expected life. Dividend yield is estimated over the expected life based on our stated dividend policy and forecasts of net income, share repurchases and stock price.

A summary of our stock option activity for the year ended December 28, 2019 is as follows:



	Options^(a)		Weighted-Average Exercise Price		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(b)
Outstanding at December 29, 2018	15,589		$	79.94
Granted	1,286		$	118.33
Exercised	(4,882	)	$	67.34
Forfeited/expired	(368	)	$	94.30
Outstanding at December 28, 2019	11,625		$	89.03	4.68	$	563,942
Exercisable at December 28, 2019	7,972		$	78.27	3.13	$	472,512
Expected to vest as of December 28, 2019	3,364		$	112.25	8.04	$	85,066


(a)	Options are in thousands and include options previously granted under the PBG plan. No additional options or shares were granted under the PBG plan after 2009.


(b)	In thousands.

Restricted Stock Units and Performance Stock Units

Each RSU represents our obligation to deliver to the holder one share of PepsiCo common stock when the award vests at the end of the service period. PSUs are awards pursuant to which a number of shares are delivered to the holder upon vesting at the end of the service period based on PepsiCo’s performance against specified financial and/or operational performance metrics. The number of shares may be increased to the maximum or reduced to the minimum threshold based on the results of these performance metrics in accordance with the terms established at the time of the award. During the vesting period, RSUs and PSUs accrue dividend equivalents that pay out in cash (without interest) if and when the applicable RSU or PSU vests and becomes payable.

The fair value of RSUs and PSUs are measured at the market price of the Company’s stock on the date of grant.

A summary of our RSU and PSU activity for the year ended December 28, 2019 is as follows:



	RSUs/PSUs^(a)		Weighted-Average Grant-Date Fair Value		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(a)
Outstanding at December 29, 2018	7,175		$	105.13
Granted ^(b)	2,754		$	116.87
Converted	(2,642	)	$	99.35
Forfeited	(852	)	$	111.11
Actual performance change ^(c)	(55	)	$	108.32
Outstanding at December 28, 2019 ^(d)	6,380		$	111.53	1.22	$	877,487
Expected to vest as of December 28, 2019	5,876		$	111.32	1.19	$	808,220


(a)	In thousands.


(b)	Grant activity for all PSUs are disclosed at target.


(c)	Reflects the net number of PSUs above and below target levels based on actual performance measured at the end of the performance period.


(d)	The outstanding PSUs for which the performance period has not ended as of December 28, 2019, at the threshold, target and maximum award levels were zero, 0.7 million and 1.3 million, respectively.

PEPunits

PEPunits provide an opportunity to earn shares of PepsiCo common stock with a value that adjusts based upon changes in PepsiCo’s absolute stock price as well as PepsiCo’s Total Shareholder Return relative to the S&P 500 over a three-year performance period.

The fair value of PEPunits is measured using the Monte-Carlo simulation model, which incorporates into the fair-value determination the possibility that the market condition may not be satisfied, until actual performance is determined.

PEPunits were last granted in 2015 and all 248,000 units outstanding at December 30, 2017, with a weighted average grant date fair value of $68.94, were converted to 278,000 shares in 2018.

Long-Term Cash

Certain executive officers and other senior executives were granted long-term cash awards for which final payout is based on PepsiCo’s Total Shareholder Return relative to a specific set of peer companies and achievement of a specified performance target over a three-year performance period.

Long-term cash awards that qualify as liability awards under share-based compensation guidance are valued through the end of the performance period on a mark-to-market basis using the Monte Carlo simulation model.

A summary of our long-term cash activity for the year ended December 28, 2019 is as follows:



	Long-Term Cash Award^(a)			Balance Sheet Date Fair Value^(a)		Contractual Life Remaining (years)
Outstanding at December 29, 2018	$	54,710
Granted^(b)	16,112
Vested	(15,438		)
Forfeited	(9,465		)
Actual performance change (c)	(1,695		)
Outstanding at December 28, 2019 ^(d)	$	44,224		$	45,875	1.10
Expected to Vest at December 28, 2019	$	42,998		$	44,557	1.10


(a)	In thousands.


(b)	Grant activity for all long-term cash awards are disclosed at target.


(c)	Reflects the net number of long-term cash awards above and below target levels based on actual performance measured at the end of the performance period.


(d)	The outstanding long-term cash awards for which the performance period has not ended as of December 28, 2019, at the threshold, target and maximum award levels were zero, 28.5 million and 57.1 million, respectively.

Other Share-Based Compensation Data

The following is a summary of other share-based compensation data:



	2019		2018		2017
Stock Options
Total number of options granted ^(a)	1,286		1,429		1,481
Weighted-average grant-date fair value of options granted	$	10.89	$	9.80	$	8.25
Total intrinsic value of options exercised ^(a)	$	275,745	$	224,663	$	327,860
Total grant-date fair value of options vested ^(a)	$	9,838	$	15,506	$	23,122
RSUs/PSUs
Total number of RSUs/PSUs granted ^(a)	2,754		2,634		2,824
Weighted-average grant-date fair value of RSUs/PSUs granted	$	116.87	$	108.75	$	109.92
Total intrinsic value of RSUs/PSUs converted ^(a)	$	333,951	$	260,287	$	380,269
Total grant-date fair value of RSUs/PSUs vested ^(a)	$	275,234	$	232,141	$	264,923
PEPunits
Total intrinsic value of PEPunits converted ^(a)	$	—	$	30,147	$	39,782
Total grant-date fair value of PEPunits vested ^(a)	$	—	$	9,430	$	18,833


(a)	In thousands.

As of December 28, 2019 and December 29, 2018, there were approximately 269,000 and 248,000 outstanding awards, respectively, consisting primarily of phantom stock units that were granted under the PepsiCo Director Deferral Program and will be settled in shares of PepsiCo common stock pursuant to the LTIP at the end of the applicable deferral period, not included in the tables above.

Pension, Retiree Medical and Savings Plans

12 Months Ended

Dec. 28, 2019

Retirement Benefits, Description [Abstract]

Pension, Retiree Medical and Savings Plans

In 2019, Plan A purchased a group annuity contract whereby a third-party insurance company assumed the obligation to pay and administer future annuity payments for certain retirees. This transaction triggered a pre-tax settlement charge in 2019 of $220 million ($170 million after-tax or $0.12 per share).

Also in 2019, certain former employees who had vested benefits in our U.S. defined benefit pension plans were offered the option of receiving a one-time lump sum payment equal to the present value of the participant’s pension benefit. This transaction triggered a pre-tax settlement charge in 2019 of $53 million ($41 million after-tax or $0.03 per share). Collectively, the group annuity contract and one-time lump sum payments to certain former employees who had vested benefits resulted in settlement charges in 2019 of $273 million ($211 million after-tax or $0.15 per share).

Effective January 1, 2017, the U.S. qualified defined benefit pension plans were reorganized into Plan A and Plan I. Actuarial gains and losses associated with Plan A are amortized over the average remaining service life of the active participants, while the actuarial gains and losses associated with Plan I are amortized over the remaining life expectancy of the inactive participants. As a result of this change, the pre-tax net periodic benefit cost decreased by $42 million ($27 million after-tax, reflecting tax rates effective for the 2017 tax year, or $0.02 per share) in 2017, primarily impacting corporate unallocated expenses.

Gains and losses resulting from actual experience differing from our assumptions, including the difference between the actual return on plan assets and the expected return on plan assets, as well as changes in our assumptions, are determined at each measurement date. These differences are recognized as a component of net gain or loss in accumulated other comprehensive loss. If this net accumulated gain or loss exceeds 10% of the greater of the market-related value of plan assets or plan liabilities, a portion of the net gain or loss is included in other pension and retiree medical benefits (expense)/income for the following year based upon the average remaining service life for participants in Plan A (approximately 10 years) and retiree medical (approximately 8 years), or the remaining life expectancy for participants in Plan I (approximately 23 years). The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost/(credit)) is included in other pension and retiree medical benefits (expense)/income on a straight-line basis over the average remaining service life for participants in Plan A or the remaining life expectancy for participants in Plan I.

Selected financial information for our pension and retiree medical plans is as follows:



	Pension												Retiree Medical
	U.S.						International
	2019			2018			2019			2018			2019			2018
Change in projected benefit liability
Liability at beginning of year	$	13,807		$	14,777		$	3,098		$	3,490		$	996		$	1,187
Service cost	381			431			73			92			23			32
Interest cost	543			482			97			93			36			34
Plan amendments	15			83			1			2			—			—
Participant contributions	—			—			2			2			—			—
Experience loss/(gain)	2,091			(972		)	515			(230		)	36			(147		)
Benefit payments	(341		)	(956		)	(100		)	(114		)	(105		)	(108		)
Settlement/curtailment	(1,268		)	(74		)	(31		)	(35		)	—			—
Special termination benefits	2			36			—			2			—			1
Other, including foreign currency adjustment	—			—			98			(204		)	2			(3		)
Liability at end of year	$	15,230		$	13,807		$	3,753		$	3,098		$	988		$	996

Change in fair value of plan assets
Fair value at beginning of year	$	12,258		$	12,582		$	3,090		$	3,460		$	285		$	321
Actual return on plan assets	3,101			(789		)	551			(136		)	78			(21		)
Employer contributions/funding	550			1,495			122			120			44			93
Participant contributions	—			—			2			2			—			—
Benefit payments	(341		)	(956		)	(100		)	(114		)	(105		)	(108		)
Settlement	(1,266		)	(74		)	(31		)	(32		)	—			—
Other, including foreign currency adjustment	—			—			98			(210		)	—			—
Fair value at end of year	$	14,302		$	12,258		$	3,732		$	3,090		$	302		$	285
Funded status	$	(928	)	$	(1,549	)	$	(21	)	$	(8	)	$	(686	)	$	(711	)



Amounts recognized
Other assets	$	744		$	185		$	99		$	81		$	—		$	—
Other current liabilities	(52		)	(107		)	(1		)	(1		)	(58		)	(41		)
Other liabilities	(1,620		)	(1,627		)	(119		)	(88		)	(628		)	(670		)
Net amount recognized	$	(928	)	$	(1,549	)	$	(21	)	$	(8	)	$	(686	)	$	(711	)

Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	$	3,516		$	4,093		$	914		$	780		$	(285	)	$	(287	)
Prior service cost/(credit)	114			109			—			(1		)	(32		)	(51		)
Total	$	3,630		$	4,202		$	914		$	779		$	(317	)	$	(338	)

Changes recognized in net (gain)/loss included in other comprehensive loss
Net (gain)/loss arising in current year	$	(120	)	$	760		$	152		$	103		$	(24	)	$	(107	)
Amortization and settlement recognition	(457		)	(187		)	(44		)	(56		)	27			8
Foreign currency translation loss/(gain)	—			—			26			(49		)	(1		)	1
Total	$	(577	)	$	573		$	134		$	(2	)	$	2		$	(98	)

Accumulated benefit obligation at end of year	$	14,255		$	12,890		$	3,441		$	2,806

The net (gain)/loss arising in the current year is attributed to the change in discount rate, primarily offset by the actual asset returns different from expected returns.

The amount we report in operating profit as pension and retiree medical cost is service cost, which is the

value of benefits earned by employees for working during the year.

The amounts we report below operating profit as pension and retiree medical cost consist of the following components:


•	Interest cost is the accrued interest on the projected benefit obligation due to the passage of time.


•	Expected return on plan assets is the long-term return we expect to earn on plan investments for our funded plans that will be used to settle future benefit obligations.


•	Amortization of prior service cost/(credit) represents the recognition in the income statement of benefit changes resulting from plan amendments.


•	Amortization of net loss/(gain) represents the recognition in the income statement of changes in the amount of plan assets and the projected benefit obligation based on changes in assumptions and actual experience.

•

Settlement/curtailment loss/(gain) represents the result of actions that effectively eliminate all or a portion of related projected benefit obligations. Settlements are triggered when payouts to settle the projected benefit obligation of a plan due to lump sums or other events exceed the annual service and interest cost. Settlements are recognized when actions are irrevocable and we are relieved of the primary responsibility and risk for projected benefit obligations. Curtailments are due to events such as plant closures or the sale of a business resulting in a reduction of future service or benefits. Curtailment losses are recognized when an event is probable and estimable, while curtailment gains are recognized when an event has occurred (when the related employees terminate or an amendment is adopted).


•	Special termination benefits are the additional benefits offered to employees upon departure due to actions such as restructuring.

The components of total pension and retiree medical benefit costs are as follows:



	Pension																		Retiree Medical
	U.S.									International
	2019			2018			2017			2019			2018			2017			2019			2018			2017
Service cost	$	381		$	431		$	401		$	73		$	92		$	91		$	23		$	32		$	28
Other pension and retiree medical benefits expense/(income):
Interest cost	$	543		$	482		$	468		$	97		$	93		$	89		$	36		$	34		$	36
Expected return on plan assets	(892		)	(943		)	(849		)	(188		)	(197		)	(176		)	(18		)	(19		)	(22		)
Amortization of prior service cost/(credits)	10			3			1			—			—			—			(19		)	(20		)	(25		)
Amortization of net losses/(gains)	161			179			123			32			45			53			(27		)	(8		)	(12		)
Settlement/curtailment losses ^(a)	296			8			8			12			6			11			—			—			—
Special termination benefits	1			36			60			—			2			—			—			1			2
Total other pension and retiree medical benefits expense/(income)	$	119		$	(235	)	$	(189	)	$	(47	)	$	(51	)	$	(23	)	$	(28	)	$	(12	)	$	(21	)
Total	$	500		$	196		$	212		$	26		$	41		$	68		$	(5	)	$	20		$	7


(a)	In 2019, U.S. includes settlement charges related to the purchase of a group annuity contract of $220 million and a pension lump sum settlement charge of $53 million.

The following table provides the weighted-average assumptions used to determine projected benefit liability and net periodic benefit cost for our pension and retiree medical plans:



	Pension												Retiree Medical
	U.S.						International
	2019		2018		2017		2019		2018		2017		2019		2018		2017
Liability discount rate	3.3	%	4.4	%	3.7	%	2.5	%	3.4	%	3.0	%	3.1	%	4.2	%	3.5	%
Service cost discount rate	4.4	%	3.8	%	4.5	%	4.2	%	3.5	%	3.6	%	4.3	%	3.6	%	4.0	%
Interest cost discount rate	4.1	%	3.4	%	3.7	%	3.2	%	2.8	%	2.8	%	3.8	%	3.0	%	3.2	%
Expected return on plan assets	7.1	%	7.2	%	7.5	%	5.8	%	6.0	%	6.0	%	6.6	%	6.5	%	7.5	%
Liability rate of salary increases	3.1	%	3.1	%	3.1	%	3.3	%	3.7	%	3.7	%
Expense rate of salary increases	3.1	%	3.1	%	3.1	%	3.7	%	3.7	%	3.6	%

The following table provides selected information about plans with accumulated benefit obligation and total projected benefit liability in excess of plan assets:



	Pension												Retiree Medical
	U.S.						International
	2019			2018			2019			2018			2019			2018
Selected information for plans with accumulated benefit obligation in excess of plan assets
Liability for service to date	$	(9,194	)	$	(8,040	)	$	(192	)	$	(155	)
Fair value of plan assets	$	8,497		$	7,223		$	151		$	121
Selected information for plans with projected benefit liability in excess of plan assets
Benefit liability	$	(10,169	)	$	(8,957	)	$	(632	)	$	(514	)	$	(988	)	$	(996	)
Fair value of plan assets	$	8,497		$	7,223		$	512		$	426		$	302		$	285

Of the total projected pension benefit liability as of December 28, 2019, approximately $847 million relates to plans that we do not fund because the funding of such plans does not receive favorable tax treatment.

Future Benefit Payments

Our estimated future benefit payments are as follows:



	2020		2021		2022		2023		2024		2025 - 2029
Pension	$	945	$	915	$	900	$	930	$	970	$	5,275
Retiree medical ^(a)	$	100	$	95	$	95	$	90	$	85	$	355


(a)	Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be approximately $2 million for each of the years from 2020 through 2024 and approximately $4 million in total for 2025 through 2029.

These future benefit payments to beneficiaries include payments from both funded and unfunded plans.

Funding

Contributions to our pension and retiree medical plans were as follows:



	Pension						Retiree Medical
	2019		2018		2017		2019		2018		2017
Discretionary ^(a)	$	417	$	1,417	$	6	$	—	$	37	$	—
Non-discretionary	255		198		158		44		56		56
Total	$	672	$	1,615	$	164	$	44	$	93	$	56


(a)	Includes $400 million contribution in 2019 and $1.4 billion contribution in 2018 to fund Plan A in the United States.

In January 2020, we made discretionary contributions of $150 million to Plan A in the United States. In addition, in 2020, we expect to make non-discretionary contributions of approximately $150 million to our U.S. and international pension benefit plans and approximately $60 million for retiree medical benefits.

We regularly evaluate opportunities to reduce risk and volatility associated with our pension and retiree medical plans.

Plan Assets

Our pension plan investment strategy includes the use of actively managed accounts and is reviewed periodically in conjunction with plan liabilities, an evaluation of market conditions, tolerance for risk and cash requirements for benefit payments. This strategy is also applicable to funds held for the retiree medical plans. Our investment objective includes ensuring that funds are available to meet the plans’ benefit obligations when they become due. Assets contributed to our pension plans are no longer controlled by us, but become the property of our individual pension plans. However, we are indirectly impacted by changes in these plan assets as compared to changes in our projected liabilities. Our overall investment policy is to prudently invest plan assets in a well-diversified portfolio of equity and high-quality debt securities and real estate to achieve our long-term return expectations. Our investment policy also permits the use of derivative instruments, such as futures and forward contracts, to reduce interest rate and foreign currency risks. Futures contracts represent commitments to purchase or sell securities at a future date and at a specified price. Forward contracts consist of currency forwards.

For 2020 and 2019, our expected long-term rate of return on U.S. plan assets is 6.8% and 7.1%, respectively. Our target investment allocations for U.S. plan assets are as follows:



	2020		2019
Fixed income	50	%	47	%
U.S. equity	25	%	29	%
International equity	21	%	20	%
Real estate	4	%	4	%

Actual investment allocations may vary from our target investment allocations due to prevailing market conditions. We regularly review our actual investment allocations and periodically rebalance our investments.

The expected return on plan assets is based on our investment strategy and our expectations for long-term rates of return by asset class, taking into account volatility and correlation among asset classes and our historical experience. We also review current levels of interest rates and inflation to assess the reasonableness of the long-term rates. We evaluate our expected return assumptions annually to ensure that they are reasonable. To calculate the expected return on plan assets, our market-related value of assets for fixed income is the actual fair value. For all other asset categories, such as equity securities, we use a method that recognizes investment gains or losses (the difference between the expected and actual return based on the market-related value of assets) over a five-year period. This has the effect of reducing year-to-year volatility.

Plan assets measured at fair value as of year-end 2019 and 2018 are categorized consistently by level, and are as follows:



	2019								2018
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
U.S. plan assets ^(a)
Equity securities, including preferred stock ^(b)	$	6,605	$	6,605	$	—	$	—	$	5,605
Government securities ^(c)	2,154		—		2,154		—		1,674
Corporate bonds ^(c)	4,737		—		4,737		—		4,145
Mortgage-backed securities ^(c)	159		—		159		—		212
Contracts with insurance companies ^(d)	9		—		—		9		9
Cash and cash equivalents	275		275		—		—		215
Sub-total U.S. plan assets	13,939		$	6,880	$	7,050	$	9	11,860
Real estate commingled funds measured at net asset value ^(e)	605								618
Dividends and interest receivable, net of payables	60								65
Total U.S. plan assets	$	14,604							$	12,543
International plan assets
Equity securities ^(b)	$	1,973	$	1,941	$	32	$	—	$	1,651
Government securities ^(c)	524		—		524		—		433
Corporate bonds ^(c)	585		—		585		—		478
Fixed income commingled funds ^(f)	384		384		—		—		356
Contracts with insurance companies ^(d)	42		—		—		42		36
Cash and cash equivalents	24		24		—		—		27
Sub-total international plan assets	3,532		$	2,349	$	1,141	$	42	2,981
Real estate commingled funds measured at net asset value ^(e)	193								102
Dividends and interest receivable	7								7
Total international plan assets	$	3,732							$	3,090


(a)	2019 and 2018 amounts include $302 million and $285 million, respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries.

(b)

The equity securities portfolio was invested in U.S. and international common stock and commingled funds, and the preferred stock portfolio in the U.S. was invested in domestic and international corporate preferred stock investments. The common stock is based on quoted prices in active markets. The commingled funds are based on the published price of the fund and the U.S. commingled funds include one large-cap fund that represents 16% and 15% of total U.S. plan assets for 2019 and 2018, respectively. The preferred stock investments are based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets.


(c)	These investments are based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets. Corporate bonds of U.S.-based companies represent 28% of total U.S. plan assets for both 2019 and 2018.


(d)	Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable. The changes in Level 3 amounts were not significant in the years ended December 28, 2019 and December 29, 2018.


(e)	The real estate commingled funds include investments in limited partnerships. These funds are based on the net asset value of the appraised value of investments owned by these funds as determined by independent third parties using inputs that are not observable. The majority of the funds are redeemable quarterly subject to availability of cash and have notice periods ranging from 45 to 90 days.


(f)	Based on the published price of the fund.

Retiree Medical Cost Trend Rates



	2020		2019
Average increase assumed	6	%	6	%
Ultimate projected increase	5	%	5	%
Year of ultimate projected increase	2039		2039

These assumed health care cost trend rates have an impact on the retiree medical plan expense and liability, however the cap on our share of retiree medical costs limits the impact.

Savings Plan

Certain U.S. employees are eligible to participate in a 401(k) savings plan, which is a voluntary defined contribution plan. The plan is designed to help employees accumulate savings for retirement, and we make Company matching contributions for certain employees on a portion of eligible pay based on years of service.

Certain U.S. salaried employees, who are not eligible to participate in a defined benefit pension plan, are also eligible to receive an employer contribution to the 401(k) savings plan based on age and years of service regardless of employee contribution.

In 2019, 2018 and 2017, our total Company contributions were $197 million, $180 million and $176 million, respectively.

Debt Obligations and Commitments

12 Months Ended

Dec. 28, 2019

Debt Obligations and Commitments [Abstract]

Debt Obligations And Commitments

Debt Obligations

The following table summarizes our debt obligations:



	2019^(a)			2018^(a)
Short-term debt obligations^(b)
Current maturities of long-term debt	$	2,848		$	3,953
Other borrowings (6.4% and 6.0%)	72			73
	$	2,920		$	4,026
Long-term debt obligations ^(b)
Notes due 2019 (3.1%)	—			3,948
Notes due 2020 (2.7% and 3.9%)	2,840			3,784
Notes due 2021 (2.4% and 3.1%)	3,276			3,257
Notes due 2022 (2.7% and 2.8%)	3,831			3,802
Notes due 2023 (2.8% and 2.9%)	1,272			1,270
Notes due 2024 (3.4% and 3.2%)	1,839			1,816
Notes due 2025-2049 (3.4% and 3.7%)	18,910			14,345
Other, due 2019-2026 (1.3% and 1.3%)	28			26
	31,996			32,248
Less: current maturities of long-term debt obligations	(2,848		)	(3,953		)
Total	$	29,148		$	28,295


(a)	Amounts are shown net of unamortized net discounts of $163 million and $119 million for 2019 and 2018, respectively.


(b)	The interest rates presented reflect weighted-average effective interest rates at year-end. Certain of our fixed rate indebtedness have been swapped to floating rates through the use of interest rate derivative instruments. See Note 9 for further information regarding our interest rate derivative instruments.

As of December 28, 2019, our international debt of $69 million was related to borrowings from external parties including various lines of credit. These lines of credit are subject to normal banking terms and conditions and are fully committed at least to the extent of our borrowings.

In 2019, we issued the following senior notes:



Interest Rate		Maturity Date	Amount^(a)
0.750	%	March 2027	€	500	^(b)
1.125	%	March 2031	€	500	^(b)
2.625	%	July 2029	$	1,000
3.375	%	July 2049	$	1,000
0.875	%	October 2039	€	500	^(b)
2.875	%	October 2049	$	1,000


(a)	Represents gross proceeds from issuances of long-term debt excluding debt issuance costs, discounts and premiums.


(b)	These notes, issued in euros, were designated as net investment hedges to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.

The net proceeds from the issuances of the above notes were used for general corporate purposes, including the repayment of commercial paper, except for an amount equivalent to the net proceeds from our 2.875% senior notes due 2049 that will be used to fund, in whole or in part, eligible green projects in the categories of investments in sustainable plastics and packaging, decarbonizing our operations and supply chain and water sustainability, which promote our selected Sustainable Development Goals, as defined by the United Nations.

In 2019, we entered into a new five-year unsecured revolving credit agreement (Five-Year Credit Agreement) which expires on June 3, 2024. The Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $3.75 billion in U.S. dollars and/or euros, including a $0.75 billion swing line subfacility for euro-denominated borrowings permitted to be borrowed on a same-day basis, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $4.5 billion (or the equivalent amount in euros). Additionally, we may, once a year, request renewal of the agreement for an additional one-year period.

In 2019, we entered into a new 364-day unsecured revolving credit agreement (364-Day Credit Agreement) which expires on June 1, 2020. The 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $3.75 billion in U.S. dollars and/or euros, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $4.5 billion (or the equivalent amount in euros). We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which would mature no later than the anniversary of the then effective termination date. The Five-Year Credit Agreement and the 364-Day Credit Agreement together replaced our $3.75 billion five-year credit agreement and our $3.75 billion 364-day credit agreement, both dated as of June 4, 2018. Funds borrowed under the Five-Year Credit Agreement and the 364-Day Credit Agreement may be used for general corporate purposes. Subject to certain conditions, we may borrow, prepay and reborrow amounts under these agreements. As of December 28, 2019, there were no outstanding borrowings under the Five-Year Credit Agreement or the 364-Day Credit Agreement.

In 2019, we entered into two unsecured bridge loan facilities (Bridge Loan Facilities) which together enable one of our consolidated subsidiaries to borrow up to 25.0 billion South African rand, or approximately $1.8 billion, to provide potential funding for our acquisition of Pioneer Foods. Each facility is available from the date the conditions precedent are met for the acquisition up through July 30, 2020 in the case of one facility and July 31, 2020 in the case of the other facility. Borrowings under the facilities are for up to one year once drawn and can be prepaid at any time. Interest rates are reset either every one month or three months. As of December 28, 2019, there were no outstanding borrowings under the Bridge Loan Facilities.

In 2019, we paid $1.0 billion to redeem all $1.0 billion outstanding principal amount of our 4.50% senior notes due 2020.

In 2018, we completed a cash tender offer for certain notes issued by PepsiCo and predecessors to a PepsiCo subsidiary for $1.6 billion in cash to redeem the following amounts:



Interest Rate		Maturity Date	Amount Tendered
7.290	%	September 2026	$	11
7.440	%	September 2026	$	4
7.000	%	March 2029	$	357
5.500	%	May 2035	$	138
4.875	%	November 2040	$	410
5.500	%	January 2040	$	408

Also in 2018, we completed an exchange offer for certain notes issued by predecessors to a PepsiCo subsidiary for the following newly issued PepsiCo notes. These notes were issued in an aggregate principal amount equal to the exchanged notes:



Interest Rate		Maturity Date	Amount Exchanged
7.290	%	September 2026	$	88
7.440	%	September 2026	$	21
7.000	%	March 2029	$	516
5.500	%	May 2035	$	107

As a result of the above transactions, we recorded a pre-tax charge of $253 million ($191 million after-tax or $0.13 per share) to interest expense in 2018, primarily representing the tender price paid over the carrying value of the tendered notes.

Financial Instruments

12 Months Ended

Dec. 28, 2019

Derivative Instruments and Hedges, Assets [Abstract]

Financial Instruments

Derivatives and Hedging

We are exposed to market risks arising from adverse changes in:


•	commodity prices, affecting the cost of our raw materials and energy;


•	foreign exchange rates and currency restrictions; and


•	interest rates.

In the normal course of business, we manage commodity price, foreign exchange and interest rate risks through a variety of strategies, including productivity initiatives, global purchasing programs and hedging. Ongoing productivity initiatives involve the identification and effective implementation of meaningful cost-saving opportunities or efficiencies, including the use of derivatives. Our global purchasing programs include fixed-price contracts and purchase orders and pricing agreements.

Our hedging strategies include the use of derivatives and, in the case of our net investment hedges, debt instruments. Certain derivatives are designated as either cash flow or fair value hedges and qualify for hedge accounting treatment, while others do not qualify and are marked to market through earnings. The accounting for qualifying hedges allows changes in a hedging instrument’s fair value to offset corresponding changes in the hedged item in the same reporting period that the hedged item impacts earnings. Gains or losses on derivatives designated as cash flow hedges are recorded in accumulated other comprehensive loss and reclassified to our income statement when the hedged transaction affects earnings. If it becomes probable that the hedged transaction will not occur, we immediately recognize the related hedging gains or losses in earnings; such gains or losses reclassified during the year ended December 28, 2019 were not material.

Cash flows from derivatives used to manage commodity price, foreign exchange or interest rate risks are classified as operating activities in the cash flow statement. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item.

We do not use derivative instruments for trading or speculative purposes. We perform assessments of our counterparty credit risk regularly, including reviewing netting agreements, if any, and a review of credit ratings, credit default swap rates and potential nonperformance of the counterparty. Based on our most recent assessment of our counterparty credit risk, we consider this risk to be low. In addition, we enter into derivative contracts with a variety of financial institutions that we believe are creditworthy in order to reduce our concentration of credit risk.

Certain of our agreements with our counterparties require us to post full collateral on derivative instruments in a net liability position if our credit rating is at A2 (Moody’s Investors Service, Inc.) or A (S&P Global Ratings) and we have been placed on credit watch for possible downgrade or if our credit rating falls below these levels. The fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position on December 28, 2019 was $415 million. We have posted no collateral under these contracts and no credit-risk-related contingent features were triggered as of December 28, 2019.

Commodity Prices

We are subject to commodity price risk because our ability to recover increased costs through higher pricing may be limited in the competitive environment in which we operate. This risk is managed through the use of fixed-price contracts and purchase orders, pricing agreements and derivative instruments, which primarily include swaps and futures. In addition, risk to our supply of certain raw materials is mitigated through purchases from multiple geographies and suppliers. We use derivatives, with terms of no more than three years, to hedge price fluctuations related to a portion of our anticipated commodity purchases, primarily for energy, agricultural products and metals. Derivatives used to hedge commodity price risk that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit.

Our commodity derivatives had a total notional value of $1.1 billion as of December 28, 2019 and December 29, 2018.

Foreign Exchange

We are exposed to foreign exchange risks in the international markets in which our products are made, manufactured, distributed or sold. Additionally, we are exposed to foreign exchange risk from net investments in foreign subsidiaries, foreign currency purchases and foreign currency assets and liabilities created in the normal course of business. We manage this risk through sourcing purchases from local suppliers, negotiating contracts in local currencies with foreign suppliers and through the use of derivatives, primarily forward contracts with terms of no more than two years. Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses on our income statement as incurred. We also use net investment hedges to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.

Our foreign currency derivatives had a total notional value of $1.9 billion as of December 28, 2019 and $2.0 billion as of December 29, 2018. The total notional amount of our debt instruments designated as net investment hedges was $2.5 billion as of December 28, 2019 and $0.9 billion as of December 29, 2018. For foreign currency derivatives that do not qualify for hedge accounting treatment, gains and losses were offset by changes in the underlying hedged items, resulting in no material net impact on earnings.

Interest Rates

We centrally manage our debt and investment portfolios considering investment opportunities and risks, tax consequences and overall financing strategies. We use various interest rate derivative instruments including, but not limited to, interest rate swaps, cross-currency interest rate swaps, Treasury locks and swap locks to manage our overall interest expense and foreign exchange risk. These instruments effectively change the interest rate and currency of specific debt issuances. Certain of our fixed rate indebtedness have been swapped to floating rates. The notional amount, interest payment and maturity date of the interest rate and cross-currency interest rate swaps match the principal, interest payment and maturity date of the related debt. Our cross-currency interest rate swaps have terms of no more than twelve years. Our Treasury locks and swap locks are entered into to protect against unfavorable interest rate changes relating to forecasted debt transactions.

Our interest rate derivatives had a total notional value of $5.0 billion as of December 28, 2019 and $10.5 billion as of December 29, 2018.

As of December 28, 2019, approximately 9% of total debt, after the impact of the related interest rate derivative instruments, was subject to variable rates, compared to approximately 29% as of December 29, 2018.

Available-for-Sale Securities

Investments in debt securities are classified as available-for-sale. All highly liquid investments with original maturities of three months or less are classified as cash equivalents. Our investments in available-for-sale debt securities are reported at fair value. Unrealized gains and losses related to changes in the fair value of available-for-sale debt securities are recognized in accumulated other comprehensive loss within common shareholders’ equity. Unrealized gains and losses on our investments in debt securities as of December 28, 2019 and December 29, 2018 were not material. Changes in the fair value of available-for-sale debt securities impact net income only when such securities are sold or an other-than-temporary impairment is recognized. We recorded no other-than-temporary impairment charges on our available-for-sale debt securities for the years ended December 28, 2019, December 29, 2018 and December 30, 2017.

In 2017, we recorded a pre-tax gain of $95 million ($85 million after-tax or $0.06 per share), net of discount and fees, associated with the sale of our minority stake in Britvic. The gain on the sale of this equity investment was recorded in our Europe segment in selling, general and administrative expenses.

Fair Value Measurements

The fair values of our financial assets and liabilities as of December 28, 2019 and December 29, 2018 are categorized as follows:



		2019				2018
	Fair Value Hierarchy Levels^(a)	Assets^(a)		Liabilities^(a)		Assets^(a)		Liabilities^(a)
Available-for-sale debt securities ^(b)	2	$	—	$	—	$	3,658	$	—
Short-term investments ^(c)	1	$	229	$	—	$	196	$	—
Prepaid forward contracts ^(d)	2	$	17	$	—	$	22	$	—
Deferred compensation ^(e)	2	$	—	$	468	$	—	$	450
Derivatives designated as fair value hedging instruments:
Interest rate ^(f)	2	$	—	$	5	$	1	$	108
Derivatives designated as cash flow hedging instruments:
Foreign exchange ^(g)	2	$	5	$	32	$	44	$	14
Interest rate ^(g)	2	—		390		—		323
Commodity ^(h)	1	2		5		—		1
Commodity ⁽ⁱ⁾	2	2		5		—		3
		$	9	$	432	$	44	$	341
Derivatives not designated as hedging instruments:
Foreign exchange ^(g)	2	$	3	$	2	$	3	$	10
Commodity ^(h)	1	23		7		2		17
Commodity ⁽ⁱ⁾	2	6		24		5		92
		$	32	$	33	$	10	$	119
Total derivatives at fair value ^(j)		$	41	$	470	$	55	$	568
Total		$	287	$	938	$	3,931	$	1,018


(a)	Fair value hierarchy levels are defined in Note 7. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities.


(b)	Based on quoted broker prices or other significant inputs derived from or corroborated by observable market data. As of December 29, 2018, these debt securities were primarily classified as cash equivalents. The decrease in available-for-sale debt securities was due to maturities and sales during the current year.


(c)	Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.


(d)	Based primarily on the price of our common stock.


(e)	Based on the fair value of investments corresponding to employees’ investment elections.

(f)

Based on LIBOR forward rates. As of December 28, 2019 and December 29, 2018, the carrying amount of hedged fixed-rate debt was $2.2 billion and $7.7 billion, respectively, and classified on our balance sheet within short-term and long-term debt obligations. As of December 28, 2019, the cumulative amount of fair value hedging adjustments to hedged fixed-rate debt was $5 million. As of December 28, 2019, the cumulative amount of fair value hedging adjustments on discontinued hedges was a $49 million loss, which is being amortized over the remaining life of the related debt obligations.


(g)	Based on recently reported market transactions of spot and forward rates.


(h)	Based on quoted contract prices on futures exchange markets.


(i)	Based on recently reported market transactions of swap arrangements.

(j)

Derivative assets and liabilities are presented on a gross basis on our balance sheet. Amounts subject to enforceable master netting arrangements or similar agreements which are not offset on the balance sheet as of December 28, 2019 and December 29, 2018 were not material. Collateral received or posted against our asset or liability positions is classified as restricted cash. See Note 15 for further information.

The carrying amounts of our cash and cash equivalents and short-term investments approximate fair value due to their short-term maturity. The fair value of our debt obligations as of December 28, 2019 and

December 29, 2018 was $34 billion and $32 billion, respectively, based upon prices of similar instruments in the marketplace, which are considered Level 2 inputs.

Losses/(gains) on our hedging instruments are categorized as follows:



	Fair Value/Non- designated Hedges					Cash Flow and Net Investment Hedges
	Losses/(Gains) Recognized in Income Statement^(a)					Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss						Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement^(b)
	2019			2018		2019			2018			2019		2018
Foreign exchange	$	(1	)	$	9	$	57		$	(52	)	$	3	$	(8	)
Interest rate	(64		)	53		67			110			7		119
Commodity	(17		)	117		7			3			4		—
Net investment	—			—		(30		)	(77		)	—		—
Total	$	(82	)	$	179	$	101		$	(16	)	$	14	$	111

(a)

Foreign exchange derivative losses/gains are primarily included in selling, general and administrative expenses. Interest rate derivative losses/gains are primarily from fair value hedges and are included in interest expense. These losses/gains are substantially offset by decreases/increases in the value of the underlying debt, which are also included in interest expense. Commodity derivative losses/gains are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.


(b)	Foreign exchange derivative losses/gains are primarily included in cost of sales. Interest rate derivative losses/gains are included in interest expense. Commodity derivative losses/gains are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.

Based on current market conditions, we expect to reclassify net losses of $47 million related to our cash flow hedges from accumulated other comprehensive loss into net income during the next 12 months.

Accumulated Other Comprehensive Loss Attributable to Pepsico

12 Months Ended

Dec. 28, 2019

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Comprehensive Income (Loss) Note [Text Block]

Accumulated Other Comprehensive Loss Attributable to PepsiCo

The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows:



	Currency Translation Adjustment			Cash Flow Hedges			Pension and Retiree Medical			Available-For-Sale Securities			Other			Accumulated Other Comprehensive Loss Attributable to PepsiCo
Balance as of December 31, 2016 ^(a)	$	(11,386	)	$	83		$	(2,645	)	$	64		$	(35	)	$	(13,919	)
Other comprehensive (loss)/income before reclassifications ^(b)	1,049			130			(375		)	25			—			829
Amounts reclassified from accumulated other comprehensive loss	—			(171		)	158			(99		)	—			(112		)
Net other comprehensive (loss)/income	1,049			(41		)	(217		)	(74		)	—			717
Tax amounts	60			5			58			6			16			145
Balance as of December 30, 2017 ^(a)	(10,277		)	47			(2,804		)	(4		)	(19		)	(13,057		)
Other comprehensive (loss)/income before reclassifications ^(c)	(1,664		)	(61		)	(813		)	6			—			(2,532		)
Amounts reclassified from accumulated other comprehensive loss	44			111			218			—			—			373
Net other comprehensive (loss)/income	(1,620		)	50			(595		)	6			—			(2,159		)
Tax amounts	(21		)	(10		)	128			—			—			97
Balance as of December 29, 2018^(a)	(11,918		)	87			(3,271		)	2			(19		)	(15,119		)
Other comprehensive (loss)/income before reclassifications ^(d)	636			(131		)	(89		)	(2		)	—			414
Amounts reclassified from accumulated other comprehensive loss	—			14			468			—			—			482
Net other comprehensive (loss)/income	636			(117		)	379			(2		)	—			896
Tax amounts	(8		)	27			(96		)	—			—			(77		)
Balance as of December 28, 2019 ^(a)	$	(11,290	)	$	(3	)	$	(2,988	)	$	—		$	(19	)	$	(14,300	)


(a)	Pension and retiree medical amounts are net of taxes of $1,280 million as of December 31, 2016, $1,338 million as of December 30, 2017, $1,466 million as of December 29, 2018 and $1,370 million as of December 28, 2019.


(b)	Currency translation adjustment primarily reflects the appreciation of the euro, Russian ruble, Pound sterling and Canadian dollar.


(c)	Currency translation adjustment primarily reflects the depreciation of the Russian ruble, Canadian dollar, Pound sterling and Brazilian real.


(d)	Currency translation adjustment primarily reflects the appreciation of the Russian ruble, Canadian dollar, Mexican peso and Pound sterling.

The following table summarizes the reclassifications from accumulated other comprehensive loss to the income statement:



	Amount Reclassified from Accumulated Other Comprehensive Loss									Affected Line Item in the Income Statement
	2019			2018			2017
Currency translation:
Divestitures	$	—		$	44		$	—		Selling, general and administrative expenses

Cash flow hedges:
Foreign exchange contracts	$	1		$	(1	)	$	—		Net revenue
Foreign exchange contracts	2			(7		)	10			Cost of sales
Interest rate derivatives	7			119			(184		)	Interest expense
Commodity contracts	3			3			4			Cost of sales
Commodity contracts	1			(3		)	(1		)	Selling, general and administrative expenses
Net losses/(gains) before tax	14			111			(171		)
Tax amounts	(2		)	(27		)	64
Net losses/(gains) after tax	$	12		$	84		$	(107	)

Pension and retiree medical items:
Amortization of net prior service credit	$	(9	)	$	(17	)	$	(24	)	Other pension and retiree medical benefits (expense)/income
Amortization of net losses	169			216			167			Other pension and retiree medical benefits (expense)/income
Settlement/curtailment losses	308			19			15			Other pension and retiree medical benefits (expense)/income
Net losses before tax	468			218			158
Tax amounts	(102		)	(45		)	(44		)
Net losses after tax	$	366		$	173		$	114

Available-for-sale securities:
Sale of Britvic securities	$	—		$	—		$	(99	)	Selling, general and administrative expenses
Tax amount	—			—			10
Net gain after tax	$	—		$	—		$	(89	)

Total net losses/(gains) reclassified for the year, net of tax	$	378		$	301		$	(82	)

Acquisitions & Divestitures (Notes)

12 Months Ended

Dec. 28, 2019

Acquisitions & Divestitures [Abstract]

Mergers, Acquisitions and Dispositions Disclosures [Text Block]

Acquisitions and Divestitures

Acquisition of Pioneer Food Group Ltd.

On July 19, 2019, we entered into an agreement to acquire all of the outstanding shares of Pioneer Foods, a food and beverage company in South Africa with exports to countries across the globe, for 110.00 South African rand per share in cash, in a transaction valued at approximately $1.7 billion. Also in 2019, one of our consolidated subsidiaries entered into Bridge Loan Facilities to provide potential funding for our acquisition of Pioneer Foods. See Note 8 for further information.

The transaction is subject to certain regulatory approvals and other customary conditions and is expected to be recorded primarily in the AMESA segment. Closing is expected in the first half of 2020.

Acquisition of SodaStream International Ltd.

On December 5, 2018, we acquired all of the outstanding shares of SodaStream, a manufacturer and distributor of sparkling water makers, for $144.00 per share in cash, in a transaction valued at approximately $3.3 billion. The total consideration transferred was approximately $3.3 billion (or $3.2 billion, net of cash and cash equivalents acquired).

We accounted for the transaction as a business combination. We recognized and measured the identifiable assets acquired and liabilities assumed at their estimated fair values on the date of acquisition. The purchase price allocation was finalized in the fourth quarter of 2019.

The following table summarizes the fair value of identifiable assets acquired and liabilities assumed in the acquisition of SodaStream and the resulting goodwill as of the acquisition date, all of which are recorded in the Europe segment.



Inventories	$	176
Property, plant and equipment	193
Amortizable intangible assets	284
Nonamortizable intangible asset (brand)	1,840
Other assets and liabilities	210
Net deferred income taxes	(303		)
Total identifiable net assets	$	2,400
Goodwill	943
Total purchase price	$	3,343

Goodwill is calculated as the excess of the aggregate of the fair value of the consideration transferred over the fair value of the net assets recognized. The goodwill recorded as part of the acquisition of SodaStream primarily reflects the value of expected synergies from our product portfolios and is not deductible for tax purposes.

Refranchising in Thailand

In 2018, we refranchised our beverage business in Thailand by selling a controlling interest in our Thailand bottling operations to form a joint venture, where we now have an equity method investment. We recorded a pre-tax gain of $144 million ($126 million after-tax or $0.09 per share) in selling, general and administrative expenses in our APAC segment as a result of this transaction.

Refranchising in Czech Republic, Hungary, and Slovakia

In 2018, we refranchised our entire beverage bottling operations and snack distribution operations in CHS. We recorded a pre-tax gain of $58 million ($46 million after-tax or $0.03 per share) in selling, general and administrative expenses in our Europe segment as a result of this transaction.

Refranchising in Jordan

In 2017, we refranchised our beverage business in Jordan by selling a controlling interest in our Jordan bottling operations to form a joint venture, where we now have an equity method investment. We recorded a pre-tax gain of $140 million ($107 million after-tax or $0.07 per share) in selling, general and administrative expenses in our AMESA segment as a result of this transaction.

Inventory Fair Value Adjustments and Merger and Integration Charges

In 2019, we recorded inventory fair value adjustments and merger and integration charges of $55 million ($47 million after-tax or $0.03 per share), including $46 million in our Europe segment, $7 million in our AMESA segment and $2 million in corporate unallocated expenses. These charges are primarily related to fair value adjustments to the acquired inventory included in SodaStream’s balance sheet at the acquisition date, recorded in cost of sales, as well as merger and integration charges, including employee-related costs, recorded in selling, general and administrative expenses.

In 2018, we recorded merger and integration charges of $75 million ($0.05 per share), including $57 million in our Europe segment and $18 million in corporate unallocated expenses, related to our acquisition of SodaStream, recorded in selling, general and administrative expenses. These charges include closing costs, advisory fees and employee-related costs.

Selected Quarterly Financial Data (Unaudited) (Notes)

12 Months Ended

Dec. 28, 2019

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information [Text Block]

Selected Quarterly Financial Data (unaudited)

Selected financial data for 2019 and 2018 is summarized as follows and highlights certain items that impacted our quarterly results:



	2019												2018
	First Quarter			Second Quarter			Third Quarter			Fourth Quarter			First Quarter			Second Quarter			Third Quarter			Fourth Quarter
Net revenue	$	12,884		$	16,449		$	17,188		$	20,640		$	12,562		$	16,090		$	16,485		$	19,524
Gross profit	$	7,196		$	9,045		$	9,494		$	11,294		$	6,907		$	8,827		$	8,958		$	10,588
Operating profit	$	2,008		$	2,729		$	2,855		$	2,699		$	1,807		$	3,028		$	2,844		$	2,431
Mark-to-market net impact ^(a)	$	60		$	(6	)	$	(4	)	$	62		$	(31	)	$	3		$	(29	)	$	(106	)
Restructuring and impairment charges ^(b)	$	(26	)	$	(158	)	$	(98	)	$	(88	)	$	(12	)	$	(32	)	$	(35	)	$	(229	)
Inventory fair value adjustments and merger and integration charges ^(c)	$	(15	)	$	(24	)	$	(7	)	$	(9	)	—			—			—			$	(75	)
Pension-related settlement charges ^(d)	—			—			—			$	(273	)	—			—			—			—
Net tax related to the TCJ Act ^(e)	$	29		—			—			$	(21	)	$	(1	)	$	(777	)	$	(76	)	$	882
Gains on sale of assets ^(f)	—			$	32		—			$	45		$	18		$	9		$	37		$	12
Other net tax benefits ^(g)	—			—			—			—			—			$	314		$	364		$	4,386
Charges related to cash tender and exchange offers ^(h)	—			—			—			—			—			—			—			$	(253	)
Tax reform bonus ⁽ⁱ⁾	—			—			—			—			$	(87	)	—			—			—
Gains on beverage refranchising ^(j)	—			—			—			—			—			$	144		—			$	58
Provision for/(benefit from) income taxes^(e)(f)	$	446		$	524		$	559		$	430		$	304		$	1,070		$	188		$	(4,932	)
Net income attributable to PepsiCo	$	1,413		$	2,035		$	2,100		$	1,766		$	1,343		$	1,820		$	2,498		$	6,854
Net income attributable to PepsiCo per common share
Basic	$	1.01		$	1.45		$	1.50		$	1.27		$	0.94		$	1.28		$	1.77		$	4.86
Diluted	$	1.00		$	1.44		$	1.49		$	1.26		$	0.94		$	1.28		$	1.75		$	4.83
Cash dividends declared per common share	$	0.9275		$	0.955		$	0.955		$	0.955		$	0.805		$	0.9275		$	0.9275		$	0.9275


(a)	Mark-to-market net gains and losses on commodity derivatives in corporate unallocated expenses.


(b)	Expenses related to the 2019 and 2014 Productivity Plans. See Note 3 to our consolidated financial statements for further information.


(c)	In 2019, inventory fair value adjustments and merger and integration charges primarily related to our acquisition of SodaStream. In 2018, merger and integration charges related to our acquisition of SodaStream. See Note 14 to our consolidated financial statements for further information.


(d)	In 2019, pension settlement charges of $220 million related to the purchase of a group annuity contract and settlement charges of $53 million related to one-time lump sum payments to certain former employees who had vested benefits, recorded in other pension and retiree medical benefits expense/income. See Note 7 to our consolidated financial statements for further information.


(e)	Net tax related to the TCJ Act. See Note 5 to our consolidated financial statements for further information.


(f)	In 2019, gains associated with the sale of assets in the following segments: $31 million in FLNA and $46 million in PBNA. In 2018, gains associated with the sale of assets in the following segments: $64 million in PBNA and $12 million in AMESA.

(g)

In 2018, other net tax benefits of $4.3 billion resulting from the reorganization of our international operations, including the intercompany transfer of certain intangible assets. Also in 2018, non-cash tax benefits of $717 million associated with both the conclusion of certain international tax audits and our agreement with the IRS resolving all open matters related to the audits of taxable years 2012 and 2013. See Note 5 to our consolidated financial statements for further information.


(h)	In 2018, interest expense in connection with our cash tender and exchange offers, primarily representing the tender price paid over the carrying value of the tendered notes. See Note 8 to our consolidated financial statements for further information.


(i)	In 2018, bonus extended to certain U.S. employees related to the TCJ Act in the following segments: $44 million in FLNA, $2 million in QFNA and $41 million in PBNA.

(j)

In 2018, gains of $58 million and $144 million associated with refranchising our entire beverage bottling operations and snack distribution operations in CHS in the Europe segment and refranchising a portion of our beverage business in Thailand in the APAC segment, respectively. See Note 14 to our consolidated financial statements for further information.

Basis of Presentation and Our Divisions Basis of Presentation and Our Divisions (Policies)

12 Months Ended

Dec. 28, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Consolidation, Policy

Use of Estimates, Policy

Fiscal Period, Policy



Quarter	United States and Canada	International
First Quarter	12 weeks	January, February
Second Quarter	12 weeks	March, April and May
Third Quarter	12 weeks	June, July and August
Fourth Quarter	16 weeks	September, October, November and December

Our Significant Accounting Policies (Policies)

12 Months Ended

Dec. 28, 2019

Accounting Policies [Abstract]

Revenue [Policy Text Block]

Revenue Recognition

Sales Incentives And Other Marketplace Spending, Policy [Policy Text Block]

Total Marketplace Spending


•	media and personal service prepayments;


•	promotional materials in inventory; and


•	production costs of future media advertising.

Shipping and Handling Cost, Policy [Policy Text Block]

Distribution Costs

Internal Use Software, Policy [Policy Text Block]

Software Costs

Commitments and Contingencies, Policy [Policy Text Block]

Commitments and Contingencies

Research and Development Expense, Policy [Policy Text Block]

Research and Development

Goodwill and Intangible Assets, Policy [Policy Text Block]

Goodwill and Other Intangible Assets

information and are consistent with our internal forecasts and operating plans. A deterioration in these assumptions could adversely impact our results.

Other Significant Accounting Policies [Policy Text Block]

Other Significant Accounting Policies

Our other significant accounting policies are disclosed as follows:


•	Basis of Presentation – Note 1 includes a description of our policies regarding use of estimates, basis of presentation and consolidation.


•	Property, Plant and Equipment – Note 4.


•	Income Taxes – Note 5.


•	Share-Based Compensation – Note 6.


•	Pension, Retiree Medical and Savings Plans – Note 7.


•	Financial Instruments – Note 9.


•	Cash Equivalents – Cash equivalents are highly liquid investments with original maturities of three months or less.


•	Inventories – Note 15. Inventories are valued at the lower of cost or net realizable value. Cost is determined using the average; first-in, first-out (FIFO) or, in limited instances, last-in, first-out (LIFO) methods.

•

Property, Plant and Equipment and Intangible Assets Property, Plant and Equipment and Intangible Assets (Policies)	12 Months Ended
	Dec. 28, 2019
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Policy	Property, plant and equipment is recorded at historical cost. Depreciation and amortization are recognized on a straight-line basis over an asset’s estimated useful life. Land is not depreciated and construction in progress is not depreciated until ready for service.
Property, Plant and Equipment, Impairment	Depreciable and amortizable assets are evaluated for impairment upon a significant change in the operating or macroeconomic environment. In these circumstances, if an evaluation of the undiscounted cash flows indicates impairment, the asset is written down to its estimated fair value, which is based on discounted future cash flows. Useful lives are periodically evaluated to determine whether events or circumstances have occurred which indicate the need for revision.
Intangible Assets Disclosure [Text Block]	Indefinite-Lived Intangible Assets We did not recognize any impairment charges for goodwill in each of the years ended December 28, 2019, December 29, 2018 and December 30, 2017. We did not recognize any material impairment charges for indefinite-lived intangible assets in each of the years ended December 28, 2019, December 29, 2018 and December 30, 2017. As of December 28, 2019, the estimated fair values of our indefinite-lived reacquired and acquired franchise rights recorded at PBNA exceeded their carrying values. However, there could be an impairment of the carrying value of PBNA’s reacquired and acquired franchise rights if future revenues and their contribution to the operating results of PBNA’s CSD business do not achieve our expected future cash flows or if macroeconomic conditions result in a future increase in the weighted-average cost of capital used to estimate fair value. We have also analyzed the impact of the macroeconomic conditions in Russia and Brazil on the estimated fair value of our indefinite-lived intangible assets in these countries and have concluded that there were no impairments for the year ended December 28, 2019. However, there could be an impairment of the carrying value of certain brands in these countries, including juice and dairy brands in Russia, if there is a deterioration in these conditions, if future revenues and their contributions to the operating results do not achieve our expected future cash flows (including perpetuity growth assumptions), if there are significant changes in the decisions regarding assets that do not perform consistent with our expectations, or if macroeconomic conditions result in a future increase in the weighted-average cost of capital used to estimate fair value. For further information on our policies for indefinite-lived intangible assets, see Note 2.

Pension, Retiree Medical and Savings Plans Pension, Retiree Medical and Savings Plans (Policies)	12 Months Ended
	Dec. 28, 2019
Retirement Benefits [Abstract]
Pension and Other Postretirement Plans, Policy [Policy Text Block]	Effective January 1, 2017, the U.S. qualified defined benefit pension plans were reorganized into Plan A and Plan I. Actuarial gains and losses associated with Plan A are amortized over the average remaining service life of the active participants, while the actuarial gains and losses associated with Plan I are amortized over the remaining life expectancy of the inactive participants. As a result of this change, the pre-tax net periodic benefit cost decreased by $42 million ($27 million after-tax, reflecting tax rates effective for the 2017 tax year, or $0.02 per share) in 2017, primarily impacting corporate unallocated expenses. Gains and losses resulting from actual experience differing from our assumptions, including the difference between the actual return on plan assets and the expected return on plan assets, as well as changes in our assumptions, are determined at each measurement date. These differences are recognized as a component of net gain or loss in accumulated other comprehensive loss. If this net accumulated gain or loss exceeds 10% of the greater of the market-related value of plan assets or plan liabilities, a portion of the net gain or loss is included in other pension and retiree medical benefits (expense)/income for the following year based upon the average remaining service life for participants in Plan A (approximately 10 years) and retiree medical (approximately 8 years), or the remaining life expectancy for participants in Plan I (approximately 23 years). The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost/(credit)) is included in other pension and retiree medical benefits (expense)/income on a straight-line basis over the average remaining service life for participants in Plan A or the remaining life expectancy for participants in Plan I.

- Definition

Disclosure of accounting policy for pension and other postretirement benefit plans. This accounting policy may address (1) the types of plans sponsored by the entity, and the benefits provided by each plan (2) groups that participate in (or are covered by) each plan (3) how plan assets, liabilities and expenses are measured, including the use of any actuaries and (4) significant assumptions used by the entity to value plan assets and liabilities and how such assumptions are derived.

+ References + Details

Basis of Presentation and Our Divisions (Tables)

12 Months Ended

Dec. 28, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Fiscal Period

The following chart details our quarterly reporting schedule for the three years presented:



Quarter	United States and Canada	International
First Quarter	12 weeks	January, February
Second Quarter	12 weeks	March, April and May
Third Quarter	12 weeks	June, July and August
Fourth Quarter	16 weeks	September, October, November and December

Share Based Compensation Percentage Allocation by Division [Table Text Block]

Share-Based Compensation Expense

Our divisions are held accountable for share-based compensation expense and, therefore, this expense is allocated to our divisions as an incremental employee compensation cost.

The allocation of share-based compensation expense of each division is as follows:



	2019		2018		2017
FLNA	13	%	13	%	13	%
QFNA	1	%	1	%	1	%
PBNA	17	%	18	%	18	%
LatAm	7	%	8	%	7	%
Europe	17	%	9	%	9	%
AMESA	3	%	4	%	5	%
APAC	5	%	4	%	4	%
Corporate unallocated expenses	37	%	43	%	43	%

Schedule of Segment Reporting Information, by Segment

Net revenue and operating profit of each division are as follows:



	Net Revenue						Operating Profit
	2019^(a)		2018^(a)		2017		2019			2018			2017
FLNA	$	17,078	$	16,346	$	15,798	$	5,258		$	5,008		$	4,793
QFNA	2,482		2,465		2,503		544			637			640
PBNA	21,730		21,072		20,936		2,179			2,276			2,700
LatAm	7,573		7,354		7,208		1,141			1,049			924
Europe	11,728		10,973		10,522		1,327			1,256			1,199
AMESA	3,651		3,657		3,674		671			661			789
APAC	2,919		2,794		2,884		477			619			401
Total division	67,161		64,661		63,525		11,597			11,506			11,446
Corporate unallocated expenses	—		—		—		(1,306		)	(1,396		)	(1,170		)
Total	$	67,161	$	64,661	$	63,525	$	10,291		$	10,110		$	10,276

(a)

Segment Reporting Information By Total Assets And Capital Spending

Total assets and capital spending of each division are as follows:



	Total Assets				Capital Spending
	2019		2018		2019		2018		2017
FLNA	$	7,519	$	6,577	$	1,227	$	840	$	665
QFNA	941		870		104		53		44
PBNA	31,449		29,878		1,053		945		904
LatAm	7,007		6,458		557		492		481
Europe	17,814		16,887		613		466		463
AMESA	3,672		3,252		267		198		181
APAC	4,113		3,704		195		138		145
Total division	72,515		67,626		4,016		3,132		2,883
Corporate^(a)	6,032		10,022		216		150		86
Total	$	78,547	$	77,648	$	4,232	$	3,282	$	2,969

(a)

Corporate assets consist principally of certain cash and cash equivalents, restricted cash, short-term investments, derivative instruments, property, plant and equipment and tax assets. In 2019, the change in assets was primarily due to a decrease in cash and cash equivalents and restricted cash.

Segment Reporting Information By Amortization Of Intangible Assets And Depreciation And Other Amortization

Amortization of intangible assets and depreciation and other amortization of each division are as follows:



	Amortization of Intangible Assets						Depreciation and Other Amortization
	2019		2018		2017		2019		2018		2017
FLNA	$	7	$	7	$	7	$	492	$	457	$	449
QFNA	—		—		—		44		45		47
PBNA	29		31		31		857		821		780
LatAm	5		5		5		270		253		245
Europe	37		23		22		341		319		317
AMESA	2		2		2		116		169		170
APAC	1		1		1		76		80		99
Total division	81		69		68		2,196		2,144		2,107
Corporate	—		—		—		155		186		194
Total	$	81	$	69	$	68	$	2,351	$	2,330	$	2,301

Segment Reporting Information By Net Revenue And Long-Lived Assets

Net revenue and long-lived assets by country are as follows:



	Net Revenue						Long-Lived Assets^(a)
	2019		2018		2017		2019		2018
United States	$	38,644	$	37,148	$	36,546	$	30,601	$	29,169
Mexico	4,190		3,878		3,650		1,666		1,404
Russia	3,263		3,191		3,232		4,314		3,926
Canada	2,831		2,736		2,691		2,695		2,565
United Kingdom	1,723		1,743		1,650		827		759
China	1,300		1,164		963		705		509
Brazil	1,295		1,335		1,427		590		639
All other countries	13,915		13,466		13,366		12,134		11,660
Total	$	67,161	$	64,661	$	63,525	$	53,532	$	50,631

(a)

Restructuring, Impairment and Integration Charges (Tables)

12 Months Ended

Dec. 28, 2019

Total Restructuring Cost and Reserve [Line Items]

Restructuring and Related Costs [Table Text Block]

A summary of our restructuring and impairment charges and other productivity initiatives is as follows:



	2019		2018		2017
2019 Productivity Plan	$	370	$	138	$	—
2014 Productivity Plan	—		170		295
Total restructuring and impairment charges	370		308		295
Other productivity initiatives	3		8		16
Total restructuring and impairment charges and other productivity initiatives	$	373	$	316	$	311

2019 Productivity Plan

Total Restructuring Cost and Reserve [Line Items]

Restructuring and Related Costs [Table Text Block]

The total expected plan pre-tax charges are expected to be incurred by division approximately as follows:



	FLNA		QFNA		PBNA		LatAm		Europe		AMESA		APAC		Corporate
Expected pre-tax charges	11	%	2	%	30	%	10	%	25	%	8	%	5	%	9	%

A summary of our 2019 Productivity Plan charges is as follows:



	2019		2018
Cost of sales	$	115	$	3
Selling, general and administrative expenses	253		100
Other pension and retiree medical benefits expense	2		35
Total restructuring and impairment charges	$	370	$	138
After-tax amount	$	303	$	109
Net income attributable to PepsiCo per common share	$	0.21	$	0.08



	2019		2018		Plan to Date through 12/28/2019
FLNA	$	22	$	31	$	53
QFNA	2		5		7
PBNA	51		40		91
LatAm	62		9		71
Europe	99		6		105
AMESA	38		3		41
APAC	47		2		49
Corporate	47		7		54
	368		103		471
Other pension and retiree medical benefits expense	2		35		37
Total	$	370	$	138	$	508



	Plan to Date through 12/28/2019
Severance and other employee costs	$	286
Asset impairments	92
Other costs ^(a)	130
Total	$	508


(a)	Includes other costs associated with the implementation of our initiatives, including contract termination costs, consulting and other professional fees.

A summary of our 2019 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs			Total
2018 restructuring charges	$	137		$	—		$	1		$	138
Non-cash charges and translation	(32		)	—			—			(32		)
Liability as of December 29, 2018	105			—			1			106
2019 restructuring charges	149			92			129			370
Cash payments ^(a)	(138		)	—			(119		)	(257		)
Non-cash charges and translation	12			(92		)	10			(70		)
Liability as of December 28, 2019	$	128		$	—		$	21		$	149

(a)

Excludes cash expenditures of $4 million reported in the cash flow statement in pension and retiree medical contributions.

2014 Productivity Plan

Total Restructuring Cost and Reserve [Line Items]

Restructuring and Related Costs [Table Text Block]

A summary of our 2014 Productivity Plan charges is as follows:



	2018		2017
Selling, general and administrative expenses	$	169	$	229
Other pension and retiree medical benefits expense	1		66
Total restructuring and impairment charges	$	170	$	295
After-tax amount	$	143	$	224
Net income attributable to PepsiCo per common share	$	0.10	$	0.16



	2018			2017
FLNA	$	8		$	67
QFNA	2			11
PBNA	51			54
LatAm	30			63
Europe	53			53
AMESA	15			2
APAC ^(a)	12			(5		)
Corporate ^(b)	(1		)	50
Total	$	170		$	295


(a)	Income amount primarily reflects a gain on the sale of property, plant and equipment.


(b)	Income amount primarily relates to other pension and retiree medical benefits.

A summary of our 2014 Productivity Plan activity is as follows:



	Severance and Other Employee Costs			Asset Impairments			Other Costs				Total
Liability as of December 31, 2016	$	88		$	—		$	8			$	96
2017 restructuring charges	280			21			(6		)	^(a)	295
Cash payments	(91		)	—			(22		)		(113		)
Non-cash charges and translation	(65		)	(21		)	34				(52		)
Liability as of December 30, 2017	212			—			14				226
2018 restructuring charges	86			28			56				170
Cash payments ^(b)	(203		)	—			(52		)		(255		)
Non-cash charges and translation	(4		)	(28		)	5				(27		)
Liability as of December 29, 2018	91			—			23				114
Cash payments	(77		)	—			(16		)		(93		)
Non-cash charges and translation	(14		)	—			(7		)		(21		)
Liability as of December 28, 2019	$	—		$	—		$	—			$	—


(a)	Income amount represents adjustments for changes in estimates and a gain on the sale of property, plant, and equipment.

(b)

Excludes cash expenditures of $11 million reported in the cash flow statement in pension and retiree medical plan contributions.

Property, Plant and Equipment and Intangible Assets (Tables)

12 Months Ended

Dec. 28, 2019

Property, Plant And Equipment And Intangible Assets [Abstract]

Property, Plant and Equipment

A summary of our property, plant and equipment is as follows:



	Average Useful Life (Years)	2019			2018			2017
Property, plant and equipment, net
Land		$	1,130		$	1,078
Buildings and improvements	15 - 44	9,314			8,941
Machinery and equipment, including fleet and software	5 - 15	29,390			27,715
Construction in progress		3,169			2,430
		43,003			40,164
Accumulated depreciation		(23,698		)	(22,575		)
Total		$	19,305		$	17,589
Depreciation expense		$	2,257		$	2,241		$	2,227

Amortizable Intangible Assets, Net

A summary of our amortizable intangible assets is as follows:



		2019							2018							2017
	Average Useful Life (Years)	Gross		Accumulated Amortization			Net		Gross		Accumulated Amortization			Net
Amortizable intangible assets, net
Acquired franchise rights	56 – 60	$	846	$	(158	)	$	688	$	838	$	(140	)	$	698
Reacquired franchise rights	5 – 14	106		(105		)	1		106		(105		)	1
Brands	20 – 40	1,326		(1,066		)	260		1,306		(1,032		)	274
Other identifiable intangibles ^(a)	10 – 24	810		(326		)	484		959		(288		)	671
Total		$	3,088	$	(1,655	)	$	1,433	$	3,209	$	(1,565	)	$	1,644
Amortization expense							$	81						$	69	$	68

Future Amortization of Intangible Assets



	2020		2021		2022		2023		2024
Five-year projected amortization	$	82	$	80	$	77	$	75	$	74

Change in Book Value of Nonamortizable Intangible Assets

The change in the book value of indefinite-lived intangible assets is as follows:



	Balance, Beginning 2018		Acquisitions/ (Divestitures)			Translation and Other			Balance, End of 2018		Acquisitions/ (Divestitures)			Translation and Other			Balance, End of 2019
FLNA
Goodwill	$	280	$	28		$	(11	)	$	297	$	(3	)	$	5		$	299
Brands	25		138			(2		)	161		—			1			162
Total	305		166			(13		)	458		(3		)	6			461
QFNA
Goodwill	175		9			—			184		6			(1		)	189
Brands	—		25			—			25		(14		)	—			11
Total	175		34			—			209		(8		)	(1		)	200
PBNA ^(a)
Goodwill	9,854		—			(41		)	9,813		66			19			9,898
Reacquired franchise rights	7,126		—			(68		)	7,058		—			31			7,089
Acquired franchise rights	1,525		—			(15		)	1,510		—			7			1,517
Brands	353		—			—			353		418			(8		)	763
Total	18,858		—			(124		)	18,734		484			49			19,267
LatAm
Goodwill	555		—			(46		)	509		—			(8		)	501
Brands	141		—			(14		)	127		—			(2		)	125
Total	696		—			(60		)	636		—			(10		)	626
Europe ^{(b) (c)}
Goodwill	3,202		526			(367		)	3,361		440			160			3,961
Reacquired franchise rights	549		(1		)	(51		)	497		—			8			505
Acquired franchise rights	195		(25		)	(9		)	161		—			(4		)	157
Brands	2,545		1,993			(350		)	4,188		(139		)	132			4,181
Total	6,491		2,493			(777		)	8,207		301			296			8,804
AMESA
Goodwill	437		—			—			437		11			(2		)	446
Total	437		—			—			437		11			(2		)	446
APAC
Goodwill	241		—			(34		)	207		—			—			207
Brands	111		—			(10		)	101		—			(1		)	100
Total	352		—			(44		)	308		—			(1		)	307

Total goodwill	14,744		563			(499		)	14,808		520			173			15,501
Total reacquired franchise rights	7,675		(1		)	(119		)	7,555		—			39			7,594
Total acquired franchise rights	1,720		(25		)	(24		)	1,671		—			3			1,674
Total brands	3,175		2,156			(376		)	4,955		265			122			5,342
Total	$	27,314	$	2,693		$	(1,018	)	$	28,989	$	785		$	337		$	30,111


(a)	The change in acquisitions/(divestitures) in 2019 is primarily related to our acquisition of CytoSport Inc.


(b)	The change in acquisitions/(divestitures) in 2019 and 2018 is primarily related to our acquisition of SodaStream. See Note 14 for further information.

(c)

Income Taxes (Tables)

12 Months Ended

Dec. 28, 2019

Income Tax Contingency [Line Items]

Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]

The components of income before income taxes are as follows:



	2019		2018		2017
United States	$	4,123	$	3,864	$	3,452
Foreign	5,189		5,325		6,150
	$	9,312	$	9,189	$	9,602

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

The provision for/(benefit from) income taxes consisted of the following:



		2019			2018			2017
Current:	U.S. Federal	$	652		$	437		$	4,925
	Foreign	807			378			724
	State	196			63			136
		1,655			878			5,785
Deferred:	U.S. Federal	325			140			(1,159		)
	Foreign	(31		)	(4,379		)	(9		)
	State	10			(9		)	77
		304			(4,248		)	(1,091		)
		$	1,959		$	(3,370	)	$	4,694

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

A reconciliation of the U.S. Federal statutory tax rate to our annual tax rate is as follows:



	2019		2018		2017
U.S. Federal statutory tax rate	21.0	%	21.0	%	35.0	%
State income tax, net of U.S. Federal tax benefit	1.6		0.5		0.9
Lower taxes on foreign results	(0.9	)	(2.2	)	(9.4	)
One-time mandatory transition tax - TCJ Act	(0.1	)	0.1		41.4
Remeasurement of deferred taxes - TCJ Act	—		(0.4	)	(15.9	)
International reorganizations	—		(47.3	)	—
Tax settlements	—		(7.8	)	—
Other, net	(0.6	)	(0.6	)	(3.1	)
Annual tax rate	21.0	%	(36.7	)%	48.9	%

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

Deferred tax liabilities and assets are comprised of the following:



	2019			2018
Deferred tax liabilities
Debt guarantee of wholly-owned subsidiary	$	578		$	578
Property, plant and equipment	1,583			1,303
Recapture of net operating losses	335			414
Right-of-use assets	345			—
Other	167			71
Gross deferred tax liabilities	3,008			2,366
Deferred tax assets
Net carryforwards	4,168			4,353
Intangible assets other than nondeductible goodwill	793			985
Share-based compensation	94			106
Retiree medical benefits	154			167
Other employee-related benefits	350			303
Pension benefits	104			221
Deductible state tax and interest benefits	126			110
Lease liabilities	345			—
Other	741			739
Gross deferred tax assets	6,875			6,984
Valuation allowances	(3,599		)	(3,753		)
Deferred tax assets, net	3,276			3,231
Net deferred tax assets	$	(268	)	$	(865	)

A summary of our valuation allowance activity is as follows:



	2019			2018			2017
Balance, beginning of year	$	3,753		$	1,163		$	1,110
Provision	(124		)	2,639			33
Other (deductions)/additions	(30		)	(49		)	20
Balance, end of year	$	3,599		$	3,753		$	1,163

Summary of Income Tax Contingencies [Table Text Block]

Our major taxing jurisdictions and the related open tax audits are as follows:



Jurisdiction	Years Open to Audit	Years Currently Under Audit
United States	2014-2018	2014-2016
Mexico	2017-2018	None
United Kingdom	2017-2018	2017
Canada (Domestic)	2015-2018	2015-2016
Canada (International)	2010-2018	2010-2016
Russia	2016-2018	None

Reserves Rollforward

A reconciliation of unrecognized tax benefits is as follows:



	2019			2018
Balance, beginning of year	$	1,440		$	2,212
Additions for tax positions related to the current year	179			142
Additions for tax positions from prior years	93			197
Reductions for tax positions from prior years	(201		)	(822		)
Settlement payments	(74		)	(233		)
Statutes of limitations expiration	(47		)	(42		)
Translation and other	5			(14		)
Balance, end of year	$	1,395		$	1,440

Share-Based Compensation Share-Based Compensation (Tables)

12 Months Ended

Dec. 28, 2019

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Schedule of Liability Award Vested and Expected to Vest [Table Text Block]



	Long-Term Cash Award^(a)			Balance Sheet Date Fair Value^(a)		Contractual Life Remaining (years)
Outstanding at December 29, 2018	$	54,710
Granted^(b)	16,112
Vested	(15,438		)
Forfeited	(9,465		)
Actual performance change (c)	(1,695		)
Outstanding at December 28, 2019 ^(d)	$	44,224		$	45,875	1.10
Expected to Vest at December 28, 2019	$	42,998		$	44,557	1.10


(a)	In thousands.


(b)	Grant activity for all long-term cash awards are disclosed at target.


(c)	Reflects the net number of long-term cash awards above and below target levels based on actual performance measured at the end of the performance period.

(d)

The outstanding long-term cash awards for which the performance period has not ended as of December 28, 2019, at the threshold, target and maximum award levels were zero, 28.5 million and 57.1 million, respectively

Share-based Payment Arrangement, Cost by Plan [Table Text Block]

The following table summarizes our total share-based compensation expense and excess tax benefits recognized:



	2019			2018			2017
Share-based compensation expense - equity awards	$	237		$	256		$	292
Share-based compensation expense - liability awards	8			20			13
Restructuring charges	(2		)	(6		)	(2		)
Total ^(a)	$	243		$	270		$	303
Income tax benefits recognized in earnings related to share-based compensation	$	39		$	45		$	89		^(b)
Excess tax benefits related to share-based compensation	$	50		$	48		$	115

Summary of Compensation Costs

Note 6 — Share-Based Compensation

The Company may use authorized and unissued shares to meet share requirements resulting from the exercise of stock options and the vesting of RSUs, PSUs and PEPunits.

As of December 28, 2019, 59 million shares were available for future share-based compensation grants under the LTIP.

The following table summarizes our total share-based compensation expense and excess tax benefits recognized:



	2019			2018			2017
Share-based compensation expense - equity awards	$	237		$	256		$	292
Share-based compensation expense - liability awards	8			20			13
Restructuring charges	(2		)	(6		)	(2		)
Total ^(a)	$	243		$	270		$	303
Income tax benefits recognized in earnings related to share-based compensation	$	39		$	45		$	89		^(b)
Excess tax benefits related to share-based compensation	$	50		$	48		$	115


(a)	Primarily recorded in selling, general and administrative expenses.


(b)	Reflects tax rates effective for the 2017 tax year.

Method of Accounting and Our Assumptions

We do not backdate, reprice or grant share-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP.

Stock Options

Schedule Of Weighted-Average Black-Scholes Fair Value Assumptions

Our weighted-average Black-Scholes fair value assumptions are as follows:



	2019		2018		2017
Expected life	5 years		5 years		5 years
Risk-free interest rate	2.4	%	2.6	%	2.0	%
Expected volatility	14	%	12	%	11	%
Expected dividend yield	3.1	%	2.7	%	2.7	%

Our Stock Option Activity

A summary of our stock option activity for the year ended December 28, 2019 is as follows:



	Options^(a)		Weighted-Average Exercise Price		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(b)
Outstanding at December 29, 2018	15,589		$	79.94
Granted	1,286		$	118.33
Exercised	(4,882	)	$	67.34
Forfeited/expired	(368	)	$	94.30
Outstanding at December 28, 2019	11,625		$	89.03	4.68	$	563,942
Exercisable at December 28, 2019	7,972		$	78.27	3.13	$	472,512
Expected to vest as of December 28, 2019	3,364		$	112.25	8.04	$	85,066


(a)	Options are in thousands and include options previously granted under the PBG plan. No additional options or shares were granted under the PBG plan after 2009.

(b)

In thousands.

Our RSU and PSU Activity



	RSUs/PSUs^(a)		Weighted-Average Grant-Date Fair Value		Weighted-Average Contractual Life Remaining (years)	Aggregate Intrinsic Value^(a)
Outstanding at December 29, 2018	7,175		$	105.13
Granted ^(b)	2,754		$	116.87
Converted	(2,642	)	$	99.35
Forfeited	(852	)	$	111.11
Actual performance change ^(c)	(55	)	$	108.32
Outstanding at December 28, 2019 ^(d)	6,380		$	111.53	1.22	$	877,487
Expected to vest as of December 28, 2019	5,876		$	111.32	1.19	$	808,220


(a)	In thousands.


(b)	Grant activity for all PSUs are disclosed at target.


(c)	Reflects the net number of PSUs above and below target levels based on actual performance measured at the end of the performance period.

(d)

The outstanding PSUs for which the performance period has not ended as of December 28, 2019, at the threshold, target and maximum award levels were zero, 0.7 million and 1.3 million, respectively.

Our PEPunit Activity

PEPunits

PEPunits were last granted in 2015 and all 248,000 units outstanding at December 30, 2017, with a weighted average grant date fair value of $68.94, were converted to 278,000 shares in 2018.

Other Share-Based Compensation Data

The following is a summary of other share-based compensation data:



	2019		2018		2017
Stock Options
Total number of options granted ^(a)	1,286		1,429		1,481
Weighted-average grant-date fair value of options granted	$	10.89	$	9.80	$	8.25
Total intrinsic value of options exercised ^(a)	$	275,745	$	224,663	$	327,860
Total grant-date fair value of options vested ^(a)	$	9,838	$	15,506	$	23,122
RSUs/PSUs
Total number of RSUs/PSUs granted ^(a)	2,754		2,634		2,824
Weighted-average grant-date fair value of RSUs/PSUs granted	$	116.87	$	108.75	$	109.92
Total intrinsic value of RSUs/PSUs converted ^(a)	$	333,951	$	260,287	$	380,269
Total grant-date fair value of RSUs/PSUs vested ^(a)	$	275,234	$	232,141	$	264,923
PEPunits
Total intrinsic value of PEPunits converted ^(a)	$	—	$	30,147	$	39,782
Total grant-date fair value of PEPunits vested ^(a)	$	—	$	9,430	$	18,833


(a)	In thousands.

Pension, Retiree Medical and Savings Plans (Tables)

12 Months Ended

Dec. 28, 2019

Defined Benefit Plan Disclosure [Line Items]

Schedule Of Plan Assets Measured At Fair Value Table Text Block

Plan assets measured at fair value as of year-end 2019 and 2018 are categorized consistently by level, and are as follows:



	2019								2018
	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
U.S. plan assets ^(a)
Equity securities, including preferred stock ^(b)	$	6,605	$	6,605	$	—	$	—	$	5,605
Government securities ^(c)	2,154		—		2,154		—		1,674
Corporate bonds ^(c)	4,737		—		4,737		—		4,145
Mortgage-backed securities ^(c)	159		—		159		—		212
Contracts with insurance companies ^(d)	9		—		—		9		9
Cash and cash equivalents	275		275		—		—		215
Sub-total U.S. plan assets	13,939		$	6,880	$	7,050	$	9	11,860
Real estate commingled funds measured at net asset value ^(e)	605								618
Dividends and interest receivable, net of payables	60								65
Total U.S. plan assets	$	14,604							$	12,543
International plan assets
Equity securities ^(b)	$	1,973	$	1,941	$	32	$	—	$	1,651
Government securities ^(c)	524		—		524		—		433
Corporate bonds ^(c)	585		—		585		—		478
Fixed income commingled funds ^(f)	384		384		—		—		356
Contracts with insurance companies ^(d)	42		—		—		42		36
Cash and cash equivalents	24		24		—		—		27
Sub-total international plan assets	3,532		$	2,349	$	1,141	$	42	2,981
Real estate commingled funds measured at net asset value ^(e)	193								102
Dividends and interest receivable	7								7
Total international plan assets	$	3,732							$	3,090


(a)	2019 and 2018 amounts include $302 million and $285 million, respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries.

(b)


(c)	These investments are based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets. Corporate bonds of U.S.-based companies represent 28% of total U.S. plan assets for both 2019 and 2018.


(d)	Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable. The changes in Level 3 amounts were not significant in the years ended December 28, 2019 and December 29, 2018.


(e)	The real estate commingled funds include investments in limited partnerships. These funds are based on the net asset value of the appraised value of investments owned by these funds as determined by independent third parties using inputs that are not observable. The majority of the funds are redeemable quarterly subject to availability of cash and have notice periods ranging from 45 to 90 days.

(f)

Based on the published price of the fund.

Selected Financial Information For Pension And Retiree Medical Plans

Pension, Retiree Medical and Savings Plans

Selected financial information for our pension and retiree medical plans is as follows:



	Pension												Retiree Medical
	U.S.						International
	2019			2018			2019			2018			2019			2018
Change in projected benefit liability
Liability at beginning of year	$	13,807		$	14,777		$	3,098		$	3,490		$	996		$	1,187
Service cost	381			431			73			92			23			32
Interest cost	543			482			97			93			36			34
Plan amendments	15			83			1			2			—			—
Participant contributions	—			—			2			2			—			—
Experience loss/(gain)	2,091			(972		)	515			(230		)	36			(147		)
Benefit payments	(341		)	(956		)	(100		)	(114		)	(105		)	(108		)
Settlement/curtailment	(1,268		)	(74		)	(31		)	(35		)	—			—
Special termination benefits	2			36			—			2			—			1
Other, including foreign currency adjustment	—			—			98			(204		)	2			(3		)
Liability at end of year	$	15,230		$	13,807		$	3,753		$	3,098		$	988		$	996

Change in fair value of plan assets
Fair value at beginning of year	$	12,258		$	12,582		$	3,090		$	3,460		$	285		$	321
Actual return on plan assets	3,101			(789		)	551			(136		)	78			(21		)
Employer contributions/funding	550			1,495			122			120			44			93
Participant contributions	—			—			2			2			—			—
Benefit payments	(341		)	(956		)	(100		)	(114		)	(105		)	(108		)
Settlement	(1,266		)	(74		)	(31		)	(32		)	—			—
Other, including foreign currency adjustment	—			—			98			(210		)	—			—
Fair value at end of year	$	14,302		$	12,258		$	3,732		$	3,090		$	302		$	285
Funded status	$	(928	)	$	(1,549	)	$	(21	)	$	(8	)	$	(686	)	$	(711	)



Amounts recognized
Other assets	$	744		$	185		$	99		$	81		$	—		$	—
Other current liabilities	(52		)	(107		)	(1		)	(1		)	(58		)	(41		)
Other liabilities	(1,620		)	(1,627		)	(119		)	(88		)	(628		)	(670		)
Net amount recognized	$	(928	)	$	(1,549	)	$	(21	)	$	(8	)	$	(686	)	$	(711	)

Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	$	3,516		$	4,093		$	914		$	780		$	(285	)	$	(287	)
Prior service cost/(credit)	114			109			—			(1		)	(32		)	(51		)
Total	$	3,630		$	4,202		$	914		$	779		$	(317	)	$	(338	)

Changes recognized in net (gain)/loss included in other comprehensive loss
Net (gain)/loss arising in current year	$	(120	)	$	760		$	152		$	103		$	(24	)	$	(107	)
Amortization and settlement recognition	(457		)	(187		)	(44		)	(56		)	27			8
Foreign currency translation loss/(gain)	—			—			26			(49		)	(1		)	1
Total	$	(577	)	$	573		$	134		$	(2	)	$	2		$	(98	)

Accumulated benefit obligation at end of year	$	14,255		$	12,890		$	3,441		$	2,806

Weighted-Average Assumptions Used To Determine Projected Benefit Liability And Benefit Expense For Pension And Retiree Medical Plans

The following table provides the weighted-average assumptions used to determine projected benefit liability and net periodic benefit cost for our pension and retiree medical plans:



	Pension												Retiree Medical
	U.S.						International
	2019		2018		2017		2019		2018		2017		2019		2018		2017
Liability discount rate	3.3	%	4.4	%	3.7	%	2.5	%	3.4	%	3.0	%	3.1	%	4.2	%	3.5	%
Service cost discount rate	4.4	%	3.8	%	4.5	%	4.2	%	3.5	%	3.6	%	4.3	%	3.6	%	4.0	%
Interest cost discount rate	4.1	%	3.4	%	3.7	%	3.2	%	2.8	%	2.8	%	3.8	%	3.0	%	3.2	%
Expected return on plan assets	7.1	%	7.2	%	7.5	%	5.8	%	6.0	%	6.0	%	6.6	%	6.5	%	7.5	%
Liability rate of salary increases	3.1	%	3.1	%	3.1	%	3.3	%	3.7	%	3.7	%
Expense rate of salary increases	3.1	%	3.1	%	3.1	%	3.7	%	3.7	%	3.6	%

Future Benefit Payments

Our estimated future benefit payments are as follows:



	2020		2021		2022		2023		2024		2025 - 2029
Pension	$	945	$	915	$	900	$	930	$	970	$	5,275
Retiree medical ^(a)	$	100	$	95	$	95	$	90	$	85	$	355


(a)	Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be approximately $2 million for each of the years from 2020 through 2024 and approximately $4 million in total for 2025 through 2029.

These future benefit payments to beneficiaries include payments from both funded and unfunded plans.

Target Investment Allocation

Plan Assets

For 2020 and 2019, our expected long-term rate of return on U.S. plan assets is 6.8% and 7.1%, respectively. Our target investment allocations for U.S. plan assets are as follows:



	2020		2019
Fixed income	50	%	47	%
U.S. equity	25	%	29	%
International equity	21	%	20	%
Real estate	4	%	4	%

Effects Of 1-Percentage-Point Change In The Assumed Health Care Trend Rate

d on the published price of the fund.

Retiree Medical Cost Trend Rates



	2020		2019
Average increase assumed	6	%	6	%
Ultimate projected increase	5	%	5	%
Year of ultimate projected increase	2039		2039

These assumed health care cost trend rates have an impact on the retiree medical plan expense and liability, however the cap on our share of retiree medical costs limits the impact.

Savings Plan

In 2019, 2018 and 2017, our total Company contributions were $197 million, $180 million and $176 million, respectively.

Schedule of Net Benefit Costs [Table Text Block]

The components of total pension and retiree medical benefit costs are as follows:



	Pension																		Retiree Medical
	U.S.									International
	2019			2018			2017			2019			2018			2017			2019			2018			2017
Service cost	$	381		$	431		$	401		$	73		$	92		$	91		$	23		$	32		$	28
Other pension and retiree medical benefits expense/(income):
Interest cost	$	543		$	482		$	468		$	97		$	93		$	89		$	36		$	34		$	36
Expected return on plan assets	(892		)	(943		)	(849		)	(188		)	(197		)	(176		)	(18		)	(19		)	(22		)
Amortization of prior service cost/(credits)	10			3			1			—			—			—			(19		)	(20		)	(25		)
Amortization of net losses/(gains)	161			179			123			32			45			53			(27		)	(8		)	(12		)
Settlement/curtailment losses ^(a)	296			8			8			12			6			11			—			—			—
Special termination benefits	1			36			60			—			2			—			—			1			2
Total other pension and retiree medical benefits expense/(income)	$	119		$	(235	)	$	(189	)	$	(47	)	$	(51	)	$	(23	)	$	(28	)	$	(12	)	$	(21	)
Total	$	500		$	196		$	212		$	26		$	41		$	68		$	(5	)	$	20		$	7

Financial Instruments (Tables)

12 Months Ended

Dec. 28, 2019

Derivative Instruments and Hedges, Assets [Abstract]

Fair Values Of Financial Assets And Liabilities

Fair Value Measurements

The fair values of our financial assets and liabilities as of December 28, 2019 and December 29, 2018 are categorized as follows:



		2019				2018
	Fair Value Hierarchy Levels^(a)	Assets^(a)		Liabilities^(a)		Assets^(a)		Liabilities^(a)
Available-for-sale debt securities ^(b)	2	$	—	$	—	$	3,658	$	—
Short-term investments ^(c)	1	$	229	$	—	$	196	$	—
Prepaid forward contracts ^(d)	2	$	17	$	—	$	22	$	—
Deferred compensation ^(e)	2	$	—	$	468	$	—	$	450
Derivatives designated as fair value hedging instruments:
Interest rate ^(f)	2	$	—	$	5	$	1	$	108
Derivatives designated as cash flow hedging instruments:
Foreign exchange ^(g)	2	$	5	$	32	$	44	$	14
Interest rate ^(g)	2	—		390		—		323
Commodity ^(h)	1	2		5		—		1
Commodity ⁽ⁱ⁾	2	2		5		—		3
		$	9	$	432	$	44	$	341
Derivatives not designated as hedging instruments:
Foreign exchange ^(g)	2	$	3	$	2	$	3	$	10
Commodity ^(h)	1	23		7		2		17
Commodity ⁽ⁱ⁾	2	6		24		5		92
		$	32	$	33	$	10	$	119
Total derivatives at fair value ^(j)		$	41	$	470	$	55	$	568
Total		$	287	$	938	$	3,931	$	1,018


(a)	Fair value hierarchy levels are defined in Note 7. Unless otherwise noted, financial assets are classified on our balance sheet within prepaid expenses and other current assets and other assets. Financial liabilities are classified on our balance sheet within accounts payable and other current liabilities and other liabilities.


(b)	Based on quoted broker prices or other significant inputs derived from or corroborated by observable market data. As of December 29, 2018, these debt securities were primarily classified as cash equivalents. The decrease in available-for-sale debt securities was due to maturities and sales during the current year.


(c)	Based on the price of index funds. These investments are classified as short-term investments and are used to manage a portion of market risk arising from our deferred compensation liability.


(d)	Based primarily on the price of our common stock.


(e)	Based on the fair value of investments corresponding to employees’ investment elections.

(f)


(g)	Based on recently reported market transactions of spot and forward rates.


(h)	Based on quoted contract prices on futures exchange markets.


(i)	Based on recently reported market transactions of swap arrangements.

(j)

Effective Portion Of Pre-Tax (Gains)/Losses On Derivative Instruments

Losses/(gains) on our hedging instruments are categorized as follows:



	Fair Value/Non- designated Hedges					Cash Flow and Net Investment Hedges
	Losses/(Gains) Recognized in Income Statement^(a)					Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss						Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement^(b)
	2019			2018		2019			2018			2019		2018
Foreign exchange	$	(1	)	$	9	$	57		$	(52	)	$	3	$	(8	)
Interest rate	(64		)	53		67			110			7		119
Commodity	(17		)	117		7			3			4		—
Net investment	—			—		(30		)	(77		)	—		—
Total	$	(82	)	$	179	$	101		$	(16	)	$	14	$	111

(a)


(b)	Foreign exchange derivative losses/gains are primarily included in cost of sales. Interest rate derivative losses/gains are included in interest expense. Commodity derivative losses/gains are included in either cost of sales or selling, general and administrative expenses, depending on the underlying commodity.

Accumulated Other Comprehensive Loss Attributable to Pepsico (Tables)

12 Months Ended

Dec. 28, 2019

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule Of Accumulated Other Comprehensive Income

The changes in the balances of each component of accumulated other comprehensive loss attributable to PepsiCo are as follows:



	Currency Translation Adjustment			Cash Flow Hedges			Pension and Retiree Medical			Available-For-Sale Securities			Other			Accumulated Other Comprehensive Loss Attributable to PepsiCo
Balance as of December 31, 2016 ^(a)	$	(11,386	)	$	83		$	(2,645	)	$	64		$	(35	)	$	(13,919	)
Other comprehensive (loss)/income before reclassifications ^(b)	1,049			130			(375		)	25			—			829
Amounts reclassified from accumulated other comprehensive loss	—			(171		)	158			(99		)	—			(112		)
Net other comprehensive (loss)/income	1,049			(41		)	(217		)	(74		)	—			717
Tax amounts	60			5			58			6			16			145
Balance as of December 30, 2017 ^(a)	(10,277		)	47			(2,804		)	(4		)	(19		)	(13,057		)
Other comprehensive (loss)/income before reclassifications ^(c)	(1,664		)	(61		)	(813		)	6			—			(2,532		)
Amounts reclassified from accumulated other comprehensive loss	44			111			218			—			—			373
Net other comprehensive (loss)/income	(1,620		)	50			(595		)	6			—			(2,159		)
Tax amounts	(21		)	(10		)	128			—			—			97
Balance as of December 29, 2018^(a)	(11,918		)	87			(3,271		)	2			(19		)	(15,119		)
Other comprehensive (loss)/income before reclassifications ^(d)	636			(131		)	(89		)	(2		)	—			414
Amounts reclassified from accumulated other comprehensive loss	—			14			468			—			—			482
Net other comprehensive (loss)/income	636			(117		)	379			(2		)	—			896
Tax amounts	(8		)	27			(96		)	—			—			(77		)
Balance as of December 28, 2019 ^(a)	$	(11,290	)	$	(3	)	$	(2,988	)	$	—		$	(19	)	$	(14,300	)


(a)	Pension and retiree medical amounts are net of taxes of $1,280 million as of December 31, 2016, $1,338 million as of December 30, 2017, $1,466 million as of December 29, 2018 and $1,370 million as of December 28, 2019.


(b)	Currency translation adjustment primarily reflects the appreciation of the euro, Russian ruble, Pound sterling and Canadian dollar.


(c)	Currency translation adjustment primarily reflects the depreciation of the Russian ruble, Canadian dollar, Pound sterling and Brazilian real.

(d)

Currency translation adjustment primarily reflects the appreciation of the Russian ruble, Canadian dollar, Mexican peso and Pound sterling.

Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]

The following table summarizes the reclassifications from accumulated other comprehensive loss to the income statement:



	Amount Reclassified from Accumulated Other Comprehensive Loss									Affected Line Item in the Income Statement
	2019			2018			2017
Currency translation:
Divestitures	$	—		$	44		$	—		Selling, general and administrative expenses

Cash flow hedges:
Foreign exchange contracts	$	1		$	(1	)	$	—		Net revenue
Foreign exchange contracts	2			(7		)	10			Cost of sales
Interest rate derivatives	7			119			(184		)	Interest expense
Commodity contracts	3			3			4			Cost of sales
Commodity contracts	1			(3		)	(1		)	Selling, general and administrative expenses
Net losses/(gains) before tax	14			111			(171		)
Tax amounts	(2		)	(27		)	64
Net losses/(gains) after tax	$	12		$	84		$	(107	)

Pension and retiree medical items:
Amortization of net prior service credit	$	(9	)	$	(17	)	$	(24	)	Other pension and retiree medical benefits (expense)/income
Amortization of net losses	169			216			167			Other pension and retiree medical benefits (expense)/income
Settlement/curtailment losses	308			19			15			Other pension and retiree medical benefits (expense)/income
Net losses before tax	468			218			158
Tax amounts	(102		)	(45		)	(44		)
Net losses after tax	$	366		$	173		$	114

Available-for-sale securities:
Sale of Britvic securities	$	—		$	—		$	(99	)	Selling, general and administrative expenses
Tax amount	—			—			10
Net gain after tax	$	—		$	—		$	(89	)

Total net losses/(gains) reclassified for the year, net of tax	$	378		$	301		$	(82	)

Leases (Tables)

12 Months Ended

Dec. 28, 2019

Leases [Abstract]

Lessee Operating Leases Supplemental Cash Flow Information and Noncash Activity Table [Table Text Block]

Supplemental cash flow information and non-cash activity related to our operating leases are as follows:



	2019
Operating cash flow information:
Cash paid for amounts included in the measurement of lease liabilities	$	478
Non-cash activity:
Right-of-use assets obtained in exchange for lease obligations	$	479

Lease, Cost [Table Text Block]

Components of lease cost are as follows:



	2019
Operating lease cost ^(a)	$	474
Variable lease cost ^(b)	$	101
Short-term lease cost ^(c)	$	379


(a)	Includes right-of-use asset amortization of $412 million.


(b)	Primarily related to adjustments for inflation, common-area maintenance and property tax.

(c)

Not recorded on our balance sheet.

Lessee Operating Lease Balance Sheet Amounts and Lines [Table Text Block]

Supplemental balance sheet information related to our operating leases is as follows:



	Balance Sheet Classification	2019
Right-of-use assets	Other assets	$	1,548
Current lease liabilities	Accounts payable and other current liabilities	$	442
Non-current lease liabilities	Other liabilities	$	1,118

Lessee Operating Lease Weighted Averages Table [Table Text Block]

Weighted-average remaining lease term and discount rate for our operating leases are as follows:



	2019
Weighted-average remaining lease term	6 years
Weighted-average discount rate	4	%

Lessee, Operating Lease, Liability, Maturity [Table Text Block]

Maturities of lease liabilities by year for our operating leases are as follows:



2020	$	501
2021	374
2022	280
2023	183
2024	117
2025 and beyond	308
Total lease payments	1,763
Less: Imputed interest	(203		)
Present value of lease liabilities	$	1,560

Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]

As of December 29, 2018, minimum lease payments under non-cancelable operating leases by period were expected to be as follows:



2019	$	459
2020	406
2021	294
2022	210
2023	161
2024 and beyond	310
Total	$	1,840

Schedule of Rent Expense [Table Text Block]

A summary of rent expense for the years ended December 29, 2018 and December 30, 2017 is as follows:



	2018		2017
Rent expense	$	771	$	742

Supplemental Financial Information (Tables)

12 Months Ended

Dec. 28, 2019

Supplemental Financial Information [Abstract]

Restricted Cash and Cash Equivalents [Table Text Block]

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement.



	2019		2018
Cash and cash equivalents	$	5,509	$	8,721
Restricted cash ^(a)	—		1,997
Restricted cash included in other assets ^(b)	61		51
Total cash and cash equivalents and restricted cash	$	5,570	$	10,769


(a)	In 2018, primarily represents consideration held by our paying agent in connection with our acquisition of SodaStream.

(b)

Primarily relates to collateral posted against our derivative asset or liability positions.

Additional Financial Information Disclosure [Text Block]

Balance Sheet



	2019			2018			2017
Accounts and notes receivable
Trade receivables	$	6,447		$	6,079
Other receivables	1,480			1,164
Total	7,927			7,243
Allowance, beginning of year	101			129			$	134
Net amounts charged to expense	22			16			26
Deductions ^(a)	(30		)	(33		)	(35		)
Other ^(b)	12			(11		)	4
Allowance, end of year	105			101			$	129
Net receivables	$	7,822		$	7,142

Inventories ^(c)
Raw materials and packaging	$	1,395		$	1,312
Work-in-process	200			178
Finished goods	1,743			1,638
Total	$	3,338		$	3,128

Other assets
Noncurrent notes and accounts receivable	$	85		$	86
Deferred marketplace spending	147			112
Pension plans ^(d)	846			269
Right-of-use assets ^(e)	1,548			—
Other	385			293
Total	$	3,011		$	760

Accounts payable and other current liabilities
Accounts payable	$	8,013		$	7,213
Accrued marketplace spending	2,765			2,541
Accrued compensation and benefits	1,835			1,755
Dividends payable	1,351			1,329
SodaStream consideration payable	58			1,997
Current lease liabilities ^(e)	442			—
Other current liabilities	3,077			3,277
Total	$	17,541		$	18,112


(a)	Includes accounts written off.


(b)	Includes adjustments related primarily to currency translation and other adjustments.


(c)	Approximately 7% and 5% of the inventory cost in 2019 and 2018, respectively, were computed using the LIFO method. The differences between LIFO and FIFO methods of valuing these inventories were not material.


(d)	See Note 7 for further information.


(e)	See Note 13 for further information.

Statement of Cash Flows



	2019		2018		2017
Interest paid ^(a)	$	1,076	$	1,388	$	1,123
Income taxes paid, net of refunds ^(b)	$	2,226	$	1,203	$	1,962


(a)	In 2018, excludes the premiums paid in accordance with the debt transactions discussed in Note 8.


(b)	In 2019 and 2018, includes tax payments of $423 million and $115 million, respectively, related to the TCJ Act.

The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement.



	2019		2018
Cash and cash equivalents	$	5,509	$	8,721
Restricted cash ^(a)	—		1,997
Restricted cash included in other assets ^(b)	61		51
Total cash and cash equivalents and restricted cash	$	5,570	$	10,769


(a)	In 2018, primarily represents consideration held by our paying agent in connection with our acquisition of SodaStream.

(b)

Primarily relates to collateral posted against our derivative asset or liability positions.

Selected Quarterly Financial Data (Unaudited) (Tables)

12 Months Ended

Dec. 28, 2019

Quarterly Financial Information Disclosure [Abstract]

Quarterly Financial Information [Table Text Block]

Selected financial data for 2019 and 2018 is summarized as follows and highlights certain items that impacted our quarterly results:



	2019												2018
	First Quarter			Second Quarter			Third Quarter			Fourth Quarter			First Quarter			Second Quarter			Third Quarter			Fourth Quarter
Net revenue	$	12,884		$	16,449		$	17,188		$	20,640		$	12,562		$	16,090		$	16,485		$	19,524
Gross profit	$	7,196		$	9,045		$	9,494		$	11,294		$	6,907		$	8,827		$	8,958		$	10,588
Operating profit	$	2,008		$	2,729		$	2,855		$	2,699		$	1,807		$	3,028		$	2,844		$	2,431
Mark-to-market net impact ^(a)	$	60		$	(6	)	$	(4	)	$	62		$	(31	)	$	3		$	(29	)	$	(106	)
Restructuring and impairment charges ^(b)	$	(26	)	$	(158	)	$	(98	)	$	(88	)	$	(12	)	$	(32	)	$	(35	)	$	(229	)
Inventory fair value adjustments and merger and integration charges ^(c)	$	(15	)	$	(24	)	$	(7	)	$	(9	)	—			—			—			$	(75	)
Pension-related settlement charges ^(d)	—			—			—			$	(273	)	—			—			—			—
Net tax related to the TCJ Act ^(e)	$	29		—			—			$	(21	)	$	(1	)	$	(777	)	$	(76	)	$	882
Gains on sale of assets ^(f)	—			$	32		—			$	45		$	18		$	9		$	37		$	12
Other net tax benefits ^(g)	—			—			—			—			—			$	314		$	364		$	4,386
Charges related to cash tender and exchange offers ^(h)	—			—			—			—			—			—			—			$	(253	)
Tax reform bonus ⁽ⁱ⁾	—			—			—			—			$	(87	)	—			—			—
Gains on beverage refranchising ^(j)	—			—			—			—			—			$	144		—			$	58
Provision for/(benefit from) income taxes^(e)(f)	$	446		$	524		$	559		$	430		$	304		$	1,070		$	188		$	(4,932	)
Net income attributable to PepsiCo	$	1,413		$	2,035		$	2,100		$	1,766		$	1,343		$	1,820		$	2,498		$	6,854
Net income attributable to PepsiCo per common share
Basic	$	1.01		$	1.45		$	1.50		$	1.27		$	0.94		$	1.28		$	1.77		$	4.86
Diluted	$	1.00		$	1.44		$	1.49		$	1.26		$	0.94		$	1.28		$	1.75		$	4.83
Cash dividends declared per common share	$	0.9275		$	0.955		$	0.955		$	0.955		$	0.805		$	0.9275		$	0.9275		$	0.9275


(a)	Mark-to-market net gains and losses on commodity derivatives in corporate unallocated expenses.


(b)	Expenses related to the 2019 and 2014 Productivity Plans. See Note 3 to our consolidated financial statements for further information.


(c)	In 2019, inventory fair value adjustments and merger and integration charges primarily related to our acquisition of SodaStream. In 2018, merger and integration charges related to our acquisition of SodaStream. See Note 14 to our consolidated financial statements for further information.


(d)	In 2019, pension settlement charges of $220 million related to the purchase of a group annuity contract and settlement charges of $53 million related to one-time lump sum payments to certain former employees who had vested benefits, recorded in other pension and retiree medical benefits expense/income. See Note 7 to our consolidated financial statements for further information.


(e)	Net tax related to the TCJ Act. See Note 5 to our consolidated financial statements for further information.


(f)	In 2019, gains associated with the sale of assets in the following segments: $31 million in FLNA and $46 million in PBNA. In 2018, gains associated with the sale of assets in the following segments: $64 million in PBNA and $12 million in AMESA.

(g)


(h)	In 2018, interest expense in connection with our cash tender and exchange offers, primarily representing the tender price paid over the carrying value of the tendered notes. See Note 8 to our consolidated financial statements for further information.


(i)	In 2018, bonus extended to certain U.S. employees related to the TCJ Act in the following segments: $44 million in FLNA, $2 million in QFNA and $41 million in PBNA.

(j)

Basis of Presentation and Our Divisions (Schedule of Segment Reporting Information, by Segment) (Details) - USD ($) $ in Millions	3 Months Ended						4 Months Ended		12 Months Ended
	Sep. 07, 2019	Jun. 15, 2019	Mar. 23, 2019	Sep. 08, 2018	Jun. 16, 2018	Mar. 24, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Segment Reporting Information [Line Items]
Net Revenue	$ 17,188	$ 16,449	$ 12,884	$ 16,485	$ 16,090	$ 12,562	$ 20,640	$ 19,524	$ 67,161	$ 64,661	$ 63,525
Operating Profit	$ 2,855	$ 2,729	$ 2,008	$ 2,844	$ 3,028	$ 1,807	$ 2,699	$ 2,431	$ 10,291	10,110	10,276
Disaggregation of Net Revenue - Food/Snack									55.00%
Disaggregation of beverage revenue from company-owned bottlers									40.00%
Frito Lay North America [Member]
Segment Reporting Information [Line Items]
Net Revenue									$ 17,078	16,346	15,798
Operating Profit									5,258	5,008	4,793
Quaker Foods North America [Member]
Segment Reporting Information [Line Items]
Net Revenue									2,482	2,465	2,503
Operating Profit									544	637	640
PepsiCo Beverages North America [Member]
Segment Reporting Information [Line Items]
Net Revenue									21,730	21,072	20,936
Operating Profit									2,179	2,276	2,700
Latin America [Member]
Segment Reporting Information [Line Items]
Net Revenue									7,573	7,354	7,208
Operating Profit									$ 1,141	1,049	924
Disaggregation of Net Revenue - Food/Snack									90.00%
Europe [Member]
Segment Reporting Information [Line Items]
Net Revenue									$ 11,728	10,973	10,522
Operating Profit									$ 1,327	1,256	1,199
Disaggregation of Net Revenue - Beverages									55.00%
Disaggregation of Net Revenue - Food/Snack									45.00%
Africa, Middle East and South Asia [Member]
Segment Reporting Information [Line Items]
Net Revenue									$ 3,651	3,657	3,674
Operating Profit									$ 671	661	789
Disaggregation of Net Revenue - Beverages									40.00%
Disaggregation of Net Revenue - Food/Snack									60.00%
Asia Pacific, Australia and New Zealand, and China Region [Member]
Segment Reporting Information [Line Items]
Net Revenue									$ 2,919	2,794	2,884
Operating Profit									$ 477	619	401
Disaggregation of Net Revenue - Beverages									25.00%
Disaggregation of Net Revenue - Food/Snack									75.00%
Operating Segments [Member]
Segment Reporting Information [Line Items]
Operating Profit									$ 11,597	11,506	11,446
Corporate
Segment Reporting Information [Line Items]
Net Revenue									0	0	0
Operating Profit									$ (1,306)	$ (1,396)	$ (1,170)

Basis of Presentation and Our Divisions (Segment Reporting Information by Total Assets and Capital Spending) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Segment Reporting Information [Line Items]
Total Assets	$ 78,547	$ 77,648
Capital Spending	4,232	3,282	$ 2,969
Frito Lay North America [Member]
Segment Reporting Information [Line Items]
Total Assets	7,519	6,577
Capital Spending	1,227	840	665
Quaker Foods North America [Member]
Segment Reporting Information [Line Items]
Total Assets	941	870
Capital Spending	104	53	44
PepsiCo Beverages North America [Member]
Segment Reporting Information [Line Items]
Total Assets	31,449	29,878
Capital Spending	1,053	945	904
Latin America [Member]
Segment Reporting Information [Line Items]
Total Assets	7,007	6,458
Capital Spending	557	492	481
Europe [Member]
Segment Reporting Information [Line Items]
Total Assets	17,814	16,887
Capital Spending	613	466	463
Africa, Middle East and South Asia [Member]
Segment Reporting Information [Line Items]
Total Assets	3,672	3,252
Capital Spending	267	198	181
Asia Pacific, Australia and New Zealand, and China Region [Member]
Segment Reporting Information [Line Items]
Total Assets	4,113	3,704
Capital Spending	195	138	145
Operating Segments [Member]
Segment Reporting Information [Line Items]
Total Assets	72,515	67,626
Capital Spending	4,016	3,132	2,883
Corporate
Segment Reporting Information [Line Items]
Total Assets	6,032	10,022
Capital Spending	$ 216	$ 150	$ 86

Basis of Presentation and Our Divisions (Segment Reporting Information by Amortization of Intangible Assets and Depreciation and Other Amortization) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	$ 81	$ 69	$ 68
Depreciation and Other Amortization	2,351	2,330	2,301
Frito Lay North America [Member]
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	7	7	7
Depreciation and Other Amortization	492	457	449
Quaker Foods North America [Member]
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	0	0	0
Depreciation and Other Amortization	44	45	47
PepsiCo Beverages North America [Member]
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	29	31	31
Depreciation and Other Amortization	857	821	780
Latin America [Member]
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	5	5	5
Depreciation and Other Amortization	270	253	245
Europe [Member]
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	37	23	22
Depreciation and Other Amortization	341	319	317
Africa, Middle East and South Asia [Member]
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	2	2	2
Depreciation and Other Amortization	116	169	170
Asia Pacific, Australia and New Zealand, and China Region [Member]
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	1	1	1
Depreciation and Other Amortization	76	80	99
Operating Segments [Member]
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	81	69	68
Depreciation and Other Amortization	2,196	2,144	2,107
Corporate
Segment Reporting Information [Line Items]
Amortization of Intangible Assets	0	0	0
Depreciation and Other Amortization	$ 155	$ 186	$ 194

Basis of Presentation and Our Divisions (Segment Reporting Information by Net Revenue and Long-Lived Assets) (Details) - USD ($) $ in Millions	3 Months Ended						4 Months Ended		12 Months Ended
	Sep. 07, 2019	Jun. 15, 2019	Mar. 23, 2019	Sep. 08, 2018	Jun. 16, 2018	Mar. 24, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Segment Reporting Information [Line Items]
Net Revenue	$ 17,188	$ 16,449	$ 12,884	$ 16,485	$ 16,090	$ 12,562	$ 20,640	$ 19,524	$ 67,161	$ 64,661	$ 63,525
Long-Lived Assets							53,532	50,631	53,532	50,631
UNITED STATES
Segment Reporting Information [Line Items]
Net Revenue									38,644	37,148	36,546
Long-Lived Assets							30,601	29,169	30,601	29,169
MEXICO
Segment Reporting Information [Line Items]
Net Revenue									4,190	3,878	3,650
Long-Lived Assets							1,666	1,404	1,666	1,404
Russia
Segment Reporting Information [Line Items]
Net Revenue									3,263	3,191	3,232
Long-Lived Assets							4,314	3,926	4,314	3,926
CANADA
Segment Reporting Information [Line Items]
Net Revenue									2,831	2,736	2,691
Long-Lived Assets							2,695	2,565	2,695	2,565
UNITED KINGDOM
Segment Reporting Information [Line Items]
Net Revenue									1,723	1,743	1,650
Long-Lived Assets							827	759	827	759
CHINA
Segment Reporting Information [Line Items]
Net Revenue									1,300	1,164	963
Long-Lived Assets							705	509	705	509
BRAZIL
Segment Reporting Information [Line Items]
Net Revenue									1,295	1,335	1,427
Long-Lived Assets							590	639	590	639
All Other Countries [Member]
Segment Reporting Information [Line Items]
Net Revenue									13,915	13,466	$ 13,366
Long-Lived Assets							$ 12,134	$ 11,660	$ 12,134	$ 11,660

Our Significant Accounting Policies (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Capitalized Computer Software, Net	$ 572	$ 577
Capitalized Computer Software, Amortization	166	204	$ 224
Shipping and handling expenses	10,900	10,500	9,900
Research and development costs	711	680	737
Amount of prepaid incentive arrangements	272	218
Advertising and other marketing activities	4,700	4,200	4,100
Advertising expenses	3,000	2,600	2,400
Deferred advertising costs	$ 55	47
Sales, use, value-added and certain excise taxes assessed by governmental authorities on revenue-producing transactions that were recognized in net revenue and cost of sales			$ 75
Retained Earnings [Member]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification		$ 137

Restructuring, Impairment and Integration Charges Restructuring, Impairment and Integration Charges (Summary of 2019 Productivity Plan Charges) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						4 Months Ended		12 Months Ended
	Sep. 07, 2019	Jun. 15, 2019	Mar. 23, 2019	Sep. 08, 2018	Jun. 16, 2018	Mar. 24, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges	$ 98	$ 158	$ 26	$ 35	$ 32	$ 12	$ 88	$ 229	$ 373	$ 316	$ 311
Cash payments for restructuring charges									(350)	(255)	(113)
2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Expected Cost							2,500		2,500
Restructuring and Related Cost, Expected Cash Expenditures							1,600		1,600
Beginning Balance			106						106
Restructuring and impairment charges									370	138	$ 0
Cash payments for restructuring charges									(257)
Non-cash charges and translation									(70)	(32)
Ending Balance							149	106	$ 149	$ 106
Net income attributable to PepsiCo per common share									$ 0.21	$ 0.08
Plan to Date through 12/28/2019							$ 508		$ 508
Cash payments reported on the cash flow statement in pension and retiree medical contributions									$ 4
Frito Lay North America [Member] \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							11.00%		11.00%
Restructuring and impairment charges									$ 22	$ 31
Plan to Date through 12/28/2019							$ 53		$ 53
Quaker Foods North America [Member] \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							2.00%		2.00%
Restructuring and impairment charges									$ 2	5
Plan to Date through 12/28/2019							$ 7		$ 7
PepsiCo Beverages North America [Member] \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							30.00%		30.00%
Restructuring and impairment charges									$ 51	40
Plan to Date through 12/28/2019							$ 91		$ 91
Latin America [Member] \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							10.00%		10.00%
Restructuring and impairment charges									$ 62	9
Plan to Date through 12/28/2019							$ 71		$ 71
Europe [Member] \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							25.00%		25.00%
Restructuring and impairment charges									$ 99	6
Plan to Date through 12/28/2019							$ 105		$ 105
Africa, Middle East and South Asia [Member] \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							8.00%		8.00%
Restructuring and impairment charges									$ 38	3
Plan to Date through 12/28/2019							$ 41		$ 41
Asia Pacific, Australia and New Zealand, and China Region [Member] \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							5.00%		5.00%
Restructuring and impairment charges									$ 47	2
Plan to Date through 12/28/2019							$ 49		$ 49
Severance and Other Employee Costs \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							70.00%		70.00%
Beginning Balance			105						$ 105
Restructuring and impairment charges									149	137
Cash payments for restructuring charges									(138)
Non-cash charges and translation									12	(32)
Ending Balance							$ 128	105	128	105
Plan to Date through 12/28/2019							$ 286		$ 286
Asset Impairments \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							15.00%		15.00%
Beginning Balance			0						$ 0
Restructuring and impairment charges									92	0
Cash payments for restructuring charges									0
Non-cash charges and translation									(92)	0
Ending Balance							$ 0	0	0	0
Plan to Date through 12/28/2019							$ 92		$ 92
Other Costs \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							15.00%		15.00%
Beginning Balance			$ 1						$ 1
Restructuring and impairment charges									129	1
Cash payments for restructuring charges									(119)
Non-cash charges and translation									(10)	0
Ending Balance							$ 21	$ 1	21	1
Plan to Date through 12/28/2019							130		130
Cost of sales \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges									115	3
Selling, general and administrative expenses \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges									253	100
Other pension and retiree medical benefits expense \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges									2	35
Plan to Date through 12/28/2019							37		37
After-tax amount \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges									303	109
Restructuring, Settlement and Impairment Provisions, less Other pension and retiree medical benefits expense [Member] \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges									368	103
Plan to Date through 12/28/2019							$ 471		$ 471
Corporate \| 2019 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Percentage of Expect Costs							9.00%		9.00%
Restructuring and impairment charges									$ 47	$ 7
Plan to Date through 12/28/2019							$ 54		$ 54

Restructuring, Impairment and Integration Charges Restructuring, Impairment and Integration Charges (Summary of 2014 Productivity Plan Charges) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						4 Months Ended		12 Months Ended
	Sep. 07, 2019	Jun. 15, 2019	Mar. 23, 2019	Sep. 08, 2018	Jun. 16, 2018	Mar. 24, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges	$ 98	$ 158	$ 26	$ 35	$ 32	$ 12	$ 88	$ 229	$ 373	$ 316	$ 311
Payments for Restructuring									(350)	(255)	(113)
2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Beginning Balance			114			226			114	226	96
Restructuring and impairment charges									0	170	295
Payments for Restructuring									(93)	(255)	(113)
Non-cash charges and translation									(21)	(27)	(52)
Ending Balance							0	114	0	$ 114	$ 226
Net income attributable to PepsiCo per common share										$ 0.10	$ 0.16
Plan to Date through 12/28/2019							1,300		1,300
Restructuring and Related Cost, Total Cash Expenditures							$ 960		$ 960
Cash payments reported on the cash flow statement in pension and retiree medical contributions										$ 11
Frito Lay North America [Member] \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										8	$ 67
Percent of Total Plan Restructuring Charges							14.00%		14.00%
Quaker Foods North America [Member] \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										2	11
Percent of Total Plan Restructuring Charges							3.00%		3.00%
PepsiCo Beverages North America [Member] \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										51	54
Percent of Total Plan Restructuring Charges							29.00%		29.00%
Latin America [Member] \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										30	63
Percent of Total Plan Restructuring Charges							15.00%		15.00%
Europe [Member] \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										53	53
Percent of Total Plan Restructuring Charges							23.00%		23.00%
Africa, Middle East and South Asia [Member] \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										15	2
Percent of Total Plan Restructuring Charges							3.00%		3.00%
Asia Pacific, Australia and New Zealand, and China Region [Member] \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										12	(5)
Percent of Total Plan Restructuring Charges							3.00%		3.00%
Severance and Other Employee Costs \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Beginning Balance			91			212			$ 91	212	88
Restructuring and impairment charges										86	280
Payments for Restructuring									(77)	(203)	(91)
Non-cash charges and translation									(14)	(4)	(65)
Ending Balance							$ 0	91	$ 0	91	212
Percent of Total Plan Restructuring Charges							59.00%		59.00%
Asset Impairments \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Beginning Balance			0			0			$ 0	0	0
Restructuring and impairment charges										28	21
Payments for Restructuring									0	0	0
Non-cash charges and translation									0	(28)	(21)
Ending Balance							$ 0	0	$ 0	0	0
Percent of Total Plan Restructuring Charges							15.00%		15.00%
Other Costs \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Beginning Balance			$ 23			$ 14			$ 23	14	8
Restructuring and impairment charges										56	(6)
Payments for Restructuring									(16)	(52)	(22)
Non-cash charges and translation									(7)	5	34
Ending Balance							$ 0	$ 23	$ 0	23	14
Percent of Total Plan Restructuring Charges							26.00%		26.00%
Selling, general and administrative expenses \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										169	229
Other pension and retiree medical benefits expense \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										1	66
After-tax amount \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										143	224
Corporate \| 2014 Productivity Plan
Total Restructuring Cost and Reserve [Line Items]
Restructuring and impairment charges										$ (1)	$ 50
Percent of Total Plan Restructuring Charges							10.00%		10.00%

Property, Plant and Equipment and Intangible Assets (Schedule of Property, Plant and Equipment and Intangible Assets) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Property, Plant and Equipment [Line Items]
Acquisitions/ (Divestitures)	$ 337	$ (1,018)
Property, plant and equipment, net:
Property, plant and equipment, gross	43,003	40,164
Accumulated depreciation	(23,698)	(22,575)
Property, Plant and Equipment, net	19,305	17,589
Depreciation	2,257	2,241	$ 2,227
Amortizable intangible assets, net:
Amortizable intangible assets, gross	3,088	3,209
Accumulated amortization	(1,655)	(1,565)
Amortizable intangible assets, net	1,433	1,644
Amortization of intangible assets	81	69	$ 68
Land [Member]
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 1,130	1,078
Land [Member] \| Minimum
Property, plant and equipment, net:
Average Useful Life (Years)	0 years
Land [Member] \| Maximum
Property, plant and equipment, net:
Average Useful Life (Years)	0 years
Buildings And Improvements
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 9,314	8,941
Buildings And Improvements \| Minimum
Property, plant and equipment, net:
Average Useful Life (Years)	15 years
Buildings And Improvements \| Maximum
Property, plant and equipment, net:
Average Useful Life (Years)	44 years
Machinery And Equipment, Including Fleet And Software
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 29,390	27,715
Machinery And Equipment, Including Fleet And Software \| Minimum
Property, plant and equipment, net:
Average Useful Life (Years)	5 years
Machinery And Equipment, Including Fleet And Software \| Maximum
Property, plant and equipment, net:
Average Useful Life (Years)	15 years
Construction In Progress
Property, plant and equipment, net:
Property, plant and equipment, gross	$ 3,169	2,430
Acquired Franchise Rights \| Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	56 years
Acquired Franchise Rights \| Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	60 years
Reacquired Franchise Rights \| Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	5 years
Reacquired Franchise Rights \| Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	14 years
Other Identifiable Intangibles \| Minimum
Amortizable intangible assets, net:
Average Useful Life (Years)	10 years
Other Identifiable Intangibles \| Maximum
Amortizable intangible assets, net:
Average Useful Life (Years)	24 years
Goodwill [Member]
Property, Plant and Equipment [Line Items]
Acquisitions/ (Divestitures)	$ 173	$ (499)

Property, Plant and Equipment and Intangible Assets (Future Amortization) (Details) $ in Millions	Dec. 28, 2019 USD ($)
Property, Plant And Equipment And Intangible Assets [Abstract]
2019	$ 82
2020	80
2021	77
2022	75
2023	$ 74

Income Taxes (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						4 Months Ended			12 Months Ended
	Sep. 07, 2019	Jun. 15, 2019	Mar. 23, 2019	Sep. 08, 2018	Jun. 16, 2018	Mar. 24, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Income Tax Contingency [Line Items]
Deferred Tax Assets, Goodwill and Intangible Assets							$ 793	$ 985		$ 793	$ 985
International Audit										$ 364
International Audit, per share										$ 0.26
Federal Audit Settlement										$ 353
Federal Audit Settlement, Net of tax, Per share amount										$ 0.24
Federal Statutory Tax Rate, Pre TCJ Act							35.00%			35.00%
Federal Statutory Tax Rate, Post TCJ Act							21.00%			21.00%
Tax Cuts and Jobs Act, Income Tax Expense (Benefit)	$ 0	$ 0	$ 29	$ (76)	$ (777)	$ (1)	$ (21)	882	$ (2,500)	$ 8	$ 28
Net tax (benefit)/expense related to the TCJ Act per share									$ (1.70)	$ (0.01)	$ 0.02
Total gross amount of reserves for income taxes							1,400			$ 1,400
Interest accrued							250	$ 179		250	$ 179
Interest accrued recognized										(84)	$ (64)
Operating loss carryforwards							24,700			24,700
Income tax undistributed international earnings							6,000			6,000
Mandatory OneTime Repatriation TCJ ACT										4,000
Remeasurement of Deferred Taxes TCJ Act										1,500
Foreign Earnings Repatriated										$ 20,400
Effective Income Tax Rate Reconciliation, Percent										21.00%	(36.70%)	48.90%
undistributed earnings of foreign subsidiaries, post distribution							6,000			$ 6,000
Transition tax liability										3,300
Transition tax, expected payments							100			100
International reorganization DTA											$ 4,300
international Reorganization DTA, per share											$ 3.05
International Reorganization Other DTA										$ 4,400
International Reorganization Other DTA, amortization period										15 years
Expire in 2016
Income Tax Contingency [Line Items]
Operating loss carryforwards							200			$ 200
Expire Between 2017 and 2035 Years
Income Tax Contingency [Line Items]
Operating loss carryforwards							20,300			20,300
Carried Forward Indefinitely
Income Tax Contingency [Line Items]
Operating loss carryforwards							$ 4,200			$ 4,200

Income Taxes (Income Taxes) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						4 Months Ended			12 Months Ended
	Sep. 07, 2019	Jun. 15, 2019	Mar. 23, 2019	Sep. 08, 2018	Jun. 16, 2018	Mar. 24, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Income Tax Contingency [Line Items]
Federal and International Audit Settlements											$ 717
Impact of Swiss Tax Reform										$ 24
Transition tax, payments made										663	150
Tax Cuts and Jobs Act, Income Tax Expense (Benefit)	$ 0	$ 0	$ (29)	$ 76	$ 777	$ 1	$ 21	$ (882)	$ 2,500	(8)	(28)
Mandatory OneTime Repatriation TCJ ACT										4,000
Federal Statutory Tax Rate, Pre TCJ Act													35.00%
Income before income taxes in U.S										4,123	3,864	$ 3,452
Income before income taxes in Foreign										5,189	5,325	6,150
Income before income taxes										9,312	9,189	9,602
Income Tax Expense (Benefit), Continuing Operations [Abstract]
Current: U.S. Federal										652	437	4,925
Current: Foreign										807	378	724
Current: State										196	63	136
Provision for income taxes, Current total										1,655	878	5,785
Deferred: U.S. Federal										325	140	(1,159)
Deferred: Foreign										(31)	(4,379)	(9)
Deferred: State										10	(9)	77
Provision for income taxes, Deferred total										304	(4,248)	(1,091)
Provision for income taxes	$ 559	$ 524	446	$ 188	$ 1,070	304	430	(4,932)		$ 1,959	$ (3,370)	$ 4,694
U.S. Federal statutory tax rate
U.S. Federal statutory tax rate										21.00%	21.00%	35.00%
State income tax, net of U.S. Federal tax benefit										1.60%	0.50%	0.90%
Lower taxes on foreign results										(0.90%)	(2.20%)	(9.40%)
Provisional One Time Mandatory Repatriation TCJ Act, Percent										(0.10%)	0.10%	41.40%
Remeasurement of Deferred Taxes TCJ Act, Percent										0.00%	(0.40%)	(15.90%)
International Reorganization										0.00%	(47.30%)	0.00%
Tax benefits										0.00%	(7.80%)	0.00%
Other, net										(0.60%)	(0.60%)	(3.10%)
Annual tax rate										21.00%	(36.70%)	48.90%
Deferred tax liabilities
Debt guarantee of wholly-owned subsidiary													$ 578	$ 578
Property, plant and equipment													1,583	1,303
Deferred tax liability, recapture of NOL													335	414
Deferred Tax - Lease liability										$ 345	$ 0
Other													167	71
Gross deferred tax liabilities													3,008	2,366
Deferred tax assets
Net carryforwards													4,168	4,353
Deferred Tax Assets, Goodwill and Intangible Assets													793	985
Share-based compensation													94	106
Retiree medical benefits													154	167
Other employee-related benefits													350	303
Pension benefits													104	221
Deductible state tax and interest benefits													126	110
Deferred Tax - Right of Use Asset										345	0
Other													741	739
Gross deferred tax assets													6,875	6,984
Valuation allowances			(3,753)			(1,163)	(3,599)	(3,753)	(1,163)	(3,753)	(1,163)	$ (1,110)	(3,599)	(3,753)	$ (1,163)
Deferred tax assets, net													3,276	3,231
Valuation Allowance [Abstract]
Balance, beginning of year			$ (3,753)			$ (1,163)				(3,753)	(1,163)	(1,110)
Provision													(124)	2,639	$ 33
Other (deductions)/additions										(30)	(49)	20
Balance, end of year							$ (3,599)	$ (3,753)	$ (1,163)	$ (3,599)	$ (3,753)	$ (1,163)
Net tax (benefit)/expense related to the TCJ Act per share									$ 1.70	$ 0.01	$ (0.02)
Federal and International Audit Settlements, per share amount											$ 0.50
Deferred Tax Assets, Net													$ (268)	$ (865)

Income Taxes (Reserves Rollforward) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Balance, beginning of year	$ 1,440	$ 2,212
Additions for tax positions related to the current year	179	142
Additions for tax positions from prior years	93	197
Reductions for tax positions from prior years	(201)	(822)
Settlement payments	(74)	(233)
Statutes of limitations expiration	(47)	(42)
Translation and other	5	(14)
Balance, end of period	$ 1,395	$ 1,440

Share-Based Compensation Share-Based Compensation (Narrative) (Details) shares in Millions, $ in Millions	12 Months Ended
	Dec. 28, 2019 USD ($) option / rsu shares	Dec. 29, 2018 USD ($)	Dec. 30, 2017 USD ($)
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Common stock, capital shares reserved for future issuance \| shares	59
Share-based Payment Arrangement, Expense	$ 237	$ 256	$ 292
Allocated Share-Based Compensation Liability Awards	8	20	13
Restructuring, Settlement and Impairment Provisions, Share-based Compensation	(2)	(6)	(2)
Allocated Share-based Compensation Expense, After Merger/Integration and Restructuring/Impairment	243	270	303
Income tax benefits recognized in earnings related to share-based compensation	39	45	89
Unrecognized compensation cost related to nonvested share-based compensation grants	$ 284
Weighted-average period for recognizing unrecognized compensation	2 years
Acquisition-related awards remaining vesting period	3 years
Percent of liability awards granted to senior officers	34.00%
Proceeds and Excess Tax Benefit from Share-based Compensation	$ 50	$ 48	$ 115
PEPunit
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Acquisition-related awards remaining vesting period	3 years
Restricted Stock Units (RSUs)
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Award equivalence, ratio of stock options to RSUs \| option / rsu	4
Stock Options
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Stock option exercisable life	10 years
Award equivalence, ratio of stock options to RSUs \| option / rsu	1
PEP Equity Performance Unit [Member]
Deferred Compensation Arrangement with Individual, Share-based Payments [Line Items]
Percent of equity awards granted to Senior Officers as performance-based RSUs	66.00%

Share-Based Compensation Share-Based Compensation (Schedule of Weighted-Average Black-Scholes Fair Value Assumptions) (Details)	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Share-based Payment Arrangement, Noncash Expense [Abstract]
Expected life	5 years	5 years	5 years
Risk-free interest rate	2.40%	2.60%	2.00%
Expected volatility	14.00%	12.00%	11.00%
Expected dividend yield	3.10%	2.70%	2.70%

Share-Based Compensation Share-Based Compensation (Stock Option Activity) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at December 29, 2018	15,589
Granted	1,286	1,429	1,481
Exercised	(4,882)
Forfeited/expired	(368)
Outstanding at December 28, 2019	11,625	15,589
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Roll Forward]
Outstanding at December 29, 2018 (in USD per share)	$ 79.94
Granted (in USD per share)	118.33
Exercised (in USD per share)	67.34
Forfeited/expired (in USD per share)	94.30
Outstanding at December 28, 2019 (in USD per share)	$ 89.03	$ 79.94
Outstanding at December 30, 2019 - average life	4 years 8 months 4 days
Outstanding Aggregate Intrinsic Value, at December 30, 2019	$ 563,942
Exercisable at December 28, 2019	7,972
Exercisable at December 30, 2019 - average price	$ 78.27
Exercisable at December 30, 2019 - average life	3 years 1 month 17 days
Exercisable Aggregate Intrinsic Value, at December 30, 2019	$ 472,512
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	3,364
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	$ 112.25
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term	8 years 14 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	$ 85,066

Share-Based Compensation Share-Based Compensation (Restricted Stock Units Activity) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	7,175
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number	6,380	7,175
Expected to Vest as of December 30, 2019	5,876
Granted (b)	2,754
Forfeited	(852)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 116.87	$ 108.75	$ 109.92
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period	(2,642)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value	$ 99.35
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value	111.11
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price	$ 111.53	$ 105.13
Outstanding, average life, at December 30, 2019	1 year 2 months 19 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Aggregate Intrinsic Value	$ 877,487
Expected to vest as of December 30, 2019 (in USD per share)	$ 111.32
Expected to vest, average life, at December 30, 2019	1 year 2 months 8 days
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Expected to Vest, Aggregate Intrinsic Value	$ 808,220
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares	(55)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Performance Assumption Change, Weighted Average Grant Date Fair Value, Amount per Share	$ 108.32
Performance Shares [Member] \| Maximum Award Level [Domain]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding	1,300
Target Award Level [Domain] [Domain] \| Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares Outstanding	700

Share-Based Compensation Share-Based Compensation (Other Stock-Based Compensation Data) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	1,286	1,429	1,481
Weighted-average grant-date fair value of options granted	$ 10.89	$ 9.80	$ 8.25
Total intrinsic value of options exercised (a)	$ 275,745	$ 224,663	$ 327,860
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	9,838	15,506	$ 23,122
LiabilityAwards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
LiabilityAwardsNonvestedNumber	44,224	$ 54,710
LiabilityAwardsNonvestedBalanceSheetFairValue	$ 45,875
LiabilityAwardsNonvestedRemainingContractualTerm	1 year 1 month 6 days
Equity Instruments Other Than Options
LiabilityAwardsGranted	$ 16,112
Liability Awards Vested	(15,438)
LiabilityAwardsForfeituresExpirations	$ (9,465)
Share-based Compensation Arrangement by Share-Based Payment Award, Equity instruments other than options, Performance Assumption Adjustment, Shares	(1,695)
LiabilityAwardsExpectedtoVest,Outstanding,Number	$ 42,998
LiabilityAwardsExpectedtoVest,BalanceSheetFairValue	$ 44,557
LiabilityAwardsExpectedtoVest,RemainingContractualTerm	1 year 1 month 6 days
Restricted Stock Units (RSUs)
Equity Instruments Other Than Options
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	2,754	2,634	2,824
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 116.87	$ 108.75	$ 109.92
Total intrinsic value of converted units	$ 333,951	$ 260,287	$ 380,269
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	275,234	232,141	264,923
PepsiCo Equity Performance Unit [Domain]
Equity Instruments Other Than Options
Total intrinsic value of converted units	0	30,147	39,782
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value	0	$ 9,430	$ 18,833
Minimum Award Level [Domain] \| PEP_LiabilityAwardsPerformanceBased [Member]
Equity Instruments Other Than Options
LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding	0
Maximum \| PEP_LiabilityAwardsPerformanceBased [Member]
Equity Instruments Other Than Options
LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding	57,100
Target Award Level [Domain] [Domain] \| PEP_LiabilityAwardsPerformanceBased [Member]
Equity Instruments Other Than Options
LiabilityAwardsPerformanceAssumptionAdjustmentAwardsOutstanding	$ 28,500

Share-Based Compensation Share Based Compensation (PEP unit + BOD activity paragraphs) (Details) - $ / shares	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
Phantom Units Granted Under Director Deferral Program, Shares Outstanding	269,000	248,000
Performance Stock Unit [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	3 years
PepsiCo Equity Performance Unit [Domain]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period		278,000
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number			248,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value		$ 68.94

Pension, Retiree Medical and Savings Plans (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						4 Months Ended		12 Months Ended
	Sep. 07, 2019	Jun. 15, 2019	Mar. 23, 2019	Sep. 08, 2018	Jun. 16, 2018	Mar. 24, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 26, 2020	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Defined Benefit Plan Disclosure [Line Items]
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ (273)	$ 0
Average remaining service period of active plan participants, pension expense										10 years
Defined Benefit Plan, Average Remaining Service Period of Active Plan Participants, Retiree Medical Expense										8 years
Defined Benefit Plan, Average remaining life expectancy of Inactive Plan Participants, Pension Expense										23 years
Pension strategy investment term, years										5 years
Defined Contribution Plan, Cost										$ 197	$ 180	$ 176
Cost Savings Related to Reorganization of U.S. Pension Plans											42
Cost Savings Related to Reorganization of U.S. Pension Plans Net of Tax											$ 27
Cost Savings Related to Reorganization of U.S. Pension Plans Net of Tax, Earnings per Share											$ 0.02
Domestic Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets										7.10%	7.20%	7.50%
Domestic - Plan A [Member]
Defined Benefit Plan Disclosure [Line Items]
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax										$ (220)
Pre-tax non-cash settlement charge, after-tax										$ 170
Pre-tax non-cash settlement charge, net of tax, per share										$ 0.12
Domestic-Plan I [Member]
Defined Benefit Plan Disclosure [Line Items]
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax										$ (53)
Pre-tax non-cash settlement charge, after-tax										$ 41
Pre-tax non-cash settlement charge, net of tax, per share										$ 0.03
Defined benefit plans [Member]
Defined Benefit Plan Disclosure [Line Items]
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax										$ 273
Pre-tax non-cash settlement charge, after-tax										$ 211
Pre-tax non-cash settlement charge, net of tax, per share										$ 0.15
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets										6.60%	6.50%	7.50%
Forecast [Member] \| Domestic Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Expected return on plan assets									6.80%

Pension, Retiree Medical and Savings Plans (Selected Financial Information for Pension and Retiree Medical Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Pension Plans, Defined Benefit
Change in fair value of plan assets
Employer contributions/funding	$ 672	$ 1,615	$ 164
Retiree Medical Plan
Change in projected benefit liability
Liability at beginning of year	996	1,187
Service cost	23	32	28
Interest cost	36	34	36
Experience loss/(gain)	36	(147)
Special termination benefits		1
Other, including foreign currency adjustment	2	(3)
Liability at end of year	988	996	1,187
Defined Benefit Plan, Benefit Obligation, Benefits Paid	(105)	(108)
Change in fair value of plan assets
Fair value at beginning of year	285	321
Actual return on plan assets	78	(21)
Employer contributions/funding	44	93	56
Defined Benefit Plan, Plan Assets, Benefits Paid	(105)	(108)
Fair value at end of year	302	285	321
Funded status	(686)	(711)
Amounts recognized
Other current liabilities	(58)	(41)
Other liabilities	(628)	(670)
Net amount recognized	(686)	(711)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	(285)	(287)
Prior service cost/(credit)	(32)	(51)
Total	(317)	(338)
Changes recognized in net (gain)/loss included in other comprehensive loss
Net (gain)/loss arising in current year	(24)	(107)
Amortization and settlement recognition	27	8
Foreign currency translation loss/(gain)	(1)	1
Total	2	(98)
Domestic Plan [Member]
Change in projected benefit liability
Liability at beginning of year	13,807	14,777
Service cost	381	431	401
Interest cost	543	482	468
Plan amendments	15	83
Experience loss/(gain)	2,091	(972)
Settlement/curtailment	(1,268)	(74)
Special termination benefits	2	36
Liability at end of year	15,230	13,807	14,777
Defined Benefit Plan, Benefit Obligation, Benefits Paid	(341)	(956)
Change in fair value of plan assets
Fair value at beginning of year	12,258	12,582
Actual return on plan assets	3,101	(789)
Employer contributions/funding	550	1,495
Defined Benefit Plan, Plan Assets, Benefits Paid	(341)	(956)
Defined Benefit Plan, Plan Assets, Payment for Settlement	(1,266)	(74)
Fair value at end of year	14,302	12,258	12,582
Funded status	(928)	(1,549)
Amounts recognized
Other assets	744	185
Other current liabilities	(52)	(107)
Other liabilities	(1,620)	(1,627)
Net amount recognized	(928)	(1,549)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	3,516	4,093
Prior service cost/(credit)	114	109
Total	3,630	4,202
Changes recognized in net (gain)/loss included in other comprehensive loss
Net (gain)/loss arising in current year	(120)	760
Amortization and settlement recognition	(457)	(187)
Total	(577)	573
Accumulated benefit obligation at end of year	14,255	12,890
Foreign Plan [Member]
Change in projected benefit liability
Liability at beginning of year	3,098	3,490
Service cost	73	92	91
Interest cost	97	93	89
Plan amendments	1	2
Defined Benefit Plan, Benefit Obligation, Contributions by Plan Participant	2	2
Experience loss/(gain)	515	(230)
Settlement/curtailment	(31)	(35)
Special termination benefits		2
Other, including foreign currency adjustment	98	(204)
Liability at end of year	3,753	3,098	3,490
Defined Benefit Plan, Benefit Obligation, Benefits Paid	(100)	(114)
Change in fair value of plan assets
Fair value at beginning of year	3,090	3,460
Actual return on plan assets	551	(136)
Employer contributions/funding	122	120
Participant contributions	2	2
Defined Benefit Plan, Plan Assets, Benefits Paid	(100)	(114)
Defined Benefit Plan, Plan Assets, Payment for Settlement	(31)	(32)
Other, including foreign currency adjustment	98	(210)
Fair value at end of year	3,732	3,090	$ 3,460
Funded status	(21)	(8)
Amounts recognized
Other assets	99	81
Other current liabilities	(1)	(1)
Other liabilities	(119)	(88)
Net amount recognized	(21)	(8)
Amounts included in accumulated other comprehensive loss (pre-tax)
Net loss/(gain)	914	780
Prior service cost/(credit)		(1)
Total	914	779
Changes recognized in net (gain)/loss included in other comprehensive loss
Net (gain)/loss arising in current year	152	103
Amortization and settlement recognition	(44)	(56)
Foreign currency translation loss/(gain)	26	(49)
Total	134	(2)
Accumulated benefit obligation at end of year	$ 3,441	$ 2,806

Pension, Retiree Medical and Savings Plans (Components of Benefit Expense) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Domestic - Plan A [Member]
Defined Benefit Plan Disclosure [Line Items]
Settlement/curtailment losses (a)	$ 220
United States Pension Plan of US Entity, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Service cost	381	$ 431	$ 401
Interest cost	543	482	468
Expected return on plan assets	(892)	(943)	(849)
Amortization of prior service cost/(credits)	10	3	1
Amortization of net losses/(gains)	161	179	123
Settlement/curtailment losses (a)	296	8	8
Special termination benefits	1	36	60
Defined Benefit Plan, Other Cost (Credit)	119	(235)	(189)
Total	500	196	212
International
Defined Benefit Plan Disclosure [Line Items]
Service cost	73	92	91
Interest cost	97	93	89
Expected return on plan assets	(188)	(197)	(176)
Amortization of net losses/(gains)	32	45	53
Settlement/curtailment losses (a)	12	6	11
Special termination benefits		2
Defined Benefit Plan, Other Cost (Credit)	(47)	(51)	(23)
Total	26	41	68
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Service cost	23	32	28
Interest cost	36	34	36
Expected return on plan assets	(18)	(19)	(22)
Amortization of prior service cost/(credits)	(19)	(20)	(25)
Amortization of net losses/(gains)	(27)	(8)	(12)
Special termination benefits		1	2
Defined Benefit Plan, Other Cost (Credit)	(28)	(12)	(21)
Total	(5)	$ 20	$ 7
Domestic-Plan I [Member]
Defined Benefit Plan Disclosure [Line Items]
Settlement/curtailment losses (a)	$ 53

Pension, Retiree Medical and Savings Plans (Weighted-Average Assumptions to Determine Projected Benefit Liability and Benefit Expense for Pension and Retiree Medical Plans) (Details)	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
United States Pension Plan of US Entity, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Liability discount rate	3.30%	4.40%	3.70%
Service Cost Discount Rate	4.40%	3.80%	4.50%
Interest cost discount rate	4.10%	3.40%	3.70%
Expected return on plan assets	7.10%	7.20%	7.50%
Liability rate of salary increases	3.10%	3.10%	3.10%
Expense rate of salary increases	3.10%	3.10%	3.10%
International
Defined Benefit Plan Disclosure [Line Items]
Liability discount rate	2.50%	3.40%	3.00%
Service Cost Discount Rate	4.20%	3.50%	3.60%
Interest cost discount rate	3.20%	2.80%	2.80%
Expected return on plan assets	5.80%	6.00%	6.00%
Liability rate of salary increases	3.30%	3.70%	3.70%
Expense rate of salary increases	3.70%	3.70%	3.60%
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Liability discount rate	3.10%	4.20%	3.50%
Service Cost Discount Rate	4.30%	3.60%	4.00%
Interest cost discount rate	3.80%	3.00%	3.20%
Expected return on plan assets	6.60%	6.50%	7.50%

Pension, Retiree Medical and Savings Plans (Selected Information About Plans with Liability for Service to Date and Total Benefit Liability in Excess of Plan Assets) (Details) - USD ($) $ in Millions	Dec. 28, 2019	Dec. 29, 2018
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit, Unfunded plans	$ 847
Domestic Plan [Member]
Selected information for plans with accumulated benefit obligation in excess of plan assets
Liability for service to date	(9,194)	$ (8,040)
Fair value of plan assets	8,497	7,223
Selected information for plans with projected benefit liability in excess of plan assets
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation	(10,169)	(8,957)
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets	8,497	7,223
Foreign Plan [Member]
Selected information for plans with accumulated benefit obligation in excess of plan assets
Liability for service to date	(192)	(155)
Fair value of plan assets	151	121
Selected information for plans with projected benefit liability in excess of plan assets
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation	(632)	(514)
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets	512	426
Retiree Medical Plan
Selected information for plans with projected benefit liability in excess of plan assets
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Projected Benefit Obligation	(988)	(996)
Defined Benefit Plan, Pension Plan with Projected Benefit Obligation in Excess of Plan Assets, Plan Assets	$ 302	$ 285

Pension, Retiree Medical and Savings Plans (Estimated Future Benefit Payments) (Details) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 21, 2020	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Member-Plan A [Member]
Defined Benefit Plan Disclosure [Line Items]
Employer contributions/funding		$ 400	$ 1,400
Domestic Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Employer contributions/funding		550	1,495
Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Discretionary		417	1,417	$ 6
Non-discretionary		255	198	158
2020		945
2021		915
2022		900
2023		930
2024		970
2025-29		5,275
Employer contributions/funding		672	1,615	164
Retiree Medical Plan
Defined Benefit Plan Disclosure [Line Items]
Discretionary		0	37	0
Non-discretionary		44	56	56
2020		100
2021		95
2022		95
2023		90
2024		85
2025-29		355
Employer contributions/funding		44	$ 93	$ 56
Years 2025 Through 2029
Defined Benefit Plan Disclosure [Line Items]
Subsidies expected to be received under the 2003 Medicare Act		4
Maximum \| Years 2020 Through 2024
Defined Benefit Plan Disclosure [Line Items]
Subsidies expected to be received under the 2003 Medicare Act		$ 2
Forecast [Member] \| Pension Plans, Defined Benefit
Defined Benefit Plan Disclosure [Line Items]
Discretionary	$ 150
Non-discretionary	150
Forecast [Member] \| Retiree Medical Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Non-discretionary	$ 60

Debt Obligations and Commitments (Schedule of Long and Short-Term Debt Contractual Commitments) (Details) € in Millions, $ in Millions	Dec. 28, 2019 USD ($)	Dec. 28, 2019 EUR (€)	Dec. 29, 2018 USD ($)
Debt Instrument [Line Items]
Debt, Current	$ 2,920		$ 4,026
Notes due	2,200		7,700
Long-term Debt	31,996		32,248
Long-Term Debt Obligations	29,148		28,295
Debt Instrument, Unamortized Discount	$ 163		$ 119
Other Borrowings Short-term [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	6.40%	6.40%	6.00%
Other borrowings	$ 72		$ 73
Notes Due 2027 [Member] \| Zero Point Seven Five Percent Notes Due 2027
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.75%	0.75%
Debt Instrument, Face Amount \| €		€ 500
Notes Due 2026 [Member] \| Seven Point Two Nine Zero Percent Notes Due 2026 [Member]
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount			$ 11
Debt Instrument, Interest Rate, Stated Percentage			7.29%
Debt Instrument, Face Amount			$ 88
Notes Due 2026 [Member] \| Seven Point Four Four Zero Percent Notes Due 2026 [Member]
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount			$ 4
Debt Instrument, Interest Rate, Stated Percentage			7.44%
Debt Instrument, Face Amount			$ 21
Current Maturities Of Long Term Debt [Member]
Debt Instrument [Line Items]
Long-term Debt, Current Maturities	$ 2,848		3,953
Long-term Debt, Current Maturities	$ (2,848)		$ (3,953)
Notes Due 2031 [Member] \| One Point One Two Five Percent Notes Due 2031
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	1.125%	1.125%
Debt Instrument, Face Amount \| €		€ 500
Notes Due 2019 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	0.00%	0.00%	3.10%
Notes due	$ 0		$ 3,948
Notes Due 2020 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.70%	2.70%	3.90%
Notes due	$ 2,840		$ 3,784
Notes Due 2021 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.40%	2.40%	3.10%
Notes due	$ 3,276		$ 3,257
Notes Due 2022 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.70%	2.70%	2.80%
Notes due	$ 3,831		$ 3,802
Notes Due 2023 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	2.80%	2.80%	2.90%
Notes due	$ 1,272		$ 1,270
Notes Due 2024 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.40%	3.40%	3.20%
Notes due	$ 1,839		$ 1,816
Notes Due 2025 to 2049 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	3.30%	3.30%	3.70%
Notes due	$ 18,910		$ 14,345
Other Debt Instruments due 2019 to 2026 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Effective Percentage	1.30%	1.30%	1.30%
Other notes due	$ 28		$ 26
Less: Current Maturities Of Long Term Debt Obligations [Member]
Debt Instrument [Line Items]
Long-term Debt, Current Maturities	2,848		3,953
Long-term Debt, Current Maturities	$ (2,848)		(3,953)
Notes Due 2029 [Member] \| Seven Point Zero Percent Notes Due 2029 [Member]
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount			$ 357
Debt Instrument, Interest Rate, Stated Percentage			7.00%
Debt Instrument, Face Amount			$ 516
Notes Due 2029 [Member] \| Two Point Six Two Five Percent Notes Due 2029 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	2.625%	2.625%
Debt Instrument, Face Amount	$ 1,000
Notes Due 2035 [Member] \| Five Point Five Zero Percent Notes Due 2035 [Member]
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount			$ 138
Debt Instrument, Interest Rate, Stated Percentage			5.50%
Debt Instrument, Face Amount			$ 107
Notes Due 2040 [Member] \| Four Point Eight Seven Five Percent Notes Due 2040 [Member]
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount			$ 410
Debt Instrument, Interest Rate, Stated Percentage			4.875%
Notes Due 2040 [Member] \| Five Point Five Zero Percent Notes Due 2040 [Member]
Debt Instrument [Line Items]
Debt Instrument, Repurchased Face Amount			$ 408
Debt Instrument, Interest Rate, Stated Percentage			5.50%
Notes Due 2049 [Member] \| Three Point Three Seven Five Percent Notes Due 2049 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	3.375%	3.375%
Debt Instrument, Face Amount	$ 1,000
Notes Due 2049 [Member] \| Two Point Eight Seven Five Percent Notes Due 2049 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	2.875%	2.875%
Debt Instrument, Face Amount	$ 1,000
Notes due 2039 [Member] \| Zero Point Eight Seven Five Percent Notes Due 2039 [Member]
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	0.875%	0.875%
Debt Instrument, Face Amount \| €		€ 500

Debt Obligations and Commitments (Narrative) (Details) $ / shares in Units, R in Billions	3 Months Ended						4 Months Ended		12 Months Ended
	Sep. 07, 2019 USD ($)	Jun. 15, 2019 USD ($)	Mar. 23, 2019 USD ($)	Sep. 08, 2018 USD ($)	Jun. 16, 2018 USD ($)	Mar. 24, 2018 USD ($)	Dec. 28, 2019 USD ($)	Dec. 29, 2018 USD ($)	Dec. 28, 2019 USD ($)	Dec. 29, 2018 USD ($) $ / shares	Dec. 28, 2019 ZAR (R)
Debt Instrument [Line Items]
Line of Credit Facility, Average Outstanding Amount									$ 0
Line of Credit, Swing Line Subfacility							$ 750,000,000		750,000,000
Debt Instrument, Repurchase Amount								$ 1,600,000,000		$ 1,600,000,000
Gain (Loss) on Extinguishment of Debt	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	0	(253,000,000)		253,000,000
Extinguishment of Debt, Gain (Loss), Net of Tax										$ 191,000,000
Extinguishment of Debt, Gain (Loss), Per Share, Net of Tax \| $ / shares										$ 0.13
International Divisions
Debt Instrument [Line Items]
Line of Credit Facility, Amount Outstanding							$ 69,000,000		$ 69,000,000
Two Point Eight Seven Five Percent Notes Due 2049 [Member] \| Notes Due 2049 [Member]
Debt Instrument [Line Items]
Interest rate on debt							2.875%		2.875%		2.875%
Fixed and floating rate notes issued							$ 1,000,000,000		$ 1,000,000,000
Four Point Five Zero Percent Notes Due 2020 [Member] \| Note Due 2020 [Member]
Debt Instrument [Line Items]
Debt Instrument, Repurchase Amount							$ 1,000,000,000.0		$ 1,000,000,000.0
Interest rate on debt							4.50%		4.50%		4.50%
Debt Instrument, Repurchased Face Amount							$ 1,000,000,000.0		$ 1,000,000,000.0
364-Day Unsecured Revolving Credit Agreement [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity							3,750,000,000	3,750,000,000	3,750,000,000	$ 3,750,000,000
Line of Credit Facility, Maximum Borrowing Capacity							4,500,000,000		4,500,000,000
Five-year Unsecured Revolving Credit Agreement (Five-Year Credit Agreement Member) [Domain]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity							3,750,000,000	$ 3,750,000,000	3,750,000,000	$ 3,750,000,000
Line of Credit Facility, Maximum Borrowing Capacity							4,500,000,000		4,500,000,000
Pioneer Bridge Loan Facilities [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity							$ 1,800,000,000		1,800,000,000		R 25.0
Line of Credit Facility, Average Outstanding Amount									$ 0

Financial Instruments (Narrative) (Details) - USD ($)	12 Months Ended
Financial Instruments (Narrative) (Details) - USD ($)	Dec. 28, 2019	Dec. 30, 2017	Dec. 29, 2018
Derivatives, Fair Value [Line Items]
Deferred (Gain) Loss on Discontinuation of Fair Value Hedge	$ 49,000,000
Senior Notes	2,200,000,000		$ 7,700,000,000
Derivative, Net Liability Position, Aggregate Fair Value	415,000,000
Collateral Already Posted, Aggregate Fair Value	0
Other-than-temporary Impairment Loss, Debt Securities, Available-for-sale	0
Gain (Loss) on Sale of Equity Investments		$ 95,000,000
Gain (Loss) on Sale of Equity Investments, after tax		$ 85,000,000
Gain (Loss) on Sale of Equity Investments, net of tax, per share amount		$ 0.06
Debt instrument, fair value	34,000,000,000		$ 32,000,000,000
Expected reclassification of net gain/(losses) related to hedge from accumulated OCI into net income within the next 12 months	$ 47,000,000
Interest Rate Contracts
Derivatives, Fair Value [Line Items]
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate	9.00%		29.00%
Commodity Contracts
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	3 years
Derivative, Notional Amount	$ 1,100,000,000		$ 1,100,000,000
Foreign Exchange Contract
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	2 years
Derivative, Notional Amount	$ 1,900,000,000		2,000,000,000.0
Net Investment Hedging [Member]
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	2,500,000,000		900,000,000
Interest Rate Contracts
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	$ 5,000,000,000.0		$ 10,500,000,000
Cross Currency Interest Rate Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative, Higher Remaining Maturity Date	12 years

Financial Instruments (Fair Values of Financial Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 28, 2019	Dec. 29, 2018
Derivatives, Fair Value [Line Items]
Senior Notes	$ 2,200	$ 7,700
Short-term Investments	229	272
Total asset derivatives at fair value	41	55
Total liability derivatives at fair value	470	568
Total Financial Assets at Fair Value	287	3,931
Total Financial Liabilities at Fair Value	938	1,018
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease)	5
Derivatives Designated As Cash Flow Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Derivatives designated as hedging instruments, Assets, Total	9	44
Derivatives Designated As Cash Flow Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Derivatives designated as hedging instruments, Liabilities, Total	432	341
Derivatives Not Designated As Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Derivatives not designated as hedging instruments, Assets, Total	32	10
Derivatives Not Designated As Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Other Derivatives Not Designated as Hedging Instruments Liabilities at Fair Value	33	119
Fair Value, Inputs, Level 1 [Member] \| Derivatives Designated As Cash Flow Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Commodity contracts - other	2	0
Fair Value, Inputs, Level 1 [Member] \| Derivatives Designated As Cash Flow Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Commodity contracts - other	5	1
Fair Value, Inputs, Level 1 [Member] \| Derivatives Not Designated As Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Commodity contracts - other	23	2
Fair Value, Inputs, Level 1 [Member] \| Derivatives Not Designated As Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Commodity contracts - other	7	17
Fair Value, Inputs, Level 2 [Member] \| Derivatives Designated As Fair Value Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Interest rate derivatives	0	1
Fair Value, Inputs, Level 2 [Member] \| Derivatives Designated As Fair Value Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Interest rate derivatives	5	108
Fair Value, Inputs, Level 2 [Member] \| Derivatives Designated As Cash Flow Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Foreign Exchange Forward contracts	5	44
Interest rate derivatives	0	0
Commodity contracts - other	2	0
Fair Value, Inputs, Level 2 [Member] \| Derivatives Designated As Cash Flow Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Foreign Exchange Forward contracts	32	14
Interest rate derivatives	390	323
Commodity contracts - other	5	3
Fair Value, Inputs, Level 2 [Member] \| Derivatives Not Designated As Hedging Instruments Assets [Member]
Derivatives, Fair Value [Line Items]
Foreign Exchange Forward contracts	3	3
Commodity contracts - other	6	5
Fair Value, Inputs, Level 2 [Member] \| Derivatives Not Designated As Hedging Instruments Liabilities [Member]
Derivatives, Fair Value [Line Items]
Foreign Exchange Forward contracts	2	10
Commodity contracts - other	24	92
Fair Value, Inputs, Level 2 [Member] \| Assets [Member]
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-sale	0	3,658
Fair Value, Inputs, Level 2 [Member] \| Liability [Member]
Derivatives, Fair Value [Line Items]
Debt Securities, Available-for-sale	0	0
Fair Value, Inputs, Level 2 [Member] \| Assets [Member]
Derivatives, Fair Value [Line Items]
Prepaid Forward Asset Fair Value	17	22
Deferred compensation	0	0
Fair Value, Inputs, Level 2 [Member] \| Liability [Member]
Derivatives, Fair Value [Line Items]
Prepaid Forward Asset Fair Value	0	0
Deferred compensation	468	450
Assets [Member] \| Fair Value, Inputs, Level 1 [Member]
Derivatives, Fair Value [Line Items]
Short-term Investments	229	196
Liability [Member] \| Fair Value, Inputs, Level 1 [Member]
Derivatives, Fair Value [Line Items]
Short-term Investments	0	0
Commodity Contract [Member]
Derivatives, Fair Value [Line Items]
Derivative, Notional Amount	$ 1,100	$ 1,100

Financial Instruments (Effective Portion of Pre-Tax (Gains)/Losses on Derivative Instruments) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss	$ 131	$ 61	$ (130)
Fair Value/Non-Designated Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	(82)	179
Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss	101	(16)
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	14	111
Foreign Exchange Forward Contracts \| Fair Value/Non-Designated Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	(1)	9
Foreign Exchange Forward Contracts \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss	57	(52)
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	3	(8)
Interest Rate Contracts \| Fair Value/Non-Designated Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	(64)	53
Interest Rate Contracts \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss	67	110
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	7	119
Commodity Contracts \| Fair Value/Non-Designated Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	(17)	117
Commodity Contracts \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss	7	3
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	4	0
Net Investment Hedging [Member] \| Fair Value/Non-Designated Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Income Statement(a)	0	0
Net Investment Hedging [Member] \| Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Losses/(Gains) Recognized in Accumulated Other Comprehensive Loss	(30)	(77)
Losses/(Gains) Reclassified from Accumulated Other Comprehensive Loss into Income Statement(b)	$ 0	$ 0

Net Income Attributable to PepsiCo per Common Share (Basic and Diluted Net Income Attributable to PepsiCo per Common Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended						4 Months Ended		12 Months Ended
	Sep. 07, 2019	Jun. 15, 2019	Mar. 23, 2019	Sep. 08, 2018	Jun. 16, 2018	Mar. 24, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Earnings Per Share [Abstract]
Net income	$ 2,100	$ 2,035	$ 1,413	$ 2,498	$ 1,820	$ 1,343	$ 1,766	$ 6,854	$ 7,314	$ 12,515	$ 4,857
Redemption premium									0	(2)	(4)
Net income available for PepsiCo common shareholders - Value									$ 7,314	$ 12,513	$ 4,853
Net income available for PepsiCo common stockholders - Shares									1,399	1,415	1,425
Basic net income attributable to PepsiCo per common share	$ 1.50	$ 1.45	$ 1.01	$ 1.77	$ 1.28	$ 0.94	$ 1.27	$ 4.86	$ 5.23	$ 8.84	$ 3.40
Stock options and RSUs - Shares									8	10	12
Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units									$ 0	$ 0	$ 0
ESOP convertible preferred stock - Value									$ 0	$ 2	$ 4
ESOP convertible preferred stock - Shares									0	0	1
Diluted shares - Value									$ 7,314	$ 12,515	$ 4,857
Diluted shares - Shares									1,407	1,425	1,438
Diluted net income attributable to PepsiCo per common share	$ 1.49	$ 1.44	$ 1.00	$ 1.75	$ 1.28	$ 0.94	$ 1.26	$ 4.83	$ 5.20	$ 8.78	$ 3.38

Preferred Stock (Narrative) (Details) - USD ($) $ in Millions	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017	Dec. 31, 2016
Preferred Stock [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion		550,102
Common Stock, Shares, Issued	1,409,000,000	1,420,000,000
Preferred Stock
Preferred Stock [Line Items]
Preferred stock, authorized (in shares)			3,000,000
Preferred Stock, Shares Issued	0	0	803,953	800,000
Outstanding preferred shares, fair value			$ 68
Preferred shares, outstanding		0	114,753

Accumulated Other Comprehensive Loss Attributable to Pepsico (Schedule of Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017	Dec. 31, 2016
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Currency translation adjustment	$ (11,290)	$ (11,918)	$ (10,277)	$ (11,386)
Cash flow hedges, net of tax	(3)	87	47	83
Unamortized pension and retiree medical, net of tax (b)	(2,988)	(3,271)	(2,804)	(2,645)
Unrealized gain on securities, net of tax	0	2	(4)	64
Other	(19)	(19)	(19)	(35)
Accumulated other comprehensive loss attributable to PepsiCo	(14,300)	(15,119)	(13,057)	(13,919)
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss), before Reclassification and Tax	636	(1,664)	1,049
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax	636	(1,620)	1,049
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, before Tax	(117)	50	(41)
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, before Tax	379	(595)	(217)
Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, before Tax	(2)	6	(74)
Other Comprehensive Income, Other, Before Tax	0	0	0
Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent	896	(2,159)	717
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax	(131)	(61)	130
Other Comprehensive (Income) Loss, Defined Benefit Plan, before Reclassification Adjustment and Tax	(89)	(813)	(375)
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, before Tax	(2)	6	25
Other Comprehensive Income (Loss), before Reclassifications, before Tax	0	0	0
OCI, before Reclassifications, before Tax, Attributable to Parent	414	(2,532)	829
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Reclassification Adjustment from AOCI, Realized upon Sale or Liquidation, before Tax	0	44	0
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax	14	111	(171)
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax	468	218	158
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax	0	0	(99)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax	0	0	0
Reclassification from AOCI, Current Period, before Tax, Attributable to Parent	482	373	(112)
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax	(8)	(21)	60
Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax	27	(10)	5
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax	(96)	128	58
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, Tax	0	0	6
Other Comprehensive Income, Other, Taxes	0	0	16
Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent	(77)	97	145
Net of taxes decrease to opening balance of accumulated other comprehensive loss attributable to Pepsico	$ 1,370	$ 1,466	$ 1,338	$ 1,280

Accumulated Other Comprehensive Loss Attributable to Pepsico Reclassification of Accumulated Other Comprehensive Loss to the Condensed Consolidated Statement of Income (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017	Dec. 31, 2016
Reclassification Adjustment out of Accumulated Other Comprehensive Income on Derivatives [Line Items]
Proceeds from Divestiture of Businesses	$ 0	$ 44	$ 0
Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Post retirement Plans Taxes	1,370	1,466	1,338	$ 1,280
Other Comprehensive (Income) Loss, Defined Benefit Plan, Prior Service Cost (Credit), Reclassification Adjustment from AOCI, before Tax	(9)	(17)	(24)
Amortization and settlement of (losses)/gains	169	216	167
Other Comprehensive Income (Loss), Defined Benefit Plan, Settlement and Curtailment Gain (Loss), before Tax	308	19	15
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, before Tax	468	218	158
Other Comprehensive (Income) Loss, Defined Benefit Plan, Reclassification Adjustment from AOCI, Tax	(102)	(45)	(44)
Remeasurement of net liabilities and translation	366	173	114
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Reclassification of net losses to net income, pre-tax amount	14	111	(171)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax	(2)	(27)	64
Net derivative losses	12	84	(107)
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax	378	301	(82)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, before Tax	0	0	(99)
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax	0	0	10
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax	0	0	(89)
Cash Flow Hedges
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	14	111
Foreign Exchange Forward Contracts \| Cash Flow Hedges
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	3	(8)
Foreign Exchange Forward Contracts \| Revenue Benchmark [Member] \| Cash Flow Hedges
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	1	(1)	0
Foreign Exchange Forward Contracts \| Cost of sales \| Cash Flow Hedges
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	2	(7)	10
Interest Rate Contracts \| Cash Flow Hedges
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	7	119
Interest Rate Contracts \| Interest Expense \| Cash Flow Hedges
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	7	119	(184)
Commodity Contracts \| Cash Flow Hedges
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	4	0
Commodity Contracts \| Cost of sales \| Cash Flow Hedges
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	3	3	4
Commodity Contracts \| Selling, general and administrative expenses \| Cash Flow Hedges
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Derivatives Qualifying as Hedges, Net of Tax [Abstract]
Derivative Instruments, Gain (Loss) Reclassified from Accumulated OCI into Income, Effective Portion, Net	$ 1	$ (3)	$ (1)

Leases (Details) - USD ($) $ in Millions	12 Months Ended
Leases (Details) - USD ($) $ in Millions	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Lessee, Lease, Description [Line Items]
Operating Leases, Rent Expense		$ 771	$ 742
Lessee, Operating Lease, Option to Extend	five years
Lessee, Operating Lease, Option to Terminate	one year
Operating Lease, Cost	$ 474
Variable Lease, Cost	101
Short-term Lease, Cost	379
lessee, operating lease, amortization amount included in operating lease cost	412
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability	479
Operating Lease, Payments	478
Operating Lease, Right-of-Use Asset	1,548	0
Operating Lease, Liability, Current	442	0
Operating Lease, Liability, Noncurrent	1,118
Operating Lease, Liability	$ 1,560
Operating Lease, Weighted Average Discount Rate, Percent	4.00%
Operating Lease, Weighted Average Remaining Lease Term	6 years
Lessee, Operating Lease, Liability, Payments, Due Next Twelve Months	$ 501
Lessee, Operating Lease, Liability, Payments, Due Year Two	374
Lessee, Operating Lease, Liability, Payments, Due Year Three	280
Lessee, Operating Lease, Liability, Payments, Due Year Four	183
Lessee, Operating Lease, Liability, Payments, Due Year Five	117
Lessee, Operating Lease, Liability, Payments, Due after Year Five	308
Lessee, Operating Lease, Liability, Payments, Due	1,763
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	203
Operating Leases, Future Minimum Payments Due, Next Twelve Months		459
Operating Leases, Future Minimum Payments, Due in Two Years		406
Operating Leases, Future Minimum Payments, Due in Three Years		294
Operating Leases, Future Minimum Payments, Due in Four Years		210
Operating Leases, Future Minimum Payments, Due in Five Years		161
Operating Leases, Future Minimum Payments, Due Thereafter		310
Operating Leases, Future Minimum Payments Due		$ 1,840
Sale and Leaseback Transaction, Gain (Loss), Net	$ 77
Maximum
Lessee, Lease, Description [Line Items]
Lessee, Operating Lease, Term of Contract	20 years

Acquisitions & Divestitures (Details) $ / shares in Units, $ in Millions	3 Months Ended						4 Months Ended		12 Months Ended
	Sep. 07, 2019 USD ($)	Jun. 15, 2019 USD ($)	Mar. 23, 2019 USD ($)	Sep. 08, 2018 USD ($)	Jun. 16, 2018 USD ($)	Mar. 24, 2018 USD ($)	Dec. 28, 2019 USD ($)	Dec. 29, 2018 USD ($) $ / shares	Dec. 28, 2019 USD ($) $ / shares	Dec. 29, 2018 USD ($) $ / shares	Dec. 30, 2017 USD ($) $ / shares	Dec. 28, 2019 R / shares
Acquisitions & Divestitures [Line Items]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory								$ 176		$ 176
Enterprise value of future acquisition							$ 1,700		$ 1,700
Business Acquisition, Share Price \| (per share)								$ 144.00		$ 144.00		R 110.00
Business Combination, Consideration Transferred										$ 3,343
Acquisition of SodaStream, net of cash and cash equivalents acquired										3,200
Inventory fair value adjustments and merger and integration costs	$ 7	$ 24	$ 15	$ 0	$ 0	$ 0	9	$ 75	55	75
Gain (Loss) on Disposition of Business	$ 0	$ 0	$ 0	$ 0	$ 144	$ 0	$ 0	58
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment								193		193
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles								284		284
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets								1,840		$ 1,840
Business Combination, Integration Related Costs, after-tax									$ 47
Business Combination, Integration-related charges, per share amounts \| $ / shares									$ 0.03	$ 0.05
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets and Liabilities								210		$ 210
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Deferred Income Taxes								(303)		(303)
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Total Identifiable Net Assets								2,400		2,400
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Goodwill								$ 943		943
Asia Pacific, Australia and New Zealand, and China Region [Member]
Acquisitions & Divestitures [Line Items]
Gain (Loss) on Disposition of Business										144
Gain (Loss) on Sale of Subsidiary, net of tax										$ 126
Gain (loss) on sale of subsidiary, net of tax, per share \| $ / shares										$ 0.09
Africa, Middle East and South Asia [Member]
Acquisitions & Divestitures [Line Items]
Inventory fair value adjustments and merger and integration costs									$ 7
Gain (Loss) on Disposition of Business											$ 140
Gain (Loss) on Sale of Subsidiary, net of tax											$ 107
Gain (loss) on sale of subsidiary, net of tax, per share \| $ / shares											$ 0.07
Europe [Member]
Acquisitions & Divestitures [Line Items]
Inventory fair value adjustments and merger and integration costs									46	$ 57
Gain (Loss) on Disposition of Business										58
Gain (Loss) on Sale of Subsidiary, net of tax										$ 46
Gain (loss) on sale of subsidiary, net of tax, per share \| $ / shares										$ 0.03
Corporate
Acquisitions & Divestitures [Line Items]
Inventory fair value adjustments and merger and integration costs									$ 2	$ 18

Supplemental Financial Information (Schedule of Supplemental Balance Sheet Information) (Details) - USD ($)	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Supplemental Financial Information [Abstract]
Inventory, LIFO Reserve	$ 0.07	$ 0.05
Accounts and notes receivable
Trade receivables	6,447,000,000	6,079,000,000
Other receivables	1,480,000,000	1,164,000,000
Total receivables	7,927,000,000	7,243,000,000
Analysis of valuation allowances
Allowance, beginning of year	101,000,000	129,000,000	$ 134,000,000
Net amounts charged to expense	22,000,000	16,000,000	26,000,000
Deductions	(30,000,000)	(33,000,000)	(35,000,000)
Other	12,000,000	(11,000,000)	4,000,000
Allowance, end of year	105,000,000	101,000,000	$ 129,000,000
Net receivables	7,822,000,000	7,142,000,000
Inventories (c)
Raw materials	1,395,000,000	1,312,000,000
Work-in-process	200,000,000	178,000,000
Finished goods	1,743,000,000	1,638,000,000
Inventories	3,338,000,000	3,128,000,000
Other assets
Other Assets	3,011,000,000	760,000,000
Noncurrent notes and accounts receivable	85,000,000	86,000,000
Deferred marketplace spending	147,000,000	112,000,000
Prepaid Expense and Other Assets, Noncurrent	846,000,000	269,000,000
Operating Lease, Right-of-Use Asset	1,548,000,000	0
Other	385,000,000	293,000,000
Accounts payable and other current liabilities
Accounts payable	8,013,000,000	7,213,000,000
Accrued marketplace spending	2,765,000,000	2,541,000,000
Accrued compensation and benefits	1,835,000,000	1,755,000,000
Dividends payable	1,351,000,000	1,329,000,000
Business Combination, Contingent Consideration, Liability	58,000,000	1,997,000,000
Operating Lease, Liability, Current	442,000,000	0
Other current liabilities	3,077,000,000	3,277,000,000
Accounts payable and other current liabilities	$ 17,541,000,000	$ 18,112,000,000

Supplemental Financial Information (Schedule of Other Supplemental Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017	Dec. 31, 2016
Supplemental Financial Information [Abstract]
Tax payments related to the TCJ Act	$ 423	$ 115	$ 0
Cash and cash equivalents	5,509	8,721
Operating Leases, Future Minimum Payments Due, Next Twelve Months		459
Rent expense		771	742
Interest paid	1,076	1,388	1,123
Income taxes paid, net of refunds	2,226	1,203	1,962
Operating Leases, Future Minimum Payments, Due in Two Years		406
Operating Leases, Future Minimum Payments, Due in Three Years		294
Operating Leases, Future Minimum Payments, Due in Four Years		210
Operating Leases, Future Minimum Payments, Due in Five Years		161
Operating Leases, Future Minimum Payments Due		1,840
Restricted Cash, Current	0	1,997
Restricted Cash, Noncurrent	61	51
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$ 5,570	$ 10,769	$ 10,657	$ 9,169

Selected Quarterly Financial Data (Unaudited) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended						4 Months Ended			12 Months Ended
	Sep. 07, 2019	Jun. 15, 2019	Mar. 23, 2019	Sep. 08, 2018	Jun. 16, 2018	Mar. 24, 2018	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017	Dec. 28, 2019	Dec. 29, 2018	Dec. 30, 2017
Selected Quarterly Financial Data [Line Items]
Net Revenue	$ 17,188	$ 16,449	$ 12,884	$ 16,485	$ 16,090	$ 12,562	$ 20,640	$ 19,524		$ 67,161	$ 64,661	$ 63,525
Gross Profit	9,494	9,045	7,196	8,958	8,827	6,907	11,294	10,588		37,029	35,280	34,729
Operating Profit	2,855	2,729	2,008	2,844	3,028	1,807	2,699	2,431		10,291	10,110	10,276
Mark-to-market net impact	(4)	(6)	60	(29)	3	(31)	62	(106)
Restructuring and impairment charges	(98)	(158)	(26)	(35)	(32)	(12)	(88)	(229)		(373)	(316)	(311)
Inventory fair value adjustments and merger and integration costs	(7)	(24)	(15)	0	0	0	(9)	(75)		(55)	(75)
Pension-related settlement charge	0	0	0	0	0	0	273	0
Tax Cuts and Jobs Act, Income Tax Expense (Benefit)	0	0	29	(76)	(777)	(1)	(21)	882	$ (2,500)	8	28
Gains on sale of assets	0	32	0	37	9	18	45	12
Other net tax benefits	0	0	0	364	314	0	0	4,386
Charges related to cash tender and exchange offers	0	0	0	0	0	0	0	(253)			253
Tax reform bonus	0	0	0	0	0	(87)	0	0
Gains on beverage refranchising	0	0	0	0	144	0	0	58
Provision for/(benefit from) income taxes	559	524	446	188	1,070	304	430	(4,932)		1,959	(3,370)	4,694
Net Income Attributable to PepsiCo	$ 2,100	$ 2,035	$ 1,413	$ 2,498	$ 1,820	$ 1,343	$ 1,766	$ 6,854		$ 7,314	$ 12,515	$ 4,857
Basic net income attributable to PepsiCo per common share	$ 1.50	$ 1.45	$ 1.01	$ 1.77	$ 1.28	$ 0.94	$ 1.27	$ 4.86		$ 5.23	$ 8.84	$ 3.40
Diluted net income attributable to PepsiCo per common share	1.49	1.44	1.00	1.75	1.28	0.94	1.26	4.83		5.20	8.78	3.38
Common Stock, Dividends, Per Share, Declared	$ 0.955	$ 0.955	$ 0.9275	$ 0.9275	$ 0.9275	$ 0.805	$ 0.955	$ 0.9275		$ 3.7925	$ 3.5875	$ 3.1675
International reorganization DTA											$ 4,300
Federal and International Audit Settlements											717
Europe [Member]
Selected Quarterly Financial Data [Line Items]
Net Revenue										$ 11,728	10,973	$ 10,522
Operating Profit										1,327	1,256	1,199
Inventory fair value adjustments and merger and integration costs										(46)	(57)
Gains on beverage refranchising											58
Asia Pacific, Australia and New Zealand, and China Region [Member]
Selected Quarterly Financial Data [Line Items]
Net Revenue										2,919	2,794	2,884
Operating Profit										477	619	401
Gains on beverage refranchising											144
Africa, Middle East and South Asia [Member]
Selected Quarterly Financial Data [Line Items]
Net Revenue										3,651	3,657	3,674
Operating Profit										671	661	789
Inventory fair value adjustments and merger and integration costs										(7)
Gains on sale of assets											12
Gains on beverage refranchising												140
Frito Lay North America [Member]
Selected Quarterly Financial Data [Line Items]
Net Revenue										17,078	16,346	15,798
Operating Profit										5,258	5,008	4,793
Gains on sale of assets										31
Tax reform bonus											(44)
Quaker Foods North America [Member]
Selected Quarterly Financial Data [Line Items]
Net Revenue										2,482	2,465	2,503
Operating Profit										544	637	640
Tax reform bonus											(2)
PepsiCo Beverages North America [Member]
Selected Quarterly Financial Data [Line Items]
Net Revenue										21,730	21,072	20,936
Operating Profit										2,179	2,276	$ 2,700
Gains on sale of assets										46	64
Tax reform bonus											$ (41)
Domestic - Plan A [Member]
Selected Quarterly Financial Data [Line Items]
Pension-related settlement charge										220
Domestic-Plan I [Member]
Selected Quarterly Financial Data [Line Items]
Pension-related settlement charge										$ 53

Preferred Stock	12 Months Ended
Preferred Stock	Dec. 28, 2019
Equity [Abstract]
Preferred Stock	Preferred Stock In connection with our merger with The Quaker Oats Company (Quaker) in 2001, shares of our convertible preferred stock were authorized and issued to an ESOP fund established by Quaker. Quaker made the final award to its ESOP in June 2001. In 2018, all of the outstanding shares of our convertible preferred stock were converted into an aggregate of 550,102 shares of our common stock. As a result, there are no shares of our convertible preferred stock outstanding as of December 29, 2018 and our convertible preferred stock is retired for accounting purposes. As of December 30, 2017, there were 3 million shares of convertible preferred stock authorized, 803,953 preferred shares issued and 114,753 shares outstanding. The outstanding preferred shares had a fair value of $68 million as of December 30, 2017. Activities of our preferred stock are included in the equity statement.

Financial Instruments Financial Instruments (Policies)	12 Months Ended
Financial Instruments Financial Instruments (Policies)	Dec. 28, 2019
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivatives, Policy	Our hedging strategies include the use of derivatives and, in the case of our net investment hedges, debt instruments. Certain derivatives are designated as either cash flow or fair value hedges and qualify for hedge accounting treatment, while others do not qualify and are marked to market through earnings. The accounting for qualifying hedges allows changes in a hedging instrument’s fair value to offset corresponding changes in the hedged item in the same reporting period that the hedged item impacts earnings. Gains or losses on derivatives designated as cash flow hedges are recorded in accumulated other comprehensive loss and reclassified to our income statement when the hedged transaction affects earnings. If it becomes probable that the hedged transaction will not occur, we immediately recognize the related hedging gains or losses in earnings; such gains or losses reclassified during the year ended December 28, 2019 were not material. Cash flows from derivatives used to manage commodity price, foreign exchange or interest rate risks are classified as operating activities in the cash flow statement. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item. We do not use derivative instruments for trading or speculative purposes. We perform assessments of our counterparty credit risk regularly, including reviewing netting agreements, if any, and a review of credit ratings, credit default swap rates and potential nonperformance of the counterparty. Based on our most recent assessment of our counterparty credit risk, we consider this risk to be low. In addition, we enter into derivative contracts with a variety of financial institutions that we believe are creditworthy in order to reduce our concentration of credit risk.

Basis of Presentation and Our Divisions (Narrative) (Details)	12 Months Ended
	Dec. 28, 2019 segment country
Basis Of Presentation And Our Divisions [Line Items]
Number of Reportable Segments \| segment	7
Manufacture and sell in (number of countries) \| country	200
Maximum
Basis Of Presentation And Our Divisions [Line Items]
Noncontrolling Interest, Ownership Percentage by Parent	50.00%

Our Significant Accounting Policies (Concentration of Credit Risk) (Details)	12 Months Ended
	Dec. 28, 2019
Customer Concentration Risk \| Wal-Mart \| Revenue, Net
Concentration Risk [Line Items]
Concentration risk, percentage	13.00%

Pension, Retiree Medical and Savings Plans Pension, Retiree Medical and Savings Plans (Target Asset Allocations) (Details)	Dec. 26, 2020	Dec. 28, 2019
Fixed Income
Target Asset Allocation [Line Items]
Target investment allocation percentage		47.00%
U.S. Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage		29.00%
International Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage		20.00%
Real Estate Funds [Member]
Target Asset Allocation [Line Items]
Target investment allocation percentage		4.00%
Forecast [Member] \| Fixed Income
Target Asset Allocation [Line Items]
Target investment allocation percentage	50.00%
Forecast [Member] \| U.S. Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage	25.00%
Forecast [Member] \| International Equity
Target Asset Allocation [Line Items]
Target investment allocation percentage	21.00%
Forecast [Member] \| Real Estate Funds [Member]
Target Asset Allocation [Line Items]
Target investment allocation percentage	4.00%

Consolidated Balance Sheet (Parenthetical) - $ / shares shares in Millions	Dec. 28, 2019	Dec. 29, 2018
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.0167	$ 0.0167
Common stock, authorized	3,600	3,600
Common stock, issued	1,409	1,420
Repurchased common stock, shares	458	446

Income Taxes Income Taxes (Policies)	12 Months Ended
Income Taxes Income Taxes (Policies)	Dec. 28, 2019
Income Tax Disclosure [Abstract]
Income Tax, Policy	Our annual tax rate is based on our income, statutory tax rates and tax planning strategies and transactions, including transfer pricing arrangements, available to us in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax rate and in evaluating our tax positions. We establish reserves when, despite our belief that our tax return positions are fully supportable, we believe that certain positions are subject to challenge and that we likely will not succeed. We adjust these reserves, as well as the related interest, in light of changing facts and circumstances, such as the progress of a tax audit, new tax laws or tax authority settlements. Settlement of any particular issue would usually require the use of cash. Favorable resolution would be recognized as a reduction to our annual tax rate in the year of resolution.

Share-Based Compensation Share-Based Compensation (Policies)	12 Months Ended
	Dec. 28, 2019
Share-based Payment Arrangement [Abstract]
Share-based Payment Arrangement	The fair value of share-based award grants is amortized to expense over the vesting period, primarily three years. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no longer required to provide service to earn the award. In addition, we use historical data to estimate forfeiture rates and record share-based compensation expense only for those awards that are expected to vest. We do not backdate, reprice or grant share-based compensation awards retroactively. Repricing of awards would require shareholder approval under the LTIP.

Pension, Retiree Medical and Savings Plans Retiree Medical Cost Trend Rates (Details)	12 Months Ended
	Dec. 26, 2020	Dec. 28, 2019
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year		6.00%
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate		5.00%
Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate		2039
Forecast [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Defined Benefit Plan, Health Care Cost Trend Rate Assumed, Next Fiscal Year	6.00%
Defined Benefit Plan, Ultimate Health Care Cost Trend Rate	5.00%
Defined Benefit Plan, Year Health Care Cost Trend Rate Reaches Ultimate Trend Rate	2039